Clinical Application: Weight Management for Better Living

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Learn about the latest advancements in the clinical application of weight management to support your healthy living journey.

Abstract

Obesity is a chronic, relapsing, and multifactorial disease with profound metabolic, psychosocial, and biomechanical consequences. In this educational post, I, Dr. Alex Jimenez, will guide you through the latest findings in obesity pharmacology from leading researchers. We will explore the complex neuroendocrine and environmental factors that contribute to obesity, the critical need to combat weight bias in healthcare, and the current evidence-based treatment strategies. I will detail the mechanisms, indications, and contraindications of various anti-obesity medications, from sympathomimetics to groundbreaking agents like GLP-1 receptor agonists. I will also present clinical case studies to illustrate how to individualize these treatments based on a patient’s unique health profile. A central theme of our integrative practice model at Injury Medical Clinic is the integration of advanced pharmacology, chiropractic care, functional medicine, and personalized lifestyle modifications. I will discuss how our collaborative practice, where I work alongside our Medical Director, Dr. Maria Guadalupe Cardenas, MD, leads to more sustainable and impactful health outcomes for our patients on their journey to better health.

Meet Our Integrative Care Team

Hello, I am Dr. Alex Jimenez. My credentials include DC (Doctor of Chiropractic), APRN (Advanced Practice Registered Nurse), FNP-BC (Family Nurse Practitioner-Board Certified), CFMP (Certified Functional Medicine Practitioner), IFMCP (Institute for Functional Medicine Certified Practitioner), ATN (Advanced Traditional Naturopath), and CCST (Chiropractic Certificate in Spinal Trauma). My life’s passion has been dedicated to understanding and treating chronic conditions, with a special focus on the complexities of obesity and its related complications.

At our practice, Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we believe in a multidisciplinary, integrative approach to patient care. I am proud to work alongside Dr. Maria Guadalupe Cardenas, MD, who serves as our Medical Director and Collaborative Physician. Dr. Cardenas is Board Certified in Internal Medicine and brings over 40 years of invaluable experience as an internist to our team. Her NPI is #1164426749, and her Texas MD License is #J2933.

This collaborative model between a Doctor of Chiropractic (DC) and a Medical Doctor (MD) is a cornerstone of modern integrative and injury care. It allows us to safely and effectively blend my expertise in chiropractic care, rehabilitation, and functional medicine with Dr. Cardenas’s deep knowledge of internal medicine. Together, we provide a comprehensive suite of services that includes:

Medical Oversight: Cardenas provides essential medical direction, ensuring that all treatments, including pharmacological interventions, are safe, appropriate, and managed in accordance with the highest medical standards.
Chiropractic Care: We address the biomechanical consequences of obesity, such as osteoarthritis and back pain, through spinal adjustments, mobilization techniques, and rehabilitative exercises.
Functional Medicine: We investigate the root causes of disease, considering genetics, environment, and lifestyle to develop personalized health strategies.
Pharmacological Management: We use the latest evidence-based medications to treat conditions such as obesity, diabetes, and hypertension.
Personal Injury Care: Our team is equipped to manage and rehabilitate injuries, which are often complicated by pre-existing conditions like obesity.
Nutritional and Lifestyle Counseling: We guide patients toward sustainable changes in diet, physical activity, and behavior.

This integrated system ensures that our patients receive truly holistic care that addresses their health from every angle.

Understanding Obesity as a Chronic Disease

It’s essential to begin by framing obesity correctly. We now understand that obesity is a chronic, progressive, relapsing, and treatable disease. The idea that it’s a simple matter of willpower is outdated and harmful. When a patient stops their anti-obesity medication and the weight returns, it’s not a failure; it’s a relapse of a chronic condition, much like hypertension or high cholesterol would return if medication were stopped.

Obesity is profoundly multifactorial, involving a complex interplay of:

Neurobehavioral Components: Habits, emotional eating, and psychological factors.
Neuroendocrine Components: A sophisticated network of hormones that regulate appetite and metabolism.
Metabolic Components: The way the body processes and stores energy.

An increase in abnormal body fat, or adipose tissue dysfunction, is a hallmark of the disease. This dysfunctional fat mass doesn’t just sit there; it actively promotes inflammation and contributes to a wide range of adverse health consequences, from metabolic issues like diabetes to biomechanical problems like osteoarthritis and incontinence. In the United States, the statistics are staggering: 41.9% of adults are classified as obese (BMI ≥ 30), and 9.2% have severe obesity (BMI ≥ 40).

The Social and Environmental Roots of Obesity

When we discuss the causes of obesity, we must look beyond the individual to the broader context. I often refer to these factors as the “social determinants of obesity”.

Economic Stability: Decades ago, poverty was often associated with being underweight. Today, the opposite is often true. Calorie-dense, nutrient-poor foods are inexpensive and widely available, while access to high-quality, fresh food can be limited in impoverished areas.
Education and Healthcare Access: A lack of nutrition education and limited access to quality healthcare create significant barriers to weight management.
Neighborhood and Built Environment: If a person’s neighborhood is unsafe for walking or lacks green spaces, it severely limits opportunities for physical activity.
Social and Community Context: Cultural perceptions of body weight and community norms can influence individual behaviors and health choices.

Beyond social factors, there’s a growing body of research on the environmental and genetic drivers of obesity. We’re identifying key hormonal players like ghrelin (the “hunger hormone”), leptin (the “satiety hormone”), and GLP-1 (a gut hormone that signals fullness). Furthermore, groundbreaking research into the gut microbiota is revealing how the balance of bacteria in our digestive system can influence weight and metabolism. Our modern, technology-driven, and often sedentary lifestyle only compounds these issues on a global scale.

The Critical Importance of Overcoming Weight Bias

For many years, the medical community debated whether obesity was a disease. Today, nearly every major medical organization, including the American Medical Association, recognizes it as such. This recognition is crucial, yet significant barriers remain: clinical inertia and weight bias.

Consider this shocking statistic: of the nearly 100 million people with obesity in the U.S., less than 1% receive a prescription for an anti-obesity medication, and less than 300,000 undergo bariatric surgery, despite 9.2% of the population having severe obesity. Why? The primary driver is weight bias.

Weight bias is the prejudice and discrimination directed at individuals because of their weight. It stems from the false belief that obesity is a simple failure of willpower. This bias is not just a social issue; it has deadly consequences. Research shows that the experience of weight bias increases complications and mortality independent of a person’s BMI. Our own biases prevent us from providing the care our patients deserve. In fact, studies from Harvard’s implicit bias project show that while biases against race, gender, and sexual orientation are decreasing, weight bias is the only form of bias that is increasing.

It is truly the last socially acceptable form of discrimination, and we, as healthcare providers, must confront it. Think about these provocative comparisons:

We would never tell a patient with schizophrenia to “just stop hearing voices,” yet we often tell patients with obesity to “just eat less and move more.” Both involve complex neurochemical processes that cannot be willed away.
We don’t require patients undergoing coronary artery bypass surgery to have a psychological screening. Yet, it has been standard practice for bariatric surgery patients, reinforcing the myth that obesity is purely a behavioral problem.

A Patient-Centered Approach to Obesity Care

So, how do we begin to change this? It starts with us, in our clinics. We must create a safe, non-judgmental space for our patients. I use frameworks like the””5 A’s” to guide these conversations:

Ask: “Is it okay if we talk about your weight and how it might be affecting your health?”
Assess: “Can you tell me about your weight history, what you’ve tried in the past, and what you understand about the effects of weight on health?”
Advise: “Even a small weight loss of 3-5% can lead to significant health improvements. Let’s discuss some options.”
Agree: “What are your goals? What feels achievable for you right now? Let’s work together to create a plan.”
Assist and Arrange: “Would you like me to connect you with resources for behavioral therapy, exercise programs, or discuss medication options?”

For anyone with a BMI of 25 or more, especially with comorbidities like high blood pressure or pre-diabetes, we should be initiating conversations about lifestyle interventions. Our goal is a realistic 5-10% weight reduction over six months. This may not seem like a lot, but it can produce dramatic improvements in health markers.

Understanding Complex Eating Behaviors: Binge Eating Disorder

Before diving into treatments, it’s essential to understand some of the underlying behaviors that can contribute to obesity. One significant condition is Binge Eating Disorder (BED). From my clinical experience, particularly from my time working in bariatric surgery, a majority of patients described symptoms that align with this diagnosis.

BED is characterized by:

Eating an amount of food in a discrete period that is definitively larger than what most people would consume in a similar timeframe.
A profound sense of a lack of control over eating during the episode.

This is not a one-time occurrence but a pattern that occurs at least weekly for at least three months. It is also associated with marked distress and at least three of the following behaviors:

Eating much more rapidly than normal.
Eating until feeling uncomfortably full.
Consuming large amounts of food even when not physically hungry.
Eating alone due to embarrassment over the quantity of food being eaten.
Experiencing feelings of disgust, depression, or intense guilt after an episode.

It’s crucial to distinguish BED from other behaviors; it is not associated with the compensatory actions seen in bulimia, such as vomiting. Recognizing and diagnosing BED is a critical step, as it opens the door to targeted and effective treatments.

Pharmacotherapy: First, Do No Harm

Before we add medications to treat obesity, we must first review what our patients are already taking. Shockingly, patients with obesity are more likely to be prescribed obesogenic medications—drugs that cause weight gain. This can happen through appetite dysregulation or other physiological mechanisms we don’t fully understand.

Key classes of medications to watch for include:

Antidepressants and Antipsychotics
Mood Stabilizers and Anticonvulsants
Antidiabetic Agents (e.g., sulfonylureas, insulin)
Hormonal Contraceptives
Corticosteroids

As an integrated team, we look at the whole person. If a patient with diabetes and obesity is on a sulfonylurea, which is known to cause weight gain, Dr. Cardenas and I might discuss switching them to a weight-neutral or weight-loss-promoting agent like a GLP-1 receptor agonist or an SGLT2 inhibitor. It’s about optimizing their entire medication regimen for better overall health, not just treating conditions in isolation.

An Overview of Anti-Obesity Medications

When lifestyle changes alone are not enough, pharmacotherapy can be a powerful tool. All approved weight-loss medications work better than placebo, which suggests they are worth trying. We generally categorize them into short-term and long-term options.

Short-Term Medications

These are primarily sympathomimetic agents that suppress appetite.

Phentermine: This is the most commonly prescribed short-term medication and is relatively inexpensive. It is approved for use up to 12 weeks, but many providers continue it long-term if the patient is responding well without adverse effects. It requires diligent monitoring of blood pressure and heart rate due to a side effect profile that includes potential headaches, dry mouth, and tachycardia (increased heart rate), and it should be avoided in patients with cardiovascular disease.

Long-Term Medications

These medications are designed for chronic management of obesity.

Orlistat (Xenical, Alli): A lipase inhibitor that blocks the absorption of about 30% of dietary fat. Available over the counter, it is relatively inexpensive and serves a dual purpose: it reduces calorie absorption. It acts as a behavioral disincentive to eating high-fat meals, since doing so can cause unpleasant gastrointestinal side effects.
Phentermine/Topiramate (Qsymia): A combination drug approved for long-term use. Phentermine suppresses appetite, while topiramate, an antiepileptic drug, also contributes to appetite suppression and may lower leptin levels. While effective, it can be expensive and has a teratogenic component, meaning it can cause harm to a developing fetus and is contraindicated in pregnancy.
Naltrexone/Bupropion (Contrave): This combination works on two different brain pathways. Bupropion, an antidepressant, stimulates the POMC system to reduce appetite and increase energy expenditure, while naltrexone blocks an inhibitory feedback loop, allowing bupropion to work more effectively and control cravings.
Liraglutide (Saxenda): A daily injectable GLP-1 receptor agonist. Originally used for diabetes (as Victoza), this drug mimics a natural gut hormone that signals fullness to the brain, slows stomach emptying, and reduces appetite.
Semaglutide (Wegovy): A weekly injectable GLP-1 receptor agonist, also used for diabetes (as Ozempic). It offers more significant weight loss than liraglutide and has become a cornerstone of modern obesity treatment. These GLP-1 agonists have been shown to produce profound and substantive weight loss that significantly impacts morbidity and mortality. Their primary drawback is high cost, though insurance coverage is improving.
Tirzepatide (Zepbound): A weekly injectable that is a dual GIP and GLP-1 receptor agonist. Known as Mounjaro for diabetes, this medication acts on two different hormone pathways, leading to even greater appetite suppression and weight loss than GLP-1 agonists alone. It has demonstrated the highest efficacy to date in terms of total weight-loss percentage due to its powerful, synergistic effect.
Lisdexamfetamine (Vyvanse): While not approved specifically for obesity, it is the only medication currently FDA-approved for binge eating disorder, a condition that is often underdiagnosed in patients with obesity. It works by impacting neurotransmitters involved in impulse control and focus. Addressing the underlying binge eating can be a critical step in managing weight.

Clinical Case Studies: Applying an Individualized Approach

Theory is important, but its application is what transforms patient lives. Let’s walk through a few clinical scenarios to see how we might tailor these pharmacological treatments.

Case 1: The Patient with Type 2 Diabetes and Hypertension

Profile: A 45-year-old male with a history of hypertension, type 2 diabetes, and hyperlipidemia. Despite diligent efforts with diet and exercise, he has been unable to lose significant weight.
Analysis and Strategy: My first principle is always “first, do no harm”. This patient is on glyburide, a sulfonylurea. This class of drugs increases insulin production, which is an obesogenic (obesity-promoting) mechanism. While it lowers his A1c, it actively works against his weight loss goals.

Our strategy would be:
1. Discontinue Obesogenic Medications: Consider stopping the glyburide and replacing it with a more beneficial agent.
2. Optimize Existing Medications: We need to know his metformin dosage. I often see patients on a suboptimal dose, like 500 mg once or twice a day. The ideal dose for diabetes control and weight neutrality is typically 1,000 mg twice a day. We would aim to titrate his dose up, monitoring for any gastrointestinal side effects.
3. Introduce a Synergistic Medication: For a patient like this, a GLP-1 or dual GLP-1/GIP agonist is a perfect fit. In this case, we prescribed semaglutide (Ozempic). Because he has a diagnosis of type 2 diabetes, his insurance is likely to cover Ozempic, making it a medically and financially sound choice. It will address his blood sugar, promote significant weight loss, and likely improve his blood pressure and lipid profile.

Case 2: The Patient with Pre-diabetes, Hypertension, and Depression

Profile: A 38-year-old male with a BMI of 34, hypertension, pre-diabetes, and depression. His only medication is amlodipine for his blood pressure. He feels his weight gain is negatively impacting his mental health.
Analysis and Strategy: This patient has multiple interconnected conditions. Our treatment choice should ideally address several of them simultaneously.

Our potential strategies include:

1. Confirm Diagnosis for Coverage: With a diagnosis of pre-diabetes, I would order both an A1c and a fasting blood glucose test. Sometimes, a patient meets the diagnostic criteria for diabetes on one test but not the other. Securing a diabetes diagnosis would open the door to insurance coverage for a GLP-1 agonist, which would be highly effective for his weight and pre-diabetes.
2. Consider a Multi-Benefit Medication: An excellent option for this patient is naltrexone-bupropion (Contrave).

- - The bupropion component is an effective antidepressant, which will directly address his depression. It also works to decrease appetite.
  - The naltrexone component modulates the brain’s reward system, helping reduce cravings and enhance bupropion’s effects.
  - The resulting weight loss would improve his pre-diabetes and likely his hypertension. This medication has a synergistic effect, targeting his weight, mood, and metabolic health all at once. We would start him on a low dose and titrate up over several weeks to manage side effects and optimize efficacy.

Case 3: The Patient with Binge Eating Disorder

Profile: A 32-year-old female with a BMI of 31, mild hypertension, and anxiety. She has a formal diagnosis of Binge Eating Disorder (BED) from a mental health provider.
Analysis and Strategy: For this patient, the primary driver of her weight gain is a specific neuropsychiatric condition. Therefore, the treatment must target the root cause.

Our approach:
1. Prescribe the FDA-Approved Treatment: The only medication currently FDA-approved for BED is lisdexamfetamine (Vyvanse). This medication works by impacting neurotransmitters involved in impulse control and focus. We would start at a dose of 30 mg daily and titrate up as needed.
2. Monitor for Side Effects: A common concern is prescribing a stimulant like Vyvanse to a patient with anxiety. While it can sometimes increase physiological symptoms like heart rate, which may trigger anxiety, it can also have the opposite effect. For many with conditions like ADHD or BED, these medications improve focus and control, which in turn can reduce anxiety. Close monitoring is essential to ensure the benefits outweigh any potential side effects.

Discovering the Benefits of Chiropractic Care- Video

Discovering the Benefits of Chiropractic Care | El Paso, Tx (2023)

The Pillars of Effective and Ethical Prescribing

As we navigate the expanding landscape of obesity pharmacotherapy, several core principles must guide our practice.

Always Start with Lifestyle: Diet, physical activity, and behavioral modifications are the foundation for all patients. Pharmacology is an adjunct, not a replacement.
First, Do No Harm: Scrutinize a patient’s current medication list for any obesogenic drugs. If safe alternatives exist, make the switch. For example, replacing a sulfonylurea with a GLP-1 agonist in a patient with diabetes and obesity is a clear win.
Individualize Treatment: There is no one-size-fits-all solution. Consider the patient’s comorbidities, the required degree of weight loss, and medication costs. A patient with 300 pounds to lose will likely need a more potent agent like tirzepatide, whereas a patient with depression may benefit most from naltrexone-bupropion.
Set Realistic Goals and Monitor Continuously: This is a long-term process. Patients will not lose 100 pounds overnight. We must set realistic expectations based on clinical trial data. Frequent follow-ups are crucial for monitoring efficacy, managing side effects, and adjusting treatment. A good benchmark is looking for at least a 5% reduction in total body weight after three months to justify continuing a medication.
Engage in Shared Decision-Making: Have open conversations about treatment options, including the pros and cons of injectables versus oral medications and the realities of cost. Empowering patients to be active participants in their care enhances adherence and improves outcomes.

Integrating Chiropractic and Functional Medicine

Where does chiropractic care fit into this picture? Excess weight places enormous biomechanical stress on the body, leading to a host of musculoskeletal problems:

Osteoarthritis, particularly in the knees and hips
Chronic low back pain
Sciatica and nerve compression
Plantar fasciitis
Poor posture and altered gait

As a chiropractor, I work to alleviate these symptoms through spinal adjustments, soft tissue therapies, and corrective exercises. This not only relieves pain but also improves mobility, making it easier for patients to engage in the physical activity that is so vital for weight loss and overall health.

From a functional medicine perspective, we dig deeper. We use advanced diagnostic testing to look for underlying imbalances—hormonal dysregulation, nutrient deficiencies, chronic inflammation, or gut dysbiosis—that may be contributing to weight gain. This allows us to create a truly personalized plan that may include targeted nutritional supplements, dietary modifications, and stress management techniques, all designed to restore metabolic balance from the inside out.

The Exciting Future of Obesity Treatment

The field of obesity medicine is advancing at an incredible pace. On the horizon, we have even more powerful tools being developed.

Retatrutide (the “Triple G” ): This peptide injection targets GLP-1, GIP, and glucagon receptors. Early trials have shown a staggering 24% average weight loss over 48 weeks, with indications of less muscle loss than other agents.
Oral GLP-1 Agonists: Oral versions of semaglutide and other new molecules like orforglipron are in late-stage trials, showing promising weight loss of around 15%. This would provide a fantastic alternative for patients who are averse to injections.
CagriSema: This weekly injectable combines a GLP-1 agonist with pramlintide (an amylin analog), resulting in up to 20% weight loss over 68 weeks.

These developments, along with many others, promise a future where we can offer even more personalized and effective treatments. Our integrated approach ensures that we are not just prescribing a pill. We are partnering with our patients on a comprehensive journey, combining the best of modern medical pharmacology, evidence-based chiropractic care, and a root-cause functional medicine approach to help them achieve lasting health. Here at Injury Medical Clinic, we are committed to staying at the forefront of this research, integrating the best of chiropractic, functional, and allopathic medicine to guide you on your journey to wellness.

References

SEO Tags: obesity treatment, weight loss medication, integrative medicine, Dr. Alex Jimenez, Dr. Maria Cardenas, El Paso TX, integrative chiropractic care, functional medicine, GLP-1 agonists, semaglutide, tirzepatide, phentermine, naltrexone-bupropion, binge eating disorder, weight management, diabetes and obesity, multidisciplinary care, metabolic health, lifestyle medicine, pharmacotherapy for obesity, weight bias, chronic disease management, biomechanical stress, sciatica, back pain, Injury Medical Clinic, evidence-based research, holistic healthcare

Regenerative and Integrative Therapies for Pain Relief

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Plant the Seed for Healing: How PRP, MFAT, and Integrative Therapies Support Fitness, Exercise, and Well-Being

Pain or slow recovery from an injury can stop you from exercising or staying active. Many people feel stuck because simple rest or pain medicine only hides symptoms for a short time. It does not fix the underlying problem. An integrative approach using regenerative therapies changes that picture. These treatments work alongside chiropractic care, targeted exercises, and nutritional support to reduce inflammation and repair tissues at a deep level. The result is safer progress back to fitness and daily movement without simply masking discomfort.

This article walks through how these therapies fit together. You will see how they create a clear path from pain to stronger function and lasting well-being.

Common Roadblocks to Fitness and Active Living

Injuries, overuse, or old accidents often leave behind swelling and weak tissue. This makes exercise feel risky or impossible. Inflammation lingers and slows natural repair. Muscles and joints lose stability, so movement patterns become off-balance. People then avoid activity, which leads to more weakness and frustration over time.

Traditional care sometimes focuses only on short-term relief. Regenerative options take a different route. They support the body’s own repair systems while building a stronger structure and better nutrition from within.

Regenerative Injection Therapies: Repairing at the Cellular Level

Regenerative injections use materials from your body to encourage real healing. They deliver growth factors and repair cells straight to damaged areas. Experts describe this as planting the seed for new tissue growth. The treatments reduce long-term inflammation instead of masking it (Open Wellness PDX, n.d.).

PRP Therapy: Using Your Blood’s Natural Healing Power

PRP stands for Platelet-Rich Plasma. A small amount of your blood is drawn and spun in a centrifuge. This concentrates the platelets, which release powerful growth factors. These signals bring repair cells to the site and help build new tissue in tendons, ligaments, joints, and muscles.

Works well for sports strains, tendon issues, early joint wear, and soft tissue injuries that limit exercise
Lowers inflammation and speeds healing without heavy medication reliance
Supports faster, safer return to activity when combined with other care
Research shows positive effects on pain and function in joint conditions (Open Wellness PDX, n.d.; Dr. Alex Jimenez, n.d.).

PFP: Platelet-Fibrin Products for a Stronger Repair Signal

PFP, or platelet-fibrin products, uses special protein concentrates from your blood. It gives an even more focused boost to the healing process in certain tissues. This option adds another layer of support for stubborn or deeper repair needs (El Paso Back Clinic, n.d.).

MFAT: Microfragmented Adipose Tissue for Advanced Joint Support

MFAT takes a small sample of your own fat tissue and processes it into tiny fragments. These contain mesenchymal cells, growth factors, and anti-inflammatory elements. The material helps cushion joints, protect cartilage, and improve the internal environment in more severely damaged areas.

Helpful for moderate to advanced joint changes where extracellular support is needed
Reduces swelling and encourages repair in cartilage and surrounding tissues
Often considered when PRP alone may not be enough or for larger joint concerns (Carolina Non-Surgical Ortho, n.d.)

These injections are usually guided by ultrasound or imaging for precision and safety.

Calming Irritated Nerves with Epidural Spinal Injections

Back pain, sciatica, or nerve irritation from discs or stenosis can make even simple movement difficult. Epidural steroid injections place a mixture of an anti-inflammatory medication and a numbing agent into the space around the spinal nerves. This lowers swelling and eases pain along the nerve path (Nuvance Health, n.d.).

The injection helps create a calmer setting, so other healing work can happen. It plants the seed by soothing agitated nerves while regenerative treatments address tissue repair deeper in the body. Many people notice improved comfort, allowing them to begin gentle movement and rehabilitation sooner.

Fueling Cellular Healing with IV Nutrition Therapy

IV infusion nutrient therapy delivers fluids, vitamins, minerals, and amino acids directly into the bloodstream. This bypasses the digestive system for quick absorption and use by your cells. It supports energy production, muscle repair, and control of inflammation during recovery (El Paso Chiropractor Blog, n.d.).

Helpful nutrients often include B vitamins for converting food into energy, magnesium for muscle and nerve function, and amino acids for building tissues. When someone is recovering from an injury or working toward fitness goals, this direct support can reduce fatigue and soreness as the body repairs itself.

IV nutrition helps alongside regenerative injections and chiropractic care. It provides the cells with the raw materials they need to respond to healing signals.

The Power of Combining Therapies: Planting the Seed and Preparing the Soil

The strongest results come from a structured plan that combines several approaches. Regenerative injections and epidural care plant the seed. They repair damaged cells and calm irritated nerves, allowing the body to start rebuilding. At the same time, customized exercises and integrative chiropractic care prepare the soil. They restore healthy joint motion, improve stability, and correct movement patterns so new tissue grows in a supported environment (Dr. Alex Jimenez, n.d.; El Paso Back Clinic, n.d.).

This combination avoids the trap of only hiding symptoms. It addresses both the biology of repair and the mechanics of the body. New tissue has a better chance to stay strong and functional. Patients often see longer-lasting improvements in pain, mobility, and strength.

Dr. Alexander Jimenez has observed in his clinical work that people with sports trauma or older injuries recover better when care targets both tissue repair and nervous system function simultaneously.

How Chiropractic Care Builds Stability and Function

Chiropractic adjustments and soft tissue work restore proper alignment and joint movement. This reduces extra stress on healing areas and helps prevent re-injury. Rehabilitation exercises then build strength, flexibility, and balance around the repaired tissues (New Regen Ortho, n.d.; Health Coach Clinic, n.d.).

When paired with regenerative therapies, chiropractic care supports:

Smoother, more comfortable daily movement
Better posture and load distribution during exercise
Stronger foundation so fitness progress feels sustainable
Lower chance of pain returning after initial relief

The goal is real function, not just temporary comfort.

The Expert Team and Multidisciplinary Approach

This type of care works best in a coordinated setting. At Injury Medical Clinic PA in El Paso, Texas, the team brings together diverse areas of expertise under a single plan.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, leads with his background in chiropractic, functional medicine, personal injury care, and rehabilitation. He emphasizes whole-person recovery through detailed exams, imaging when needed, and personalized plans that combine regenerative procedures with adjustments and lifestyle support.

Working with him is Dr. Maria Guadalupe Cardenas, MD, a board-certified internal medicine physician with over 40 years of experience (NPI #1164426749, Texas MD License #J2933). She serves as Medical Director and Collaborative Physician. Her role provides medical oversight, safety guidance, and an internal medicine perspective on overall health factors. This includes managing complex health considerations and ensuring procedures fit each patient’s broader needs.

This multidisciplinary setup is common in integrative and injury care clinics. The medical doctor offers direction and oversight while the chiropractor provides hands-on structural and functional care. Functional medicine, regenerative therapies, rehabilitation, and personal injury support all connect through shared records and goals. Everyone works together so your recovery plan stays consistent and complete (El Paso Back Clinic, n.d.).

Benefits for Fitness, Exercise, and Overall Well-Being

When cellular repair, nerve calming, nutrition support, alignment, and movement work as one system, people experience real advantages:

Noticeable drops in pain and swelling without depending only on medications
Faster tissue healing and reduced chronic inflammation
Improved energy and nutrient delivery that supports active days
Better joint stability and smoother motion for safer workouts
Lower risk of setbacks or new injuries during return to exercise
Longer-lasting results because root causes receive attention
Greater confidence in daily movement and fitness goals (Health Coach Clinic, n.d.; Carolina Non-Surgical Ortho, n.d.)

Many patients find they can return to sports, gym routines, walking programs, or other activities they enjoy with more ease and fewer limitations. The focus stays on building lasting well-being rather than ongoing symptom management.

Taking the Next Step Toward Stronger Recovery

Fitness and exercise feel better when your body receives support both within the tissues and in the way you move. Regenerative therapies like PRP, PFP, and MFAT, together with epidural care and IV nutrition, plant the seeds of repair. Chiropractic care and guided exercises prepare the soil for strong, stable growth. With coordinated oversight from professionals such as Dr. Jimenez and Dr. Cardenas, you can move forward with a clearer, safer path.

If pain, slow healing, or limited activity has held you back, consider reaching out to a clinic that offers this full integrative model. A thorough evaluation can show whether these options fit your situation and help you build real progress toward better health and function.

Transform your Body! | El Paso, Tx (2023)

References

What Is Regenerative Injection Therapy? A Complete Guide to PRP, Prolotherapy, Perineural Injection (n.d.). Open Wellness PDX.

PRP vs. MFAT Cell Therapy: Which Regenerative Treatment Is Right for You? (n.d.). Carolina Non-Surgical Ortho.

Regenerative Therapies Combined with Chiropractic for Pain Relief (n.d.). El Paso Back Clinic.

Chiropractors: How to Integrate Regenerative Medicine into Your Practice the Right Way (n.d.). New Regen Ortho.

IV Infusion Nutrient Therapy in El Paso (n.d.). El Paso Chiropractor Blog.

Epidural Steroid Injection (n.d.). Nuvance Health.

Regenerative Medicine and Integrative Chiropractic Approaches (n.d.). Health Coach Clinic.

How PRP Composition Influences Your Healing Journey (n.d.). Dr. Alex Jimenez.

Regenerative Therapy for Auto and Workplace Injuries Overview

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Regenerative Therapy for Auto and Workplace Injuries in El Paso

A work injury, car crash, fall, or sports accident can affect more than one part of the body. A person may have joint stiffness, swelling, ligament strain, disc irritation, nerve symptoms, weakness, and poor movement at the same time. Because these problems are connected, recovery may require more than one type of treatment.

An integrative wellness plan combines structural care, tissue-supporting therapies, medical oversight, nutrition, and rehabilitation. The goal is not only to reduce discomfort. It also aims to improve mobility, support natural repair, rebuild strength, and help the patient return to work and daily life.

Treatment is usually completed in phases. Care may begin with medical screening and control of inflammation. It can then move toward better spinal mechanics, tissue healing, strength, and long-term prevention. Each phase should be based on the patient’s diagnosis, medical history, imaging, symptoms, and response to treatment.

Why Injuries Need a Layered Treatment Plan

Injuries are rarely limited to one tissue. A rear-end collision may strain neck ligaments, irritate spinal joints, tighten muscles, and trigger headaches or arm symptoms. A lifting injury may affect a spinal disc, surrounding muscles, and a nearby nerve. Shoulder trauma may involve the rotator cuff, tendons, joint capsule, and neck mechanics.

An integrated treatment plan may include:

Medical and neurological screening
Chiropractic adjustments
Spinal decompression
Soft-tissue care
Laser or shockwave therapy
Regenerative medicine consultation
Functional medicine and nutritional support
Corrective exercise and rehabilitation
Progress measurements and injury documentation

Each service has a different purpose. Structural care helps restore movement. Regenerative procedures may support injured tissues. Nutritional care supports the body’s general healing needs. Rehabilitation teaches the body how to move safely again.

This layered approach is especially useful after accidents because patients may need pain control, improved movement, tissue support, medical evaluation, and functional rehabilitation at different points in recovery (Sciatica Clinic, 2026b).

Phase One: Reduce Inflammation and Identify Risks

The first phase focuses on safety. The healthcare team must decide whether the injury is appropriate for conservative care or requires urgent imaging, emergency treatment, or referral to another specialist.

Early treatment may aim to reduce swelling, muscle guarding, and nerve irritation. It may include gentle movement, changes in activity, soft-tissue care, or laser therapy. Photobiomodulation uses red or near-infrared light to influence cellular activity. Research suggests it may reduce pain in certain musculoskeletal conditions, although results depend on the diagnosis, treatment setting, and dosage used (Harrington, 2026; Oliveira et al., 2024).

Pain control matters because severe discomfort can stop a patient from walking, sleeping, working, or exercising. However, reducing pain is only the first step. The team must still address the mechanical and functional problems that continue to irritate the injured area.

Phase Two: Restore Mechanical Function

Chiropractic care focuses on joint motion, spinal mechanics, posture, and movement patterns. After an accident, joints may become stiff while nearby muscles tighten to protect the injured area. This protective response can change the way a person walks, turns, lifts, drives, or sits.

Chiropractic adjustments, joint mobilization, corrective exercises, posture coaching, and soft-tissue techniques may help improve movement when they are appropriate for the patient’s condition.

Spinal decompression may be considered for selected patients with disc-related back pain, protruding or bulging discs, or sciatica. It uses controlled stretching forces to reduce mechanical pressure on sensitive spinal structures. Decompression is not a stand-alone cure. It is generally paired with strengthening, chiropractic care, movement correction, and lifestyle changes (Sciatica Clinic, 2026a).

The mechanical goal is to reduce repeated stress on the injured area. Even an advanced biological treatment may have limited value if poor posture, muscle imbalance, or abnormal loading continues to irritate the same tissue.

Phase Three: Support Biological Tissue Repair

Persistent ligament, tendon, joint, or soft-tissue injuries may not fully improve with rest alone. In selected cases, a qualified medical provider may discuss platelet-rich plasma, commonly called PRP, or micro-fragmented adipose tissue, known as MFAT.

Platelet-Rich Plasma

PRP is prepared from the patient’s own blood. The blood is processed to concentrate platelets, which release growth factors and other signals involved in tissue healing.

The final PRP product can vary because platelet concentration, white blood cell content, and preparation methods are not always the same. Dr. Alexander Jimenez’s clinical discussions emphasize that the composition and dose of PRP matter. Accurate diagnosis, precise placement, and correction of the underlying mechanical problem are also important parts of the treatment plan (Jimenez, 2026a).

Micro-Fragmented Adipose Tissue

MFAT is prepared from a small amount of the patient’s own fat tissue. It contains structural tissue, signaling factors, and other components that may support the local healing environment.

PRP is generally less invasive because it requires a blood draw. MFAT requires a small fat-harvesting procedure. The choice between these treatments may depend on:

The type of tissue injured
The severity of the condition
Previous treatment results
Imaging findings
Medical history
Cost and recovery needs
The treating provider’s judgment

PRP may be considered for certain tendon, muscle, ligament, or mild joint problems. MFAT may be discussed for larger joints or more complex tissue conditions. However, no single regenerative treatment is right for every patient (Sports Medicine of the Rockies, 2026).

These procedures should not be described as guaranteed cures or as treatments that automatically regrow a spinal disc. A safer explanation is that they may support tissue repair, influence inflammation, or improve function in carefully selected patients.

Some products marketed as “stem cell” or regenerative treatments for orthopedic conditions are not approved by the U.S. Food and Drug Administration. Patients should ask exactly which product is being used, who will perform the procedure, whether imaging guidance will be used, and what research supports the proposed treatment (U.S. Food and Drug Administration, 2024).

Laser and Shockwave Therapy as Supportive Treatments

These therapies work in different ways.

Laser therapy uses light energy to influence cellular processes. It may help manage pain and inflammation while supporting tissue recovery. It is often used as a noninvasive addition to chiropractic care, regenerative procedures, or rehabilitation.

Shockwave therapy uses focused or radial acoustic energy. It may stimulate local circulation, collagen activity, and tissue remodeling. It is often used for chronic tendon problems, scar-like restrictions, plantar fasciitis, shoulder conditions, and other focused musculoskeletal problems.

A systematic review found that shockwave therapy may be beneficial for selected sports-related conditions, including plantar fasciitis, lateral elbow tendinopathy, and proximal hamstring tendinopathy. It may also work as an addition to exercise therapy for certain injuries (Rhim et al., 2024).

These tools do not replace a complete examination or active rehabilitation. They are supportive treatments that may help patients tolerate movement and make progress through the recovery process.

Phase Four: Nutritional and Systemic Support

Healing requires protein, fluids, vitamins, minerals, sleep, and stable metabolic health. Functional medicine and nutritional planning may review:

Daily eating patterns
Protein intake
Hydration
Blood sugar control
Nutrient deficiencies
Inflammation
Sleep quality
Stress
Medications and supplements

IV nutrition delivers fluids and nutrients directly into the bloodstream. It may have a medical role when a patient has dehydration, poor absorption, a confirmed deficiency, or another clear clinical need. It should not be presented as a direct method for rebuilding ligaments or spinal discs.

Evidence for routine IV vitamin therapy in otherwise healthy people remains limited. IV treatment can also cause bruising, infection, medication interactions, fluid problems, or vitamin toxicity. Heart disease, kidney disease, pregnancy, high blood pressure, and certain medications may increase treatment risks.

IV nutrition should therefore be provided under qualified medical supervision after the patient’s health history, medications, kidney function, allergies, and true nutritional needs are reviewed (Cleveland Clinic, 2026; Mayo Clinic Press, 2024).

For many patients, the foundation of recovery remains a balanced diet, enough protein, proper hydration, adequate sleep, and safe physical activity. IV support may be one part of an integrative plan, but it does not replace these daily habits.

Phase Five: Rebuild Strength and Function

Pain relief without rehabilitation can leave the body weak and more prone to injury. As symptoms improve, the plan should move toward active treatment.

Rehabilitation may include:

Range-of-motion exercises
Core and hip strengthening
Balance and coordination training
Posture correction
Safe lifting instruction
Work-specific movements
Gradual return to driving or exercise
Home exercises
Injury-prevention planning

This phase helps patients regain the ability to sit, stand, walk, lift, sleep, work, and complete normal daily tasks. Progress can be measured through strength, mobility, pain levels, neurological findings, and functional goals.

A phased injury plan commonly moves from the initial evaluation and symptom reduction to active treatment, rehabilitation, re-evaluation, and documentation of the patient’s final functional status (Sciatica Clinic, 2026b).

A Multidisciplinary Injury Care Model in El Paso

At Injury Medical Clinic PA in El Paso, clinic materials identify Dr. Maria Guadalupe Cardenas, MD, as the medical director and collaborative physician working with Dr. Alex Jimenez.

Dr. Cardenas is board-certified in internal medicine and has more than 40 years of medical experience. Public provider records list her Texas medical license as J2933 and her verified National Provider Identifier as 1164426748. Some clinic pages display 1164426749, but current public provider records identify 1164426748 as the valid NPI (Healthgrades, 2026; ProviderWire, 2026).

This arrangement reflects a multidisciplinary model used in many integrative and injury care settings. Dr. Cardenas contributes an internal medicine viewpoint and physician-level medical oversight.

Dr. Jimenez integrates chiropractic care with his training as an advanced practice registered nurse and family nurse practitioner. His professional materials list the credentials DC, APRN, FNP-BC, CFMP, IFMCP, ATN, and CCST. His clinical work also includes functional medicine, personal injury care, rehabilitation, spinal care, and related wellness services (Jimenez, n.d.; Jimenez, 2026b).

The value of this model is coordination.

Chiropractic care focuses on spinal mechanics, joint motion, posture, and neuromusculoskeletal function.
Medical oversight helps identify health risks, review medications and laboratory results, and guide treatments requiring medical decision-making.
Functional medicine examines nutrition, metabolic health, sleep, stress, and other factors that may influence recovery.
Rehabilitation turns improved movement into strength and practical function.
Personal injury care helps document how the injury occurred, what treatment was needed, and how the patient progressed.

Collaboration between chiropractors and regenerative medicine providers can be valuable because structural alignment and biological tissue support address different parts of the same problem. Each provider must remain within the limits of professional training and state scope-of-practice requirements (Leiber, 2021).

Clinical Observations From Dr. Alexander Jimenez

In his educational work, Dr. Jimenez describes injury recovery as a two-part process.

The first part addresses biomechanics, including:

Joint motion
Spinal alignment
Posture
Walking patterns
Muscle balance
Abnormal loading

The second part addresses biology, including:

Inflammation
Tissue quality
Nutritional status
Circulation
Cellular healing signals
General metabolic health

This view explains why one treatment may not be enough. A regenerative procedure may provide biological support, but poor movement can continue to overload the tissue. Chiropractic care may improve motion, but a severely damaged ligament or tendon may require medical evaluation. IV nutrients may correct a true deficiency, but they cannot replace exercise and structural rehabilitation.

The strongest plan connects these parts instead of treating them as separate problems.

Realistic Expectations for Long-Term Recovery

Not every patient needs every therapy. Many people improve with conservative chiropractic care, exercise, activity changes, and time. Others may need imaging, specialist referral, injections, or surgical evaluation.

A responsible integrative wellness plan should include:

A clear diagnosis
Measurable treatment goals
Discussion of risks and alternatives
Qualified providers working within their licenses
Regular re-evaluation
Honest expectations about time and cost
Referral when the patient is not improving

The goal of layered care is not to hide pain or promise a quick cure. It is to manage present symptoms while creating better conditions for healing, movement, and long-term function.

When structural care, medical oversight, tissue-supporting therapies, nutrition, and rehabilitation are properly coordinated, patients can follow a clearer journey from injury toward recovery.

References

Cleveland Clinic. (2026, March 9). IV vitamin therapy: Does it work?

Harrington, P. (2026). Comparing Class 4 laser therapy, PEMF, and shockwave treatments in chiropractic care

Healthgrades. (2026). Dr. Maria Cardenas, MD: Internist in El Paso, Texas

Jimenez, A. (n.d.). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP, ATN

Jimenez, A. (2026a). How PRP composition influences your healing journey

Jimenez, A. (2026b). El Paso, Texas, doctor of chiropractic and integrative health clinic

Leiber, J. (2021, January 20). Integrating regenerative medicine in chiropractic practice

Mayo Clinic Press. (2024, October 3). IV vitamin therapy: Understanding the lack of proven benefit and potential risks

Oliveira, S., et al. (2024). Effectiveness of photobiomodulation in reducing pain and improving disability in patients with knee osteoarthritis

ProviderWire. (2026). Dr. Maria G. Cardenas, MD: Internal medicine physician in El Paso, Texas

Rhim, H. C., et al. (2024). Use of extracorporeal shockwave therapies for athletes and physically active individuals: A systematic review

Sciatica Clinic. (2026a). Integrated posture care combining multiple therapies

Sciatica Clinic. (2026b). Integrated treatment solutions: Healing after accidents

Sports Medicine of the Rockies. (2026, February 26). Comparing PRP, BMAC, and MFAT: Choosing the right regenerative treatment

U.S. Food and Drug Administration. (2024). Important patient and consumer information about regenerative medicine therapies

GLP-1 Receptor Agonist Updates for Cardiometabolic Health Research

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Explore the impact of GLP-1 receptor agonists on cardiometabolic health and their role in managing related conditions.

Abstract

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I present a clinically grounded, first-person overview of the close relationship between type 2 diabetes and heart failure, and how modern therapeutics—especially SGLT2 inhibitors and GLP-1 receptor agonists—are reshaping outcomes across the heart, kidney, and metabolic domains. I explain the physiologic underpinnings that bind diabetes to heart failure, the mechanistic rationale for SGLT2 and GLP-1 therapies, and landmark results that inform current guidelines. I also show how our multidisciplinary practice at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas integrates chiropractic care, functional medicine, rehabilitation, and personal injury services under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who brings over 40 years of internal medicine experience. You will see how integrative chiropractic and rehabilitative approaches complement cardiometabolic therapy to improve function, reduce hospitalizations, protect kidneys, and enhance quality of life. I include case-informed protocols and clinical observations from my platforms at sciatica.clinic and my LinkedIn profile.

Our Multidisciplinary Model in El Paso: Internal Medicine Direction Meets Integrative Chiropractic Care

In our clinic, I practice within a team-based, integrative framework—a common model in injury and integrative clinics—where an MD provides medical direction alongside a chiropractor to unite pharmacotherapy with non-pharmacologic strategies.

Maria Guadalupe Cardenas, MD: Medical Director and Collaborative Physician, Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933), providing guideline-aligned cardiometabolic care, diagnostics, risk stratification, and medication oversight with more than 40 years of experience.
Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST: Integrative chiropractic and functional medicine lead, aligning spine and joint function, autonomic balance, and rehabilitation with modern cardiometabolic therapies.

How we integrate care:

Medical oversight and safety: Advanced therapies (SGLT2 inhibitors, GLP-1 RAs, ARNI/ACEI/ARB, beta-blockers, MRAs) are initiated and monitored by Dr. Cardenas to ensure safety and adherence to guidelines.
Chiropractic and rehabilitation: I optimize gait, posture, thoracic mobility, and neuromuscular control to improve venous return, respiratory mechanics, and autonomic balance—critical for heart failure and diabetes.
Functional medicine: We evaluate systemic inflammation, visceral adiposity, sleep and circadian health, gut-metabolic signals, and nutrition to reduce cardiometabolic load.
Personal injury care: Coordinated management reduces pain barriers, improves adherence to activity plans, and supports overall outcomes.

Clinical observations from my work, including case patterns and outcomes, are shared at:

The Cardio-Metabolic Interlock: Why Diabetes Drives Heart Failure

Type 2 diabetes and heart failure are biologically intertwined. Diabetes doesn’t just raise atherosclerosis risk; it independently drives heart failure through pathways beyond obstructive coronary disease.

Key physiologic sequence:

Hyperglycemia → Insulin resistance → Hyperinsulinemia
Chronic inflammation from visceral and epicardial adiposity
Dyslipidemia and endothelial dysfunction causing arterial stiffness and microvascular compromise
Neurohormonal activation (RAAS and sympathetic overdrive) raising preload/afterload
Myocardial remodeling (fibrosis, hypertrophy, impaired energetics)
Diabetic cardiomyopathy: structural and functional changes independent of ischemia

Why this matters:

Inflammation and oxidative stress stiffen vessels and myocardium.
Endothelial dysfunction reduces coronary microvascular flow, worsening perfusion.
Neurohormonal activation promotes remodeling and fluid retention.
Energetic deficits in cardiomyocytes lower contractile efficiency and relaxation.

These mechanisms explain the excess risk of both HFpEF and HFrEF in diabetes and guide why therapies that modulate renal sodium handling, energetics, and inflammation deliver outsized benefits (Heidenreich et al., 2022).

Heart Failure Phenotypes and Treatment Targets

Heart failure is categorized by left ventricular ejection fraction (LVEF), reflecting distinct physiologies:

Heart Failure with Preserved Ejection Fraction (HFpEF; LVEF ≥50%)

- Dominant diastolic dysfunction with stiff ventricles and impaired relaxation
- Often linked to obesity, type 2 diabetes, hypertension, AF, CKD
- Driven by microvascular dysfunction, interstitial fibrosis, and systemic inflammation
- Care priorities: meticulous decongestion, risk-factor control, weight and sleep optimization, and SGLT2 inhibitors to reduce HF events (Anker et al., 2021)

Heart Failure with Reduced Ejection Fraction (HFrEF; LVEF <40%)

- Primarily systolic dysfunction with reduced contractility and eccentric remodeling
- Often post-ischemic but may evolve from HFpEF
- Care priorities: quadruple therapy (ARNI/ACEI/ARB, evidence-based beta-blocker, MRA, SGLT2 inhibitor), device consideration, and inflammation reduction (McMurray et al., 2019; Packer et al., 2020)

Converging theme: Controlling glycemia, adiposity (including epicardial fat), sodium balance, and inflammatory tone alters the remodeling trajectory.

SGLT2 Inhibitors: A Heart-Kidney-Metabolism Bridge

SGLT2 inhibitors act in the proximal convoluted tubule, reducing glucose and sodium reabsorption. Their system-level benefits connect heart, kidney, and metabolism:

Mechanisms that matter:

Natriuresis and osmotic diuresis: reduce preload and interstitial congestion with less neurohormonal activation than loop diuretics
Tubuloglomerular feedback restoration: lower intraglomerular pressure, slowing CKD progression
Energetic rebalancing: mild ketosis provides a more efficient fuel for the failing heart
Anti-inflammatory and anti-fibrotic effects: attenuate oxidative stress and fibrotic signaling
Endothelial improvement and plaque stabilization
Weight and blood pressure reduction: modest, synergistic gains for HF goals

Clinical evidence:

HFrEF: Empagliflozin and dapagliflozin reduce CV death/HF hospitalizations—even without diabetes (DAPA-HF; EMPEROR-Reduced) (McMurray et al., 2019; Packer et al., 2020).
HFpEF: Empagliflozin lowers HF hospitalizations across LVEF >40% (EMPEROR-Preserved) (Anker et al., 2021).
CKD: Empagliflozin slows CKD progression and reduces HF events (EMPA-KIDNEY); canagliflozin improves kidney and CV outcomes in T2D with CKD (CREDENCE) (The EMPA-KIDNEY Collaborative Group, 2022; Perkovic et al., 2019).
Acute HF: In-hospital initiation is feasible and beneficial (EMPULSE) (Voors et al., 2022).

Safety and application:

Effective down to eGFR ~20 mL/min/1.73 m² for several agents; monitor volume status, renal function, and euglycemic DKA risk in insulin-deficient or acutely ill patients (Heerspink et al., 2020).

GLP-1 Receptor Agonists: Weight, Vascular Protection, and Inflammation Control

GLP-1 receptor agonists extend beyond glucose lowering to address atherosclerosis, weight, and inflammation.

Outcome highlights:

Reduced MACE in high-risk T2D: LEADER (liraglutide), SUSTAIN-6 and PIONEER (semaglutide), REWIND (dulaglutide) (Marso et al., 2016; Husain et al., 2019; Gerstein et al., 2019).
Benefits in obesity without diabetes: SELECT shows ~20% reduction in composite CV outcomes with semaglutide, including stroke signals; STEP trials demonstrate 15–16% weight loss with cardiometabolic improvements (Wilding et al., 2021; Lincoff et al., 2023; Wadden et al., 2024).
Functional gains in HFpEF with obesity: Semaglutide improves quality of life and exercise capacity (STEP HFpEF).

Mechanistic rationale:

Glucose-dependent insulin effects and glucagon suppression reduce postprandial stress.
Endothelial stabilization and improvements in plaque biology—less macrophage infiltration and better nitric oxide bioavailability (Nystrom et al., 2018).
Inflammation downshift: lower IL-6, TNF-α, and CRP (Bethel & Patel, 2016).
Appetite and gastric emptying effects drive weight loss, reducing epicardial fat and systemic cytokines.

Safety:

Low risk of hypoglycemia due to nutrient-responsive action; titrate to overcome GI symptoms.

Translating Evidence Into Practice: How We Choose and Combine Therapies

Guideline alignment:

Established ASCVD: Prioritize GLP-1 RAs for MACE reduction; SGLT2s complement (ADA, 2024).
Heart failure or CKD: Prioritize SGLT2 inhibitors; add GLP-1 RAs for weight and vascular benefits (Heidenreich et al., 2022).
Combination therapy: Common and supported for high-risk patients, targeting HF risk, CKD progression, and atherosclerotic events.

Clinical considerations:

Replace sulfonylureas to avoid hypoglycemia without CV benefit.
Avoid DPP-4 inhibitors when GLP-1 RAs are available, given superior outcomes in weight and CV protection.

Optimizing Your Wellness- Video

Optimizing Your Wellness | El Paso, Tx (2023)

Case Integration: Transition After MI With HFrEF and Type 2 Diabetes

A typical scenario from our practice:

A patient post-MI with new HFrEF on metformin, a sulfonylurea, and a DPP-4 inhibitor.

Reasoned plan:

Remove the sulfonylurea to reduce hypoglycemia risk.
Stop the DPP-4 inhibitor and add a GLP-1 RA (e.g., semaglutide or liraglutide) to reduce MACE and promote weight loss.
Add an SGLT2 inhibitor (empagliflozin or dapagliflozin) to reduce the risk of HF hospitalization and protect the kidneys.
Maintain metformin if tolerated; consider combination formulations to reduce pill burden.
Initiate the four pillars of HFrEF therapy: ARNI (or ACEI/ARB), a proven beta-blocker, an MRA, and an SGLT2 inhibitor, titrated carefully.

Why this works:

We simultaneously relieve hemodynamic stress, optimize fuel handling, dampen inflammation, and stabilize vascular risk—each pillar addressing a distinct pathophysiologic domain (McMurray et al., 2019; Packer et al., 2020; ADA, 2024).

Off-Label Nuance: Type 1 Diabetes, CKD, and Heart Failure

In selected type 1 diabetes patients (including LADA) with obesity, CKD, and HF features, off-label use of SGLT2 inhibitors and GLP-1 RAs can be discussed under strict safety protocols:

SGLT2 inhibitors: lower intraglomerular pressure, reduce HF hospitalizations, and improve natriuresis; in type 1, they can reduce insulin requirements but increase the risk of euglycemic DKA. With sick-day rules and ketone monitoring, some international practices use them carefully (Heerspink et al., 2020; Zelniker & Braunwald, 2018).
GLP-1 RAs: potent weight-loss and atheroprotective effects support cardiometabolic risk reduction even when endogenous insulin is absent; used off-label in type 1 diabetes with informed consent (Marso et al., 2016; Gerstein et al., 2019).

Safety playbook:

Do not stop basal insulin during illness; provide ketone strips and instructions.
Hold SGLT2s during acute GI illness or poor intake; reassess upon recovery (Fadini et al., 2017).
Monitor potassium and renal function when adding MRAs and SGLT2s; expect a small dip in eGFR that typically stabilizes by 3–4 weeks (Heerspink et al., 2020).

Access strategies:

Use obesity indications for GLP-1 RAs where BMI criteria are met.
Use HF and CKD indications for SGLT2s independent of diabetes.
Explore manufacturer assistance and competitive cash programs to ensure continuity.

Integrative Chiropractic, Rehabilitation, and Functional Medicine: Making Medical Therapy Work Better

How integrative chiropractic care fits:

Posture and thoracic mobility: Restoring ribcage and diaphragmatic motion optimizes venous return and reduces cardiac workload during exertion.
Autonomic balance: Manual therapy, targeted breathing, and neuromuscular re-education reduce sympathetic overdrive, lowering resting heart rate and blood pressure variability.
Gait and load management: Biomechanical correction reduces energy cost of movement, improving exercise tolerance in obesity and heart failure.

Functional medicine integration:

Visceral adiposity reduction: Emphasis on nutrient-dense eating, adequate protein, fiber-rich patterns, and circadian alignment to reduce IL-6 and TNF-α
Endothelial support: Omega-3s, polyphenols, and nitric-oxide–supportive foods (leafy greens, beets) complement pharmacotherapy.
Gut-metabolic axis: Managing dysbiosis and postprandial spikes improves incretin dynamics and reduces endotoxemia.
Rehabilitation protocols: Graded aerobic and resistance training improve VO2, insulin sensitivity, and mood; we dose carefully to avoid exacerbating HF symptoms.

Clinical observations:

In my practice, combining GLP-1–driven weight loss with thoracic mobility, diaphragmatic training, and graded rehab consistently improves dyspnea and stamina, especially in HFpEF with obesity, echoing STEP HFpEF signals.
In sciatica and biomechanical pain populations, reducing pain enhances sleep and autonomic balance, improving adherence to cardioprotective activities—patterns I share at sciatica.clinic and on my LinkedIn profile.

Practical Protocols: Implementation, Monitoring, and Safety

Initiation steps:

Baseline labs: A1C, fasting lipid panel, NT-proBNP, BMP (renal function), LFTs, CRP.
Vitals and function: Sitting/standing BP, weight and waist circumference, 6-minute walk, symptom scores (e.g., KCCQ).
Medication plan: Select a GLP-1 RA and an SGLT2 agent based on comorbidities; titrate the GLP-1 RA slowly to mitigate GI effects.

Follow-up schedule:

2–4 weeks: GI tolerance, hydration, BP trends, weight trajectory.
8–12 weeks: Lipids, CRP, renal function; adjust HF pillars and rehab intensity.
3–6 months: Reassess MACE markers, quality-of-life scores, exercise capacity; refine nutrition and autonomic training.

Safety considerations:

GLP-1 RAs: Manage GI upset with titration and meal pacing; rare pancreatitis—evaluate abdominal symptoms promptly.
SGLT2 inhibitors: Watch for euglycemic DKA in high-risk contexts, genital mycotic infections, and volume shifts; enforce sick-day rules.
Heart failure therapies: Titrate ARNI/ACEI/ARB and beta-blocker with BP/renal monitoring; add MRA with potassium checks.

Modern guidance on sodium and fluids:

Avoid rigid fluid restriction in stable HF; extreme sodium restriction can harm nutrition and quality of life. With ARNI, MRA, and SGLT2 natriuresis, we guide patients to follow thirst cues, maintain adequate protein, and use daily weights to adjust diuretics under physician oversight.

Broader organ protection:

Sleep apnea screening: Treating OSA improves BP, glycemic variability, and sympathetic tone (Patel & Redline, 2018).
Liver health: Assess NAFLD/NASH risk via FIB-4/elastography; GLP-1–driven weight loss reduces hepatic steatosis and systemic inflammation (Armstrong et al., 2016).
Frailty safeguards: For older adults on SGLT2s, monitor muscle mass, ensure adequate protein intake, and prioritize resistance training.

Bringing It Together: A Patient-Centered Care Map

Phenotype heart failure: Distinguish HFpEF vs. HFrEF; assess CKD and ASCVD risks.
Select mechanisms-matched therapies:

HF and CKD risk → prioritize SGLT2 inhibitor.
ASCVD and obesity-driven inflammation → prioritize GLP-1 RA.
HFrEF → ensure quadruple therapy and rehab pacing.

Integrate chiropractic and rehabilitative strategies to restore movement, reduce sympathetic tone, and support endothelial health.
Monitor closely with shared medical-chiropractic oversight for safety and sustained progress.

This collaborative approach helps patients move, breathe, and live better while reducing hospitalizations, protecting kidneys, and improving long-term cardiovascular outcomes.

References

EMPEROR-Reduced: Empagliflozin in HFrEF (Packer, M. et al., 2020). New England Journal of Medicine.
DAPA-HF: Dapagliflozin in HFrEF (McMurray, J. J. V., et al., 2019). New England Journal of Medicine.
EMPEROR-Preserved: Empagliflozin in HFpEF (Anker, S. D., et al., 2021). New England Journal of Medicine.
EMPULSE: Empagliflozin in acute heart failure (Voors, A. A., et al., 2022). Nature Medicine.
EMPA-KIDNEY: Empagliflozin in CKD (The EMPA-KIDNEY Collaborative Group, 2022). New England Journal of Medicine.
CREDENCE: Canagliflozin in T2D with CKD (Perkovic, V. et al., 2019). New England Journal of Medicine.
ADA Standards of Medical Care in Diabetes—2024 (ADA Professional Practice Committee, 2024). Diabetes Care.
2022/2023 AHA/ACC/HFSA Heart Failure Guidelines (Heidenreich, P. A., et al., 2022). Circulation.
Cardiovascular outcomes with liraglutide (LEADER) (Marso, S. P., et al., 2016). New England Journal of Medicine.
Oral semaglutide cardiovascular outcomes (PIONEER) (Husain, M. et al., 2019). New England Journal of Medicine.
Dulaglutide cardiovascular outcomes (REWIND) (Gerstein, H. C., et al., 2019). The Lancet.
Semaglutide outcomes in obesity without diabetes (SELECT) (Lincoff, A. M., et al., 2023). New England Journal of Medicine.
STEP trials: Semaglutide 2.4 mg and weight loss (Wilding, J. P. H., et al., 2021). New England Journal of Medicine.
Mechanisms and significance of SGLT2 in HF (Ferrannini, E. et al., 2016). Diabetes Care.
GLP-1 RAs and endothelial function (Nystrom, T. et al., 2018). Cardiovascular Diabetology.
GLP-1 RAs: Inflammation and CV effects (Bethel, M. A., & Patel, R. A., 2016). Diabetologia.
SGLT2 inhibitors and renal/hemodynamic mechanisms (Heerspink, H. J. L., et al., 2020). New England Journal of Medicine.
SGLT2 inhibitors, CV and renal benefits overview (Zelniker, T. A., & Braunwald, E., 2018). Circulation Research.
SGLT2 inhibitors and the risk of euglycemic ketoacidosis (Fadini, G. P., et al., 2017). Diabetes Care.
High-intensity statins and secondary prevention (Grundy, S. M., et al., 2019). Journal of the American College of Cardiology.
Finerenone in diabetic CKD (Butler, J., et al., 2021). New England Journal of Medicine.
Mediterranean diet and CV prevention (Estruch, R. et al., 2018). New England Journal of Medicine.
GLP-1 RAs in NAFLD/NASH (Armstrong, M. J., et al., 2016). Gut.
OSA treatment and cardiometabolic outcomes (Patel, S. R., & Redline, S., 2018). JAMA.

SEO tags: heart failure, HFrEF, HFpEF, type 2 diabetes, type 1 diabetes LADA, SGLT2 inhibitors, GLP-1 receptor agonists, EMPEROR-Reduced, DAPA-HF, EMPEROR-Preserved, EMPA-KIDNEY, CREDENCE, EMPULSE, LEADER, REWIND, SELECT, STEP, integrative chiropractic care, functional medicine, internal medicine collaboration, epicardial adipose tissue, diabetic cardiomyopathy, renal protection, autonomic balance, thoracic mobility, diaphragmatic training, El Paso Injury Medical Clinic, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alexander Jimenez DC, euglycemic DKA, sodium guidance, cardiac rehab, obesity and cardiometabolic risk, endothelial function, plaque stabilization, sciatica clinic, rehabilitation protocols

Integrative and Regenerative Sports Chiropractic Healing

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Integrative and Regenerative Sports Chiropractic: Healing Injuries from the Outside In and the Inside Out

Sports injuries can sideline athletes for weeks or months. A twisted ankle, a strained back, or a sore shoulder often starts with pain and swelling. Traditional care may focus only on rest, ice, or pain pills. Integrative sports chiropractic takes a different path. It treats the injury at both the mechanical and cellular levels simultaneously. This dual approach helps the body repair tissue faster and more completely.

Chiropractors restore proper position to the spine and joints. Spinal decompression eases pressure on nerves and pulls healing nutrients into damaged discs. At the same time, shockwave therapy breaks up scar tissue. MLS laser therapy and peptide therapies reduce inflammation and activate the body’s own repair systems. The result is active tissue regeneration instead of simple symptom control. Athletes return to play sooner and with a lower risk of the problem recurring.

How Mechanical Care Sets the Stage for Healing

The body works best when bones, joints, and discs sit in the right place. Misaligned vertebrae or joints create extra stress on nearby tissues. Nerves become pinched. Muscles tighten to protect the area. Blood and nutrient flow slow down. Healing stalls.

Chiropractic adjustments gently restore normal motion and alignment. When the spine and joints move freely again, pressure drops and the nervous system works better. This step alone reduces pain and improves range of motion.

Spinal decompression builds on that foundation. The patient lies on a specialized table that slowly stretches the spine. The gentle traction creates a vacuum effect inside the disc. This negative pressure pulls herniated or bulging material away from the nerve and draws oxygen-rich fluid and nutrients back into the disc. Over a series of sessions, the disc can rehydrate and regain height. Nerve irritation eases. The body gains a better environment for repair.

Together, adjustments and decompression handle the mechanical side of the injury. They correct the body’s “frame” so that the soft tissues and cells can heal in the proper position.

Cellular Therapies That Restart the Repair Process

Once the mechanical barriers are removed, cellular therapies accelerate the actual rebuilding of tissue.

Shockwave therapy sends focused acoustic waves into the injured area. These waves break down dense scar tissue and calcifications that limit movement. They also increase blood flow and release growth factors that restart stalled healing. Athletes with chronic tendon problems, plantar fasciitis, or stubborn muscle knots often feel improved mobility after only a few sessions.

MLS laser therapy works at an even deeper level. The laser delivers synchronized wavelengths of light that penetrate soft tissue. Inside the cells, the light stimulates the mitochondria—the tiny power plants of the cell. This boosts ATP production, the energy cells need to repair themselves. At the same time, the laser reduces inflammatory chemicals and swelling. Pain signals quiet down. Collagen production rises. Soft-tissue injuries heal faster and with stronger tissue.

Peptide therapies add another layer of support. Certain peptides, such as BPC-157 and TB-500, promote new blood vessel growth, reduce inflammation, and encourage collagen formation in discs, tendons, and joints. When used under medical guidance, these therapies help the body rebuild stronger tissue from the inside.

Why the Combination Works Better Than Any Single Treatment

Each therapy targets a different layer of the injury:

Chiropractic adjustments correct joint position and reduce nerve irritation.
Spinal decompression relieves disc pressure and improves nutrient flow.
Shockwave therapy clears scar tissue and boosts circulation in soft tissues.
MLS laser therapy supplies cellular energy and calms inflammation.
Peptide therapies support long-term regeneration of collagen and connective tissue.

When used together, these tools create a cascade of healing. The mechanical corrections open pathways for blood and nutrients. The cellular therapies then use those pathways to rebuild tissue more efficiently. Patients often notice reduced pain and better function in fewer weeks than with adjustments or rest alone.

This approach is especially valuable for athletes. It is non-invasive. There is no surgery, no long recovery from invasive procedures, and usually little to no downtime between sessions. Athletes can continue light training or progressive rehabilitation while the tissues heal. The goal shifts from simply managing symptoms to actively regenerating healthy tissue.

Clinical Observations from an Integrative Practice

In El Paso, Texas, Injury Medical Clinic PA puts this model into daily practice. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, leads the chiropractic and functional medicine side of care. His clinical observations, drawn from years of treating personal-injury and sports patients, show that combining structural correction with cellular support yields clearer, faster results. Patients with disc injuries, chronic tendon problems, or post-accident soft-tissue damage often regain strength and mobility more completely when all layers of the injury receive attention.

Medical oversight is provided by Dr. Maria Guadalupe Cardenas, MD. Board-certified in internal medicine, with Texas MD License #J2933 and NPI #1164426749, Dr. Cardenas brings more than 40 years of experience as an internist. She serves as Medical Director and Collaborative Physician at the clinic. This multidisciplinary setup is common in modern injury and integrative care clinics. The MD provides medical direction, reviews complex cases, and ensures that regenerative therapies, such as peptides, remain within safe, evidence-informed protocols. Meanwhile, Dr. Jimenez and the chiropractic team focus on spinal and joint mechanics, rehabilitation, and functional recovery.

The entire team also includes rehabilitation specialists and functional medicine support. Together they address personal-injury cases, sports injuries, and chronic musculoskeletal problems with a clear plan: restore alignment, reduce inflammation, clear scar tissue, and stimulate cellular repair. Patients receive coordinated care rather than isolated treatments.

Practical Benefits Athletes Notice

Athletes and active people who follow this combined approach commonly report:

Faster drop in pain and swelling
Improved range of motion without forcing tight tissues
Stronger, more resilient soft tissue after healing
Lower chance of the same injury returning
Ability to return to training and competition sooner
Reduced reliance on pain medication or surgery

Because the care stays non-invasive, most people continue daily activities and progressive exercise throughout the process. The focus remains on active regeneration rather than passive symptom control.

A Clear Path Forward for Recovery

Sports injuries do not have to mean long layoffs or incomplete healing. By treating both the mechanical structure and the cellular environment, integrative sports chiropractic creates better conditions for the body to repair itself. Spinal adjustments and decompression restore space and alignment. Shockwave therapy clears the debris of old scar tissue. MLS laser and peptide therapies supply the energy and signals cells need to rebuild.

At clinics that combine these tools under proper medical collaboration, patients gain a practical, science-supported route back to full activity. The result is not just less pain—it is stronger, more functional tissue ready for the demands of sport and life.

El Paso, TX Chiropractic Care For Sports Injuries

References

Beyond the adjustment: How decompression, shockwave therapy, and laser treatment work together. (n.d.). Sleppy Chiropractic. https://www.sleppy.net/beyond-the-adjustment-how-decompression-shockwave-therapy-and-laser-treatment-work-together/

Combining chiropractic care with laser and decompression. (n.d.). Freedom Spine Care. https://freedomspinecare.com/blog/what-are-the-benefits-of-combining-chiropractic-care-with-laser-and-decompression

Comparing Class 4 laser therapy, PEMF, and shockwave treatments in chiropractic care. (n.d.). Dr. Phil Harrington. https://drphilharrington.com/my-laser-articles/comparing-class-4-laser-therapy-pemf-and-shockwave-treatments-in-chiropractic-care

Deep tissue laser and chiropractic. (n.d.). Dr. DiGrado. https://drdigrado.com/deep-tissue-laser-and-chiropractic/

Enhancing recovery: How chiropractic care, shockwave therapy, and laser therapy work together for soft tissue injuries. (n.d.). Trinity Advanced Health. https://trinityadvancedhealth.com/enhancing-recovery-how-chiropractic-care-shockwave-therapy-and-laser-therapy-work-together-for-soft-tissue-injuries/

Integrating shockwave therapy with chiropractic care for lower back pain relief. (n.d.). The Disc Chiropractic. https://thediscchiropractic.com/integrating-shockwave-therapy-with-chiropractic-care-for-lower-back-pain-relief/

Jimenez, A. (n.d.). Injury specialists. https://dralexjimenez.com/

Peptide injections vs. platelet-rich plasma (PRP) therapy for musculoskeletal injuries: A review of the evidence. (n.d.). OSI. https://www.osiftl.com/peptide-injections-vs-platelet-rich-plasma-prp-therapy-for-musculoskeletal-injuries-a-review-of-the-evidence/

Shockwave therapy in chiropractic care. (n.d.). InSpine Chiropractic. https://inspinechiro.com/shockwave-therapy-in-chiropractic-care/

Spinal disc & joint healing peptide. (n.d.). Elite Spinal Care. https://www.elite-spinal-care.com/peptide-spinal-disc-and-joint

The power of combining chiropractic treatment and shockwave therapy. (n.d.). Holistiq. https://goholistiq.com/chiropractic-treatment-shockwave-treatment/

Advancing lower back pain relief: Spinal decompression and shockwave therapy. (n.d.). The Disc Chiropractic. https://thediscchiropractic.com/advancing-lower-back-pain-relief-spinal-decompression-and-shockwave-therapy/

Combining shockwave therapy & chiropractic: A powerful duo for chronic back pain. (n.d.). Healthworks. https://healthworksmed.com/combining-shockwave-therapy-chiropractic-a-powerful-duo-for-chronic-back-pain-copy/

Integrative Chiropractic and Regenerative Spine Care Approach

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Integrative Chiropractic and Regenerative Spine Care

Back and neck pain can be difficult to treat because the spine is not made of bones alone. It also depends on healthy discs, muscles, ligaments, tendons, joints, nerves, and connective tissues. When several of these structures are injured, using only one type of treatment may not address the whole problem.

Integrative chiropractic and regenerative spine care takes a broader approach. Chiropractic adjustments help improve joint motion and spinal mechanics. Rehabilitation strengthens the muscles that support the spine. Spinal decompression may reduce pressure on sensitive discs and nerves. Shockwave and laser therapies may support soft-tissue recovery. Regenerative options, such as platelet-rich plasma, or PRP, may provide biological signals that support healing in selected injuries.

These treatments cannot promise to eliminate every case of pain or prevent every surgery. However, when the patient is carefully examined and the treatments are medically appropriate, a coordinated plan may reduce discomfort, improve movement, rebuild strength, and help some patients recover without surgery.

The Spine

The spine can be compared to a house in terms of its structure.

The bones and joints form the frame. The muscles and ligaments act like support beams and cables. The spinal discs are similar to cushions between the floors. Nerves are like electrical wires that carry messages throughout the body.

When the frame does not move correctly, a chiropractic adjustment may help restore joint motion. However, correcting the frame may not be enough when the supporting tissues are weak, inflamed, scarred, or injured.

A complete repair crew may also be needed:

Chiropractic adjustments address restricted joint movement.
Rehabilitation rebuilds strength and stability.
Massage reduces muscle tension and guarding.
Spinal decompression may reduce pressure on discs and nerves.
Shockwave therapy stimulates injured soft tissues.
Laser therapy delivers light energy to targeted tissues.
PRP and related regenerative procedures may support tissue-healing signals.

Each treatment performs a different job. Together, they may create a better environment for recovery than a single treatment. This layered approach is described in clinical resources that combine chiropractic care, decompression, shockwave therapy, laser therapy, and rehabilitation (Oakland Spine & Physical Therapy, 2025; Sleppy Chiropractic Family Wellness Center, n.d.).

Chiropractic Care Restores Better Joint Motion

Chiropractic care commonly involves controlled adjustments to the spine or other joints. The goals may include improving restricted movement, reducing mechanical irritation, easing pain, and helping the body move more normally.

According to MedlinePlus, chiropractors may also use exercise, electrical stimulation, heat, ice, relaxation methods, and lifestyle guidance. Many people seek chiropractic care for back pain, neck pain, and headaches (MedlinePlus, n.d.).

It is more accurate to say that adjustments improve joint motion and mechanics than to say they permanently “put bones back into place.” Lasting improvement usually requires the muscles and soft tissues around the spine to become stronger and more balanced.

That is why chiropractic care is often combined with:

Corrective exercises
Core strengthening
Posture training
Mobility work
Balance and coordination exercises
Home activity guidance

Physical rehabilitation helps the body maintain better movement after an adjustment. Stronger muscles also reduce repeated strain on spinal joints and injured tissues (Oakland Spine & Physical Therapy, 2025).

Spinal Decompression May Reduce Pressure

Spinal decompression uses controlled traction to gently stretch specific areas of the spine. It is commonly considered for selected patients with disc-related pain, sciatica, or nerve irritation.

The treatment is intended to temporarily increase space between spinal structures and reduce mechanical pressure. This may help some people move more comfortably while they complete rehabilitation and strengthening.

Decompression should not be presented as a treatment that automatically pulls every herniated disc back into place. Results depend on the diagnosis, severity of the injury, age of the condition, general health, and whether weakness or serious nerve damage is present.

When properly selected, decompression may complement chiropractic care:

Decompression focuses on pressure affecting discs and nerves.
Adjustments focus on restricted joint movement.
Rehabilitation strengthens the muscles that protect the area.
Massage reduces muscle tension around the spine.

This is another example of treatments performing separate but connected jobs (Sleppy Chiropractic Family Wellness Center, n.d.).

Shockwave Therapy Stimulates Soft Tissue

Extracorporeal shockwave therapy sends acoustic pressure waves into a targeted area. It is often used for chronic tendon problems, tight muscle bands, scarred tissues, and injuries that have stopped improving.

Shockwave therapy does not replace damaged tissue with new tissue overnight. Instead, the controlled mechanical energy may stimulate circulation, affect pain signals, and encourage a new healing response.

A randomized clinical trial involving people with chronic nonspecific low back pain found that one form of shockwave treatment reduced immediate pain and local sensitivity. However, the authors studied short-term effects, so shockwave should still be used as part of a wider recovery plan rather than as a guaranteed cure (Back et al., 2024).

Shockwave therapy may be especially useful when the surrounding muscles, tendons, or ligaments remain painful after spinal movement has improved. It can then be paired with gradual exercise, helping the healing tissue become stronger and better able to handle normal activity.

Laser Therapy Supports Cellular Activity

Therapeutic laser treatment, sometimes called photobiomodulation, applies specific wavelengths of light to targeted tissues. The light is absorbed by cells and may affect cellular energy production, inflammation, circulation, and pain signaling.

Laser therapy is generally used as a supportive treatment. It does not physically realign the spine, repair a major ligament tear, or replace the need for exercise. Its purpose is to support the biological environment in which healing occurs.

A practical treatment sequence may include:

Reducing pain and irritation with laser or another supportive therapy.
Improving restricted movement with gentle manual care.
Reducing pressure when decompression is appropriate.
Rebuilding strength through progressive rehabilitation.
Teaching safer posture and movement habits.

The exact sequence should be based on examination findings rather than giving every patient the same treatment package.

PRP and Regenerative Therapies

PRP is prepared from a sample of the patient’s blood. The blood is centrifuged to obtain plasma with a higher platelet concentration. These platelets contain growth factors involved in the body’s normal healing response.

The PRP is then injected into a carefully selected joint, tendon, ligament, or other injured area. Ultrasound guidance may be used to improve accuracy.

Johns Hopkins Medicine explains that PRP may support healing in certain joint and soft-tissue injuries. However, results are not immediate or permanent for every patient, and additional treatment may be needed (Johns Hopkins Medicine, 2026).

Regenerative treatment is not magic. Research is still developing, especially for complex spinal conditions. Patients should be properly screened, and the diagnosis should be clear before an injection is considered. Imaging, medications, bleeding risks, infection risks, metabolic health, and the patient’s recovery goals must all be reviewed.

Regenerative procedures may support tissue biology, but rehabilitation remains necessary. New healing tissue must gradually learn to tolerate lifting, bending, walking, work duties, and exercise.

Massage and Rehabilitation Complete the Plan

Pain often causes the body to protect itself. Muscles tighten, movement becomes limited, and the patient begins using other areas to avoid the painful region. These compensation patterns can create additional problems in the hips, shoulders, knees, or opposite side of the back.

Massage and soft-tissue therapy may help reduce:

Muscle guarding
Trigger points
Local stiffness
Restricted movement
Pain caused by compensation

Rehabilitation then helps the patient maintain the progress. Exercises may improve core control, hip strength, posture, balance, endurance, and spinal stability.

This is why long-term recovery is rarely based on passive treatment alone. The patient must gradually become an active part of the repair process.

Multidisciplinary Spine Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, works within a multidisciplinary model that combines chiropractic care, advanced clinical assessment, functional medicine, rehabilitation, personal injury care, and related supportive therapies.

Dr. Jimenez’s published clinical observations emphasize the need to examine both the mechanical and biological aspects of an injury. A patient may have restricted spinal movement, but that same patient may also have muscle weakness, inflammation, poor posture, nerve irritation, metabolic concerns, or damaged soft tissue. Addressing these connected problems may provide a more complete path toward recovery (Jimenez, n.d.; Personal Injury Doctor Group, 2026).

Dr. Maria Guadalupe Cardenas, MD, works with Dr. Jimenez as medical director and collaborative physician. Dr. Cardenas is a board-certified internal medicine physician who graduated from medical school in 1981 and has more than 40 years of clinical experience. Public provider information identifies her NPI as 1164426748 and lists Texas medical license J2933.

In this collaborative model:

Dr. Jimenez leads chiropractic, neuromusculoskeletal, functional, and rehabilitative care within his professional scope.
Dr. Cardenas provides internal medicine experience and medical direction.
The team reviews health risks that may affect healing.
Imaging, laboratory findings, medications, and medical conditions can be considered.
Personal injury documentation and rehabilitation goals can be coordinated.
Patients can be referred to surgeons or other specialists when conservative care is not appropriate.

This type of team structure allows chiropractic and rehabilitative care to occur under medical oversight, rather than each part of treatment operating separately.

When Surgery or Urgent Care May Be Necessary

Integrative care is not the right answer for every spinal problem. Some conditions require emergency treatment or a surgical consultation.

Immediate medical evaluation is important for:

New loss of bladder or bowel control
Numbness in the groin or saddle region
Rapidly worsening arm or leg weakness
Major trauma or suspected fracture
Fever with severe spinal pain
A history of cancer with new unexplained back pain
Severe pain with unexplained weight loss
Signs of infection
Progressive spinal cord or nerve compression

A responsible integrative clinic does not promise to prevent surgery in every case. The goal is to provide the least invasive, safe, and appropriate treatment while referring patients when a higher level of care is needed.

Building Recovery From the Inside Out

The house comparison helps explain integrative spine care. Chiropractic adjustments improve the way the frame moves. Decompression may reduce pressure on sensitive structures. Shockwave and laser therapies support the soft-tissue environment. PRP may provide biological healing signals for selected injuries. Massage reduces protective tension, while rehabilitation rebuilds the strength needed to support the repairs.

The greatest benefit does not come from collecting as many treatments as possible. It comes from choosing the right treatments for the right patient at the right time.

With careful evaluation, medical oversight, realistic goals, and active rehabilitation, integrative chiropractic and regenerative spine care may help select patients reduce pain, restore mobility, improve strength, and return to daily activities without immediately resorting to surgery.

Is Motion Key to Healing? | El Paso, Tx (2023)

References

Back, C. G. N., Peron, R., Lopes, C. V. R., de Souza, J. V. E., and Liebano, R. E. (2024). Immediate effect of extracorporeal shockwave therapy in patients with chronic nonspecific low back pain: A randomized placebo-controlled triple-blind trial. Clinical Rehabilitation, 38(8), 1080–1090.

Health Coach Clinic. (n.d.). Poor posture and regenerative chiropractic recovery methods.

Jimenez, A. (n.d.). El Paso, TX chiropractor Dr. Alex Jimenez: Personal injury specialist.

Jimenez, A. (n.d.). Dr. Alex Jimenez’s professional profile. LinkedIn.

Johns Hopkins Medicine. (2026). Platelet-rich plasma injections.

MedlinePlus. (n.d.). Chiropractic. U.S. National Library of Medicine.

Oakland Spine & Physical Therapy. (2025, November 5). Benefits of combining chiropractic care with physical therapy.

Personal Injury Doctor Group. (2026, June 29). Regenerative therapies and chiropractic for injury recovery.

Personal Injury Doctor Group. (2026, June 30). Chiropractic and regenerative therapies for structural support.

Sciatica Pain and Treatment Clinic. (2026, June 30). Integrated posture care combining multiple therapies.

Sleppy Chiropractic Family Wellness Center. (n.d.). Beyond the adjustment: How decompression, shockwave therapy, and laser treatment work together.

Wellness Doctor Rx. (n.d.). Regenerative spine care for chronic back pain.

Speeding and Aggressive Driving MVAs: Understanding Risks

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Speeding and Aggressive Driving MVAs: Why They Are So Dangerous and How Integrative Injury Care Supports Recovery

Speeding and aggressive driving accidents are among the most dangerous crashes on the road. These crashes happen when drivers ignore traffic laws, rush through traffic, tailgate, switch lanes without care, run red lights, or drive too fast for the weather, road, or traffic conditions. Speeding is not only driving above the posted limit. It also means driving too fast for rain, darkness, road work, traffic, curves, or poor visibility (National Highway Traffic Safety Administration [NHTSA], n.d.).

For more than two decades, speeding has been involved in about one-third of motor vehicle deaths in the United States. In 2024, NHTSA reported 11,288 speeding-related traffic deaths, and speeding was a factor in 29% of all traffic fatalities that year (NHTSA, n.d.).

What Counts as Speeding?

Speeding includes:

Driving above the posted speed limit
Driving too fast during rain, fog, dust, or darkness
Going too fast through construction zones
Driving too fast around curves or intersections
Moving faster than traffic conditions safely allow

Speed limits are designed to protect drivers, passengers, pedestrians, bicyclists, and law enforcement officers. They are not random numbers. They are based on roadway design, traffic flow, visibility, and crash risk. When drivers ignore these limits, they reduce their reaction time and increase the force of a crash (Zero Deaths Maryland, n.d.).

What Is Aggressive Driving?

Aggressive driving is more than one bad choice behind the wheel. It usually includes a pattern of risky traffic violations. NHTSA describes aggressive driving behaviors as actions such as driving much faster than traffic, following too closely, making unsafe lane changes, and running red lights. Road rage is different. Road rage means an intentional assault with a vehicle or weapon after a roadway conflict (NHTSA, n.d.).

Common aggressive driving behaviors include:

Tailgating
Cutting off other drivers
Racing through yellow or red lights
Weaving through traffic
Failing to yield
Blocking passing lanes
Speeding to “beat” traffic
Making angry gestures or threats
Using the vehicle to intimidate others

These choices can quickly turn a normal commute into a high-impact crash.

Why Drivers Speed or Become Aggressive

Many drivers do not start the day planning to drive dangerously. But stress, frustration, and poor judgment can build fast. NHTSA lists traffic congestion, running late, feeling anonymous inside a vehicle, and disregard for others as common reasons people speed or drive aggressively (NHTSA, n.d.).

Common triggers include:

Being late for work, school, court, or an appointment
Heavy traffic
Road construction
Feeling blocked by slower vehicles
Anger after being cut off
Overconfidence in driving skill
Habitual speeding on familiar roads
Emotional stress before getting behind the wheel

The problem is that aggressive driving rarely saves much time. Instead, it raises the chance of a serious crash.

Why High-Speed Crashes Cause More Severe Injuries

Speed changes everything in a crash. At higher speeds, the driver has less time to notice danger, less time to brake, and less space to stop. A speeding vehicle also hits with more force. Zero Deaths Maryland notes that the chance of death or serious injury grows at higher speeds and can double for every 10 mph over 50 mph (Zero Deaths Maryland, n.d.).

The Florida Department of Transportation explains that speeding can cause:

Greater loss of vehicle control
Reduced protection from seat belts and airbags
Longer stopping distance
More severe crash injuries
Higher fuel cost and economic loss (Florida Department of Transportation, n.d.).

This is why high-speed car accidents often lead to deeper tissue damage, more severe spinal stress, and longer recovery times.

Common Injuries After Speeding and Aggressive Driving Crashes

A high-impact crash can push the body beyond its normal limits. The neck, back, shoulders, hips, knees, nerves, muscles, ligaments, and discs may all be affected.

Common injuries include:

Whiplash
Herniated discs
Bulging discs
Sciatica
Neck and back sprains
Ligament injuries
Shoulder injuries
Hip and knee trauma
Headaches after neck trauma
Nerve pain, numbness, or tingling
Muscle spasms
Joint stiffness
Fatigue and inflammation

Some symptoms appear right away. Others may take hours or days to show up. This happens because adrenaline can hide pain after a crash. Inflammation can also build slowly.

Why Early Evaluation Matters

After a speeding or aggressive driving crash, the body may feel “shaken up” before pain becomes clear. A person may think they are fine, then wake up the next day with neck stiffness, back pain, headaches, shoulder pain, or radiating leg pain.

Early evaluation can help identify:

Spinal joint restriction
Nerve irritation
Disc injury signs
Soft-tissue inflammation
Range-of-motion loss
Muscle guarding
Functional changes that affect work, sleep, and daily activity

In personal injury care, documentation is also important. Clear records can help show how the crash affected movement, pain levels, work ability, sleep, and quality of life.

Integrative Injury Care in El Paso, Texas

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alex Jimenez, DC, works within a multidisciplinary model under the medical oversight of Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine, has over 40 years of experience as an internist, and serves as Medical Director and Collaborative Physician. Clinic materials identify her as NPI #1164426749 and Texas MD License #J2933 (Jimenez, n.d.).

This setup is common in integrative and injury care clinics. Dr. Cardenas provides internal medicine oversight and medical direction, while Dr. Jimenez focuses on chiropractic care, functional medicine, personal injury care, rehabilitation, and neuromusculoskeletal recovery. Dr. Jimenez’s clinical observations emphasize identifying the injury pattern, reducing pain, improving mobility, supporting healing, and helping patients return to daily activities (Jimenez, n.d.).

How Chiropractic Care Helps After a Crash

Chiropractic care focuses on joint motion, spinal alignment, nervous system stress, and body mechanics. After a crash, the spine and joints can become stiff, inflamed, and guarded by tight muscles.

Chiropractic care may help:

Improve neck and back mobility
Reduce joint restriction
Decrease muscle guarding
Support better posture and movement
Improve comfort during daily activity
Help restore normal spinal mechanics

For crash patients, chiropractic care is often combined with rehabilitation exercises, soft-tissue care, and medical review when needed.

Spinal Decompression for Disc and Nerve Pressure

Spinal decompression is used to reduce pressure on spinal structures. Cleveland Clinic describes spinal decompression as treatment designed to relieve pressure on spinal nerves or spinal structures that may contribute to pain from bulging discs, herniated discs, pinched nerves, sciatica, or spinal stenosis (Cleveland Clinic, 2022).

In an injury clinic, decompression may be used when a crash causes neck or back pain with radiating symptoms, such as pain into the arm or leg. The goal is to reduce pressure, calm irritated nerves, and support better motion.

MLS Laser Therapy and Photobiomodulation

MLS Laser Therapy uses light-based photobiomodulation to support cellular repair and reduce inflammation in injured tissue. Research on photobiomodulation suggests it may help with pain and inflammation, though results depend on the condition, dose, and patient factors (González-Muñoz et al., 2023).

After a crash, laser therapy may be used to support muscles, ligaments, tendons, and irritated soft tissue. It is non-surgical and often used as part of a larger recovery plan.

Shockwave Therapy for Scar Tissue and Soft-Tissue Pain

Shockwave Therapy uses acoustic sound waves to stimulate injured tissue. It is often used for tendon, ligament, and muscle-related pain. A 2024 review reported that extracorporeal shockwave therapy can help reduce pain in people with tendinopathy (Majidi et al., 2024).

In auto injury care, shockwave therapy may be considered when soft tissue remains painful, tight, or irritated after the first stage of healing.

Regenerative Therapies: PRP, PFP, and MFAT

Regenerative therapies use the body’s natural healing materials. These may include PRP, PFP, and MFAT when clinically appropriate.

PRP, or Platelet-Rich Plasma, is made from a patient’s own blood. Johns Hopkins Medicine explains that PRP contains a higher concentration of growth factors that may stimulate or speed healing in certain injuries (Johns Hopkins Medicine, n.d.).

PFP, or Platelet-Poor Plasma, may be used in some regenerative protocols to support tissue recovery. MFAT, or Micro-Fragmented Adipose Tissue, uses processed adipose tissue to provide cushioning and healing signals in injured joints. These options are not magic fixes. They are supportive tools that may be used with rehabilitation, chiropractic care, nutrition, and medical oversight.

Epidural Spinal Injections for Severe Nerve Inflammation

Some crash patients develop strong nerve pain from inflamed spinal nerves. This may feel like burning, shooting pain, numbness, tingling, or weakness. Cleveland Clinic explains that epidural steroid injections deliver anti-inflammatory medication into the epidural space around the spinal nerves to help reduce inflammation and nerve-related pain (Cleveland Clinic, 2021).

These injections are not for every patient. They are usually considered when conservative care needs a medical boost and when symptoms suggest significant spinal nerve irritation.

IV Infusion Therapy and Healing Support

After a high-impact crash, the body may deal with inflammation, pain, poor sleep, fatigue, and stress. IV infusion therapy delivers fluids, vitamins, minerals, and nutrients directly into the bloodstream. It does not replace food, rest, rehabilitation, or medical care. Instead, it may support hydration and nutrient status when medically appropriate.

In an integrative clinic, IV therapy may be part of a broader recovery plan that includes movement, nutrition, functional medicine, and injury care.

Functional Medicine, Rehabilitation, and Whole-Person Recovery

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, uses clinical observations from chiropractic care, functional medicine, personal injury care, and rehabilitation. His approach looks at how the crash affected the whole person, not just one painful area (Jimenez, n.d.).

This may include reviewing:

Pain patterns
Inflammation
Sleep quality
Nutrition
Movement limits
Nerve symptoms
Posture
Work duties
Daily function
Recovery goals

A patient who was hit by an aggressive or speeding driver may need more than one type of care. A complete plan may include chiropractic adjustments, decompression, rehabilitation, soft-tissue care, laser therapy, shockwave therapy, regenerative support, injections, IV support, and medical oversight when needed.

Safer Roads and Stronger Recovery

Speeding and aggressive driving accidents are preventable, but their effects can be serious. These crashes reduce reaction time, increase crash force, and raise the risk of severe injury. The safest choice is to slow down, allow extra travel time, avoid tailgating, stay calm in traffic, and give aggressive drivers space.

When a crash does happen, early evaluation matters. In El Paso, the multidisciplinary model at Injury Medical Clinic PA connects chiropractic care from Dr. Alex Jimenez with medical direction from Dr. Maria Guadalupe Cardenas, MD. This team-based approach helps patients move from pain and confusion toward structure, documentation, rehabilitation, and recovery.

Personal Injury Rehabilitation | El Paso, Tx (2024)

References

Cleveland Clinic. (2021). Epidural steroid injection: What it is, benefits, risks & side effects.

Cleveland Clinic. (2022). Spinal decompression therapy.

Florida Department of Transportation. (n.d.). Speeding and aggressive driving.

González-Muñoz, A., et al. (2023). Efficacy of photobiomodulation therapy in the treatment of chronic pain.

Governors Highway Safety Association. (2026). Speeding and aggressive driving.

Jimenez, A. (n.d.). Dr. Maria Cardenas, MD: Board-certified internal medicine specialist.

Jimenez, A. (n.d.). El Paso car accident shoulder injury recovery care strategies.

Jimenez, A. (n.d.). El Paso, TX chiropractor Dr. Alex Jimenez, DC | Personal injury specialist.

Johns Hopkins Medicine. (n.d.). Platelet-rich plasma injections.

Majidi, L., et al. (2024). The effect of extracorporeal shock-wave therapy on pain in tendinopathy.

National Highway Traffic Safety Administration. (n.d.). Speeding and aggressive driving prevention.

National Highway Traffic Safety Administration. (n.d.). Aggressive driving and other laws.

National Safety Council. (n.d.). Speeding.

Texas Department of Insurance. (2020). Aggressive driving fact sheet.

Zero Deaths Maryland. (n.d.). Speed and aggressive driving.

Zero Deaths Maryland. (2022). The dangers of speeding.

SGLT2 Inhibitors: A Comprehensive Guide in Cardi-Renal Benefits

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Find out about the crucial cardio-renal benefits that SGLT2 inhibitors can offer for those managing chronic conditions.

Abstract

In this educational post, I walk you through the latest evidence on sodium-glucose cotransporter-2 (SGLT2) inhibitors and how these medications deliver powerful cardio-renal benefits that extend far beyond simple blood sugar control. Drawing from landmark clinical trials, current guidelines from the American Diabetes Association (ADA) and the American Association of Clinical Endocrinology (AACE), and real-world patient experience, I explain the physiology behind why type 2 diabetes, chronic kidney disease (CKD), and heart failure so frequently intertwine — and how a modern, multidisciplinary treatment strategy can interrupt that dangerous progression. I also present a detailed patient case study demonstrating how integrating SGLT2 inhibitors, GLP-1 receptor agonists, Continuous Glucose Monitoring (CGM), and integrative chiropractic care led to dramatic, measurable improvements in metabolic and renal health. Throughout, I highlight the collaborative role of Dr. Maria Guadalupe Cardenas, MD, our Medical Director at Injury Medical Clinic PA in El Paso, Texas, whose expertise in internal medicine anchors our integrative model.

Why Cardio-Renal Health Must Be the New Focus of Diabetes Management

For decades, the primary metric of diabetes management was the hemoglobin A1C — a measure of average blood glucose over approximately three months. While A1C remains important, modern evidence has fundamentally shifted how I think about diabetes care in my clinic. The real goal is not merely to lower a number; it is to protect organs, prevent hospitalizations, and extend quality of life.

Diabetes rarely travels alone. In my daily clinical experience at Injury Medical Clinic PA — and across the cases I document at sciatica.clinic and through my professional updates on LinkedIn — I consistently observe that patients carrying a diabetes diagnosis also present with hypertension, hyperlipidemia, CKD, and early signs of heart failure. These are not coincidental. They share deep physiological roots, and understanding those roots is the first step toward treating the whole patient rather than a single lab value.

The Physiological Ties That Bind: How High Glucose Damages the Heart and Kidneys

To appreciate why SGLT2 inhibitors are so powerful, we first need to understand how chronically elevated blood glucose creates a cascade of harm throughout the cardiovascular and renal systems.

Increased Hemodynamic Load on the Heart

Hyperglycemia effectively increases the functional viscosity of circulating blood. When blood is thicker and more glucose-laden, the heart must generate greater force with each contraction to maintain adequate flow. Over time, this elevated workload raises myocardial wall stress, promotes ventricular hypertrophy, and progressively impairs cardiac efficiency. The muscle of the heart is essentially working overtime — and like any overworked muscle, it eventually begins to fail.

RAAS Activation and Sodium Retention

Elevated glucose triggers osmotic diuresis — water is drawn out of cells and into the renal tubules, altering effective circulating volume. The body interprets this shift as a volume deficit and activates the renin-angiotensin-aldosterone system (RAAS). The resulting surge in angiotensin II levels drives vasoconstriction, sodium retention, and elevation of blood pressure. Chronically elevated angiotensin II also promotes fibrosis and adverse ventricular remodeling, compounding the structural damage to the heart.

Glomerular Hypertension and Albuminuria

The kidneys are exquisitely sensitive to pressure changes. As systemic blood pressure climbs and the RAAS remains activated, intraglomerular pressure rises. The delicate filtration apparatus — the glomerulus — begins to stretch. I often explain this to patients with a simple image: think of the glomerular filter as a fine mesh screen. When the pressure behind that screen increases, the mesh holes widen, and proteins that should stay in the blood begin leaking through into the urine. This albuminuria is both a hallmark and a driver of CKD progression.

Advanced Glycation End Products and Oxidative Stress

Excess glucose also drives the formation of advanced glycation end products (AGEs) — sticky molecules that attach to proteins and lipids throughout the body. AGEs promote oxidative stress, endothelial dysfunction, and vascular stiffness, affecting the arteries, the myocardium, and the renal microcirculation simultaneously. This biochemical environment accelerates the aging and scarring of tissues that should otherwise remain supple and functional.

How SGLT2 Inhibitors Interrupt This Harmful Cascade

The Mechanism: Blocking Glucose Reabsorption at Its Source

Each kidney contains approximately one million filtering units called nephrons. Within each nephron, the proximal convoluted tubule performs the critical job of reabsorbing filtered glucose back into the bloodstream — a task accomplished primarily by the Sodium-Glucose Cotransporter 2 (SGLT2) protein. Under normal circumstances, this system is efficient and appropriate. In a person with hyperglycemia, however, it becomes part of the problem by continuously returning excess glucose to the circulation.

SGLT2 inhibitors selectively block these transporters. The result: filtered glucose is no longer reabsorbed. It passes through the tubule and is excreted in the urine — a process called glycosuria. This lowers blood glucose independently of insulin, making these medications effective even when insulin resistance is high or insulin production is diminished.

Beyond Glucose Lowering: The Cardio-Renal Benefits

The real power of SGLT2 inhibition lies in its downstream effects:

Tubuloglomerular feedback restoration: When more sodium reaches the macula densa at the end of the tubule, the kidney corrects the maladaptive afferent arteriolar dilation that drives intraglomerular hypertension. This directly reduces the pressure stretching the glomerular filter and decreases albuminuria.
Natriuresis and volume reduction: Glucose excretion carries sodium and water, producing a mild but sustained diuretic effect that reduces cardiac preload and afterload — lightening the workload of a struggling heart.
Blood pressure reduction: The combined effect of natriuresis and reduced RAAS stimulation contributes to meaningful blood pressure lowering without the side effects of traditional antihypertensives.
Improved myocardial energetics: Emerging evidence suggests that the metabolic shift induced by SGLT2 inhibition — favoring ketone utilization — may provide the heart with a more efficient fuel source, potentially improving cardiac function in patients with heart failure.
Caloric excretion and modest weight loss: Excreting glucose also means excreting approximately 200–300 calories per day, supporting weight management without dietary restriction alone.

What the Evidence Shows: Landmark Clinical Trials

The cardio-renal benefits of SGLT2 inhibitors are not theoretical — they are backed by some of the most rigorous cardiovascular and renal outcome trials ever conducted:

EMPA-REG OUTCOME demonstrated that empagliflozin significantly reduced major adverse cardiovascular events (MACE) and heart failure hospitalizations in patients with type 2 diabetes and established cardiovascular disease (Zinman et al., 2015).
VERTIS CV confirmed cardiovascular safety and heart failure benefits with ertugliflozin (Cannon et al., 2020).
CREDENCE showed that canagliflozin produced strong renal protection, reducing risk of end-stage renal disease (ESRD), doubling of serum creatinine, and renal or cardiovascular death in patients with diabetic nephropathy (Perkovic et al., 2019).
DAPA-CKD demonstrated that dapagliflozin significantly slowed kidney disease progression and reduced cardiovascular outcomes — including in patients without diabetes (Heerspink et al., 2020).
EMPA-KIDNEY expanded evidence for empagliflozin’s renal protection across a broader CKD population (Herrington et al., 2023).

Across these trials, relative risk reductions for heart failure hospitalization consistently range from approximately 30–40%, while renal outcome benefits are similarly robust.

Guideline Alignment

Both the ADA Standards of Care 2024 and the AACE Clinical Practice Guidelines 2022 now recommend SGLT2 inhibitors — irrespective of A1C — for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease (ASCVD) or are at high risk for ASCVD, heart failure, or CKD. This represents a paradigm shift: these medications are now primarily organ-protective agents and, secondarily, glucose-lowering drugs.

Cardiometabolic Risk Causes & Effects- Video

Cardiometabolic Risk *Causes & Effects* | El Paso, Tx (2022)

A Real-World Case Study: R.B.’s Journey From Uncontrolled Diabetes to Renewed Health

Initial Presentation

R.B. is a 73-year-old Hispanic male who came to our endocrinology referral clinic with a deeply concerning clinical picture:

A1C:2%, up from a prior value of 8%
eGFR: Declined from 55 to 43 (Stage 3 CKD), with a creatinine of 1.54
Daily blood sugars: Consistently 200–300 mg/dL
Nocturnal hypoglycemia: Waking shaky at night, consuming juice to recover
Current medications: Linagliptin, losartan, hydrochlorothiazide, simvastatin, and insulin glargine (reduced from 60 to 42 units to address nighttime lows — a reduction that only worsened his daytime hyperglycemia)

R.B. had also preemptively refused a Continuous Glucose Monitor (CGM) before I could even propose one, citing a deep fear of needles.

Building the Foundation: Education, Trust, and Breaking the Hypoglycemia Cycle

My priority was not to prescribe — it was to educate. R.B. viewed his medications as band-aids and had no understanding of how his preemptive eating habits (driven by fear of hypoglycemic episodes) were creating a self-reinforcing cycle of daytime hyperglycemia and nighttime lows. A hypoglycemic event triggers a powerful sympathetic response — adrenaline, trembling, a sense of impending doom — that naturally drives patients to overcorrect with fast-acting carbohydrates, spiking glucose hours later.

We took the following steps immediately:

Discontinued glipizide (a sulfonylurea) to eliminate its hypoglycemia-inducing mechanism
Reduced insulin glargine further to stop the nocturnal drops
Shifted nutritional focus from restriction to substitution — replacing refined carbohydrates with protein and vegetables rather than simply eliminating foods
Introduced mealtime lispro (rapid-acting insulin) to address postprandial glucose spikes that long-acting insulin cannot adequately manage
Ordered a C-peptide level to assess endogenous insulin production — I explain this to patients as: “The insulin is the candy, and the C-peptide is the candy wrapper. By measuring the wrappers, we can see how much candy your own body is still making.”

On the CGM, I took a completely different approach. Rather than overriding R.B.’s concern, I asked him to explain it. His fear was specific: he believed a large needle would remain permanently under his skin. I produced a demo sensor, let him hold it, and showed him the tiny, flexible filament — softer than a human hair — that actually resides beneath the skin surface, and the insertion needle that retracts immediately after placement. He agreed on the spot. Understanding the “why” and “how” behind a technology is often the most powerful prescription a clinician can write.

Two Weeks Later: Early Progress and Safe Introduction of SGLT2 Inhibition

At his two-week telehealth follow-up, R.B.’s blood sugars had already improved to the 180s. Nocturnal hypoglycemia had stopped completely. His C-peptide returned normal, confirming that his pancreas was still producing adequate insulin — a critical finding, because initiating an SGLT2 inhibitor in a patient who is glucose-toxic and insulin-deficient carries elevated risk of euglycemic diabetic ketoacidosis (DKA).

With his glucose trajectory improving and endogenous insulin production confirmed, I added dapagliflozin (Farxiga) 5 mg daily — an SGLT2 inhibitor with robust evidence for both renal protection (DAPA-CKD) and cardiovascular benefit.

Three Months Later: Measurable Organ Protection

The three-month laboratory results were striking:

A1C:2% → 8.2%
Creatinine:54 → 1.3
eGFR: 43 → 53 — a meaningful recovery of kidney function

At this visit, I transitioned R.B. from linagliptin (a DPP-4 inhibitor with modest efficacy) to semaglutide (Ozempic) 0.5 mg weekly — a GLP-1 receptor agonist with proven cardiovascular outcome benefits (Marso et al., 2016) and additional support for postprandial glucose management and weight reduction.

Seven Months Later: Sustained Improvement and Insulin Reduction

By his seven-month follow-up, R.B.’s transformation was profound:

Blood sugar average: ~150 mg/dL, with no hypoglycemic episodes
A1C: 2%
Creatinine: 25
eGFR: 55 — back to his previous baseline

His mealtime lispro was discontinued for routine use (retained only as a correction tool), and his insulin glargine was reduced from 60 units to just 10 units daily.

I made a point of explaining his improvement in terms he could feel connected to: “Remember when your blood was thick and sticky from all the sugar? Now that your glucose is under control, your blood flows more easily, and your kidneys can filter it much more efficiently. That is why this number went up.” Helping patients understand the physiology behind their progress transforms compliance into genuine engagement.

Safety Considerations: What Every Patient and Clinician Must Know

SGLT2 inhibitors are powerful, but their use requires careful individualization:

Euglycemic DKA risk: Can occur without significantly elevated blood glucose, particularly in patients who are fasting, acutely ill, or following unsupervised ketogenic diets. We strongly discourage oscillating between very-low-carbohydrate and high-carbohydrate eating patterns while on these medications.
Sick-day rules: Patients must temporarily hold SGLT2 inhibitors during acute illness, sepsis, surgical procedures, or prolonged fasting. We provide written protocols for every patient.
Genitourinary infections: Increased urinary glucose creates conditions favorable for genital mycotic infections and urinary tract infections. We counsel all patients on adequate hydration, hygiene practices, and prompt reporting of symptoms.
eGFR thresholds: Each agent has specific cutoffs below which initiation is not recommended. Monitoring eGFR, electrolytes, and urine albumin-to-creatinine ratio (UACR) is essential.
Foot infections: During complex foot wounds or nonhealing ulcers — common in diabetic patients — we pause SGLT2 therapy and shift to alternative glycemic strategies until healing is confirmed.

Our Multidisciplinary Model at Injury Medical Clinic PA

Dr. Maria Guadalupe Cardenas, MD — Medical Director and Collaborative Physician

At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, our model is built on a foundational collaboration between my chiropractic and advanced practice nursing expertise and the internal medicine mastery of Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749, Texas MD License #J2933). Dr. Cardenas is Board Certified in Internal Medicine and brings over 40 years of experience as an internist to her role as our Medical Director and Collaborative Physician.

This structure is not merely administrative — it is clinically transformative. Dr. Cardenas verifies indications and contraindications, monitors eGFR thresholds and metabolic labs, coordinates cardiology and nephrology referrals when warranted, and implements perioperative and sick-day protocols. Her oversight ensures that complex pharmacologic decisions — including SGLT2 inhibitor initiation, insulin titration, and GLP-1 receptor agonist selection — are made with the full weight of internal medicine expertise and evidence-based rigor.

How the Team Works Together

Our integrated care model brings together the following disciplines under one coordinated framework:

Internal Medicine (Dr. Cardenas): Medical diagnosis, pharmacologic management, metabolic monitoring, and specialist coordination
Integrative Chiropractic Care (Dr. Jimenez): Spinal and peripheral joint optimization, neuromusculoskeletal rehabilitation, and autonomic nervous system support
Functional Medicine: Individualized nutrition therapy, anti-inflammatory protocols, sleep optimization, and stress reduction
Personal Injury Care: Non-pharmacologic inflammation management and post-injury recovery
Rehabilitation: Progressive cardiopulmonary conditioning, resistance training, balance work, and gait retraining

Where Integrative Chiropractic Care Fits in Cardio-Renal Disease Management

One of the most common questions I receive is: “What does chiropractic care have to do with diabetes or kidney disease?” The answer lies in understanding the body as a fully interconnected system.

Autonomic Nervous System Regulation

The autonomic nervous system (ANS) controls involuntary functions including heart rate, blood pressure, vascular tone, and endocrine activity. The sympathetic and parasympathetic divisions of the ANS originate from specific spinal levels. Vertebral subluxations — subtle misalignments that create mechanical irritation of adjacent neural tissue — can dysregulate autonomic output, contributing to elevated sympathetic tone, increased vascular resistance, and impaired heart rate variability. Through precise chiropractic adjustments, I work to restore proper spinal mechanics and reduce this neurological interference. A well-regulated ANS supports healthier cardiovascular hemodynamics and complements the blood-pressure-lowering effects of SGLT2 inhibitors.

Reducing Systemic Inflammation

Chronic inflammation is a shared driver of insulin resistance, cardiovascular disease, and CKD progression. Chiropractic adjustments reduce mechanical stress on joints and surrounding soft tissues, which has been shown to modulate the production of pro-inflammatory cytokines. By decreasing the body’s overall inflammatory burden, we help create an internal environment more conducive to metabolic healing — working synergistically with the anti-inflammatory effects of improved glycemic control.

Enabling Physical Activity

For a patient like R.B., diabetic neuropathy creates pain, balance instability, and fear of movement. These barriers make regular physical activity feel dangerous or impossible. Physical activity is, however, one of the most powerful tools available for improving insulin sensitivity, lowering blood pressure, and supporting cardiovascular fitness. By addressing joint restrictions, nerve compression, and soft tissue dysfunction through manual therapy and neuromuscular rehabilitation, I make movement accessible again. Personalized programs — low-impact aerobic training, resistance work, and balance exercises — directly synergize with the hemodynamic benefits that SGLT2 inhibitors produce at the pharmacological level.

Nutritional and Lifestyle Synergy

My functional medicine approach to nutrition is specifically calibrated around SGLT2 inhibitor use. Rather than encouraging extreme carbohydrate restriction (which can precipitate euglycemic DKA in these patients), I guide patients toward a moderate-carbohydrate, high-fiber, anti-inflammatory diet that stabilizes glucose flux, supports electrolyte balance, and reduces oxidative stress. Consistent dietary patterns — rather than oscillating high-carb and low-carb cycles — are essential for safety and sustained metabolic improvement.

Key Clinical Takeaways

Move beyond A1C. The true goal of diabetes management is organ protection — preventing heart failure hospitalizations, slowing CKD progression, and reducing cardiovascular mortality.
SGLT2 inhibitors are guideline-recommended irrespective of A1C in patients with established or high-risk ASCVD, heart failure, or CKD.
Patient education transforms compliance into partnership. Addressing fears — such as R.B.’s needle phobia — with demonstration and explanation is often the highest-value intervention in a visit.
Safety protocols are non-negotiable. Sick-day rules, hydration counseling, infection monitoring, and eGFR-based dosing decisions must accompany every SGLT2 inhibitor prescription.
Integrative care amplifies pharmacologic benefits. Chiropractic care, functional nutrition, and supervised rehabilitation address the structural, autonomic, and lifestyle dimensions that medication alone cannot reach.
Multidisciplinary oversight produces superior outcomes. The combination of internal medicine expertise, chiropractic care, and functional medicine creates a comprehensive support system capable of transforming the trajectory of complex chronic disease.

References

American Association of Clinical Endocrinology. (2022). AACE clinical practice guideline: Developing a diabetes comprehensive care plan — 2022 update. Endocrine Practice. https://www.endocrinepractice.org/article/S1530-891X(22)00631-5/fulltext
American Diabetes Association. (2024). Standards of medical care in diabetes — 2024. Diabetes Care, 47(Suppl. 1). https://doi.org/10.2337/dc24-S011
Cannon, C. P., Pratley, R., Dagogo-Jack, S., Mancuso, J., Huyck, S., Masiukiewicz, U., Charbonnel, B., Frederich, R., Gallo, S., Cosentino, F., Cherney, D. Z. I., & McGuire, D. K. (2020). Cardiovascular outcomes with ertugliflozin in type 2 diabetes. New England Journal of Medicine, 383(15), 1425–1435. https://www.nejm.org/doi/full/10.1056/NEJMoa2004967
Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., Sjöström, C. D., Toto, R. D., & Wheeler, D. C. (2020). Dapagliflozin in patients with chronic kidney disease. New England Journal of Medicine, 383(15), 1436–1446. https://www.nejm.org/doi/full/10.1056/NEJMoa2024816
Herrington, W. G., Staplin, N., Wanner, C., Green, J. B., Hauske, S. J., Emberson, J. R., Preiss, D., Judge, P., Mayne, K. J., Ng, S. Y., Sammons, E., Zhu, D., Hill, M., Stevens, W., Wallendszus, K., Brenner, S., Cheung, A. K., Liu, Z.-H., Li, J., … Landray, M. J. (2023). Empagliflozin in patients with chronic kidney disease. New England Journal of Medicine, 388(2), 117–127. https://www.nejm.org/doi/full/10.1056/NEJMoa2204233
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., Vilsbøll, T., Hansen, O., & Buse, J. B. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834–1844. https://www.nejm.org/doi/full/10.1056/NEJMoa1607141
McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., Böhm, M., Chiang, C.-E., Chopra, V. K., de Boer, R. A., Desai, A. S., Diez, M., Drozdz, J., Dukát, A., & Feng, S. (2019). Dapagliflozin in patients with heart failure and reduced ejection fraction. New England Journal of Medicine, 381(21), 1995–2008. https://www.nejm.org/doi/full/10.1056/NEJMoa1911925
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017). Canagliflozin and cardiovascular and renal events in type 2 diabetes. New England Journal of Medicine, 377(7), 644–657. https://www.nejm.org/doi/full/10.1056/NEJMoa1611925
Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., Cannon, C. P., Capuano, G., Chu, P.-L., de Zeeuw, D., Greene, T., Levin, A., Pollock, C., Wheeler, D. C., Yavin, Y., … Mahaffey, K. W. (2019). Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. New England Journal of Medicine, 380(24), 2295–2306. https://www.nejm.org/doi/full/10.1056/NEJMoa1811744
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Inzucchi, S. E. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), 2117–2128. https://www.nejm.org/doi/full/10.1056/NEJMoa1504720

SEO Tags: SGLT2 inhibitors, cardio-renal protection, type 2 diabetes management, chronic kidney disease treatment, heart failure prevention, dapagliflozin, empagliflozin, canagliflozin, semaglutide, GLP-1 receptor agonists, ADA guidelines 2024, AACE diabetes guidelines, integrative chiropractic care, functional medicine El Paso, Dr. Alex Jimenez DC APRN, Dr. Maria Guadalupe Cardenas MD, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, continuous glucose monitor, A1C reduction, diabetic neuropathy, albuminuria, eGFR improvement, RAAS activation, osmotic diuresis, intraglomerular pressure, euglycemic DKA, multidisciplinary diabetes care, cardiometabolic health, insulin resistance, autonomic nervous system, systemic inflammation, evidence-based diabetes treatment

Cardiometabolic Mechanisms with GLP-1 Receptor Therapy

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Learn how GLP-1 receptor therapy and cardiometabolic approaches can aid in managing chronic conditions in the body.

Abstract

In this educational post, I walk you through the modern transformation of type 2 diabetes care: a shift from a glucocentric approach to a comprehensive, cardio-renal-metabolic strategy. I synthesize landmark cardiovascular outcome trials (CVOTs) and current guidelines to explain how newer therapies—particularly sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists—deliver robust cardiovascular and renal protection beyond glucose control (American Diabetes Association Professional Practice Committee, 2024; Gerstein et al., 2019; Marso, Bain, et al., 2016; Zinman et al., 2015). I also detail clinical decision-making around over-basalization, why escalating basal insulin often fails, and why prioritizing GLP-1 receptor agonists before prandial insulin frequently achieves superior outcomes. Throughout, I explain how our multidisciplinary model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas integrates chiropractic care, functional medicine, rehabilitation, and personal injury services under the medical direction of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). Together, we blend evidence-based pharmacology with integrative chiropractic care to improve metabolic resilience, reduce systemic inflammation, and elevate long-term quality of life.

About Our Multidisciplinary, Patient-Centered Model in El Paso, Texas

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. At Injury Medical Clinic PA—also known as Mission Plaza Injury Medical Clinic—we operate a multidisciplinary and integrative model that is common in progressive injury and chronic care settings. Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), brings over 40 years of experience in internal medicine. Her oversight ensures our treatment plans align with rigorous medical standards while leveraging the full capabilities of our team.

How we integrate care:

Medical oversight by Internal Medicine (Dr. Cardenas): Cardiometabolic risk assessment, medication management, safety monitoring, guideline-based protocols.
Chiropractic care (Dr. Jimenez): Neuromusculoskeletal optimization, autonomic balance, pain reduction, movement restoration.
Functional medicine: Nutrition, inflammation and gut health strategies, metabolic resilience, targeted supplementation.
Rehabilitation: Strength preservation, mobility retraining, aerobic conditioning to improve insulin sensitivity.
Personal injury services: Coordinated care pathways addressing biomechanical dysfunction that often coexists with metabolic disease.

This integrated model allows us to manage complex diabetes, cardiovascular risk, kidney health, and musculoskeletal issues in a unified, patient-centered way. Clinical observations from our practice, including those shared on Sciatica Clinic and my professional profile, underscore how restoring movement, reducing pain, and addressing lifestyle drivers elevate outcomes across metabolic and cardiovascular domains.

The New Paradigm: Beyond Glucose Control to Cardio-Renal-Metabolic Protection

For decades, diabetes care focused almost exclusively on lowering blood glucose. We now know that patients with type 2 diabetes face a disproportionately high risk of atherosclerotic cardiovascular disease (ASCVD)—including heart attack, stroke, and cardiovascular death—and progression of chronic kidney disease (CKD). Landmark guideline updates harmonize a broader set of priorities (American Diabetes Association Professional Practice Committee, 2024):

Blood pressure management
Lipid control and plaque stabilization
Glycemic control beyond A1C alone
Weight reduction and visceral adiposity targeting
Physical activity and fitness
Smoking cessation
Cardiorenal protection using GLP-1 receptor agonists and SGLT2 inhibitors

Why this matters: More than 70% of people with diabetes older than 65 ultimately succumb to heart disease or stroke. Even with “good” A1C numbers, outcomes after a cardiovascular event are worse in diabetes. Thus, modern therapy must directly reduce major adverse cardiovascular events (MACE) and slow renal decline, not just lower sugar.

Why the FDA Mandated CVOTs—and How Trials Changed the Field

In 2008, the FDA required long-term cardiovascular outcomes trials (CVOTs) for new diabetes drugs to ensure they did not increase MACE. Unexpectedly, several CVOTs demonstrated clear cardiovascular benefit, shifting guidelines in favor of therapies with proven outcomes:

EMPA-REG OUTCOME (empagliflozin, SGLT2): Significant reductions in cardiovascular death and heart failure hospitalization (Zinman et al., 2015).
CANVAS (canagliflozin, SGLT2): Reduced MACE and heart failure hospitalization (Neal et al., 2017).
DECLARE-TIMI 58 (dapagliflozin, SGLT2): Reduced heart failure hospitalization and beneficial renal signals (Wiviott et al., 2019).
LEADER (liraglutide, GLP-1): Reduced MACE and cardiovascular death (Marso, Daniels, et al., 2016).
SUSTAIN-6 (semaglutide, GLP-1): Reduced MACE (Marso, Bain, et al., 2016).
REWIND (dulaglutide, GLP-1): Risk reduction even in primary prevention cohorts, broad applicability (Gerstein et al., 2019).

Key takeaway: These trials reoriented treatment toward reducing cardiorenal risk. In many patients—especially with established ASCVD, high risk, or CKD—GLP-1 receptor agonists and SGLT2 inhibitors are prioritized, often in combination, for synergistic protection (American Diabetes Association Professional Practice Committee, 2024).

SGLT2 Inhibitors: Mechanisms That Protect the Heart and Kidneys

The SGLT2 inhibitors lower glucose by increasing urinary glucose excretion. Their benefits, however, emerge from multifactorial physiology:

Hemodynamic effects: Mild natriuresis and osmotic diuresis lower blood pressure, reduce preload/afterload, and unload the heart.
Renal glomerular protection: Afferent arteriolar constriction and reduced intraglomerular pressure improve kidney hemodynamics and reduce albuminuria.
Metabolic remodeling: Promotes modest weight loss, improves insulin sensitivity, decreases inflammation and oxidative stress, and may shift myocardial fuel utilization toward ketones, which are efficient for stressed myocardium.
Vascular benefits: Enhanced endothelial function, plaque stabilization, and reduced vascular stiffness.

Clinical outcomes: Across HFrEF and HFpEF populations—with and without diabetes—SGLT2 inhibitors reduce heart failure hospitalization by 25–35% and slow CKD progression. This is why they are considered foundational therapy for heart failure and CKD risk reduction (Zinman et al., 2015; Wiviott et al., 2019; Packer et al., 2020).

How we use them in clinic:

A1C lowering: About 0.7–1.0%.
Combination strategies: Commonly paired with metformin to simplify regimens.
Practical counseling: Hydration, morning dosing to reduce nocturia, and meticulous genital hygiene to mitigate mycotic infection risk.

GLP-1 Receptor Agonists: Restoring Incretin Physiology for Metabolic and Cardiovascular Gain

The incretin effect—robust insulin response to oral glucose—depends on gut hormones, chiefly GLP-1. In type 2 diabetes, this system is blunted, fueling hyperglycemia and appetite dysregulation. GLP-1 receptor agonists pharmacologically restore these signals (Drucker, 2018):

Pancreatic actions: Increase glucose-dependent insulin secretion and suppress glucagon secretion, thereby reducing hepatic glucose output.
Gastric emptying: Slow transit to enhance satiety, lower postprandial spikes, and reduce caloric intake.
Central appetite regulation: Act on hypothalamic pathways to decrease hunger and cravings.
Hepatic effects: Reduce gluconeogenesis and improve lipid handling.

Clinical impact:

A1C reduction: Often 1.0–1.5% with dose titration.
Weight loss: Meaningful reductions in adiposity, visceral fat, and cardiometabolic risk.
CV outcomes: Trials such as LEADER, SUSTAIN-6, and REWIND demonstrate reductions in MACE, with signals for renal protection and reduced progression of albuminuria (Gerstein et al., 2019; Marso, Bain, et al., 2016; Marso, Daniels, et al., 2016).
Broader exploration: Emerging evidence for benefits across NAFLD/MASH, neuroinflammation, and appetite dysregulation, aligning with their systemic anti-inflammatory and metabolic effects.

Practical considerations:

Start low, go slow: Titrate gradually to minimize GI effects (nausea, constipation, diarrhea).
Contraindications: Avoid in personal/family history of medullary thyroid carcinoma or MEN 2.
Safety pearls: Monitor hydration to prevent AKI during GI symptoms; counsel on gallbladder risk with rapid weight loss. Large datasets show no significant increase in the risk of pancreatitis, and overall metabolic improvement likely reduces lifetime risk.

Over-Basalization: Recognizing When More Basal Insulin Stops Helping

A common clinical trap is over-basalization—escalating basal insulin beyond the point of effective glycemic control. Signals that basal insulin is excessive include:

Basal dose exceeds ~0.5 units/kg/day with diminishing returns.
Postprandial glucose consistently >180 mg/dL, despite reasonable fasting.
A1C remains above goal while morning readings look acceptable.
Bedtime-to-morning differential larger than ~50 mg/dL, indicating prandial hyperglycemia is unaddressed.

Why this happens: Basal insulin targets hepatic glucose production and fasting levels. It cannot adequately suppress postprandial excursions driven by meals, gut hormones, and misregulated glucagon. Escalating basal doses increases the risk of hypoglycemia, weight gain, and complexity without solving the core problem.

Modern solution: Before adding prandial insulin, consider a GLP-1 receptor agonist. GLP-1 agonists directly target postprandial glucose, reduce appetite, support weight loss, and deliver CV protection—a far more favorable risk-benefit profile for many patients (American Diabetes Association Professional Practice Committee, 2024; Gerstein et al., 2019; Marso, Bain, et al., 2016).

Case Integration: High-Risk Patients and Rational Sequencing

Consider a high-risk profile similar to patients I often see:

Age >55 with multiple risk factors: obesity, hypertension, dyslipidemia, albuminuria/proteinuria.
On metformin, an SGLT2 inhibitor, statin, and ARB.
A1C above goal with postprandial elevations and basal insulin approaching or exceeding 0.5 units/kg/day.

Rational sequencing:

Prioritize a GLP-1 receptor agonist to address postprandial spikes, reduce appetite, and deliver MACE
Continue SGLT2 inhibitor for heart failure and kidney benefits.
Optimize lifestyle and rehabilitation to enhance insulin sensitivity.
Titrate gradually, monitor GI tolerability and hydration, and reassess A1C, weight, and cardiometabolic markers at defined intervals.

Outcome goals: Lower A1C toward individualized targets, reduce visceral adiposity, improve blood pressure and lipid profile, and demonstrate measurable reductions in albuminuria and heart failure risk.

The Silent Threat: Hyperhomocysteinemia and its Impact on Your Health- Video

The Silent Threat: Hyperhomocysteinemia and its Impact on Your Health | El Paso, Tx (2023)

How Integrative Chiropractic Care Enhances Cardio-Renal-Metabolic Health

Chiropractic care may not treat diabetes directly, but it meaningfully influences systemic physiology that interacts with metabolic and cardiovascular health:

Neuromusculoskeletal optimization: Reducing pain and improving biomechanics decrease systemic stress and inflammatory load, thereby favoring insulin sensitivity and adherence to daily activity.
Autonomic regulation: Restoring balance between sympathetic and parasympathetic tone can support blood pressure regulation, sleep quality, and recovery—critical in cardiometabolic disease.
Movement restoration and rehabilitation: Tailored exercise improves mitochondrial function, glucose uptake in muscle, and lipid oxidation, amplifying pharmacologic benefits.
Functional medicine nutrition: Anti-inflammatory dietary patterns, gut health strategies, and targeted supplementation (e.g., omega-3s, magnesium, berberine, alpha-lipoic acid, chromium) can strengthen insulin signaling, reduce hepatic steatosis, and stabilize glycemic variability.

What I observe clinically (as featured on Sciatica Clinic and reinforced in my professional practice):

Patients who regain mobility and reduce pain participate more consistently in structured exercise, leading to meaningful improvements in A1C and weight.
Reductions in chronic pain often correlate with decreased cortisol and sympathetic overdrive, stabilizing glucose patterns and blood pressure.
Combining chiropractic adjustments, soft tissue therapy, and progressive rehabilitation with GLP-1/SGLT2 therapy accelerates improvements in daily function and cardiometabolic resilience.

Team-Based Safety and Quality: Role of the Medical Director

Under Dr. CCardenas’smedical direction:

We screen for contraindications, assess kidney and liver function, and prioritize therapies with CV/renal outcome data.
We synchronize dosing and titration schedules with monitoring plans (A1C, lipids, eGFR, albuminuria, blood pressure).
We coordinate injection education, device training, side-effect mitigation, and contingency plans for GI intolerance (hold medication, hydration, prompt follow-up).
We audit care plans for consistency with ADA Standards of Care and major CVOT evidence, ensuring every intervention is justified, safe, and effective.

This collaborative approach is the backbone of our model—bridging advanced medicine with integrative care to deliver measurable, durable outcomes.

Practical Prescribing and Patient Education

Medication selection and counseling:

SGLT2 inhibitors: Empagliflozin, dapagliflozin, canagliflozin. Emphasize hydration, morning dosing, and hygiene.
GLP-1 receptor agonists: Semaglutide (injectable and oral formulations), dulaglutide, liraglutide; and dual agonists like tirzepatide for potent weight and glycemic effects.
Dosing strategy: Start low, go slow to enhance tolerance; titrate based on A1C, weight, and symptom feedback.
Lifestyle partnership: Reinforce protein sufficiency, resistance training, and aerobic exercise; tailor plans to pain, mobility, and life demands.

Outcome targets:

Reduce MACE risk, improve heart failure hospitalization rates, slow CKD progression, and support sustainable weight loss.
Improve quality-of-life markers: pain, sleep, stress, and functional capacity.

Conclusion: Setting a New Standard of Care

The integration of GLP-1 receptor agonists and SGLT2 inhibitors—supported by robust CVOTs—represents a pivotal advance in type 2 diabetes management. We are moving decisively beyond glucose-only strategies to a cardio-renal-metabolic framework that measurably reduces the most devastating complications of diabetes. In our clinic, the partnership between medical oversight (Dr. Cardenas) and integrative chiropractic care (Dr. Jimenez) ensures that powerful medications are embedded in a holistic, movement-centered, and lifestyle-integrated program. This is modern, evidence-based, patient-centered care—the kind that transforms health trajectories and restores human potential.

References

Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes—2024. (2024). American Diabetes Association Professional Practice Committee. Diabetes Care, 47(Supplement_1), S158–S178.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomized placebo-controlled trial. (2019). Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., et al. The Lancet, 394(10193), 121–130.
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. (2016). Marso, S. P., Bain, S. C., Consoli, A., et al. The New England Journal of Medicine, 375(19), 1834–1844.
Liraglutide and cardiovascular outcomes in type 2 diabetes. (2016). Marso, S. P., Daniels, G. H., Brown-Frandsen, K., et al. The New England Journal of Medicine, 375(4), 311–322.
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. (2015). Zinman, B., Wanner, C., Lachin, J. M., et al. The New England Journal of Medicine, 373(22), 2117–2128.
Dapagliflozin and cardiovascular outcomes in type 2 diabetes. (2019). Wiviott, S. D., Raz, I., Bonaca, M. P., et al. The New England Journal of Medicine, 380(4), 347–357.
Dapagliflozin in patients with heart failure and reduced ejection fraction. (2019). McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., et al. The New England Journal of Medicine, 381(21), 1995–2008.
Cardiovascular and renal outcomes with empagliflozin in heart failure. (2020). Packer, M., Anker, S. D., Butler, J., et al. The New England Journal of Medicine, 383(15), 1413–1424.
Canagliflozin and cardiovascular and renal events in type 2 diabetes. (2017). Neal, B., Perkovic, V., Mahaffey, K. W., et al. The New England Journal of Medicine, 377(7), 644–657.
Mechanisms of action and therapeutic application of glucagon-like peptide-1. (2018). Drucker, D. J. Cell Metabolism, 27(4), 740–756.

SEO Tags: type 2 diabetes, GLP-1 receptor agonists, SGLT2 inhibitors, cardiovascular outcomes, kidney protection, ASCVD risk reduction, MACE, integrative chiropractic care, functional medicine, rehabilitation, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, over-basalization, prandial insulin alternatives, incretin effect, semaglutide, liraglutide, dulaglutide, empagliflozin, dapagliflozin, heart failure, CKD prevention, evidence-based medicine

Peptides Nutrition and Chiropractic Care Integration

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Peptides, Nutrition, and Chiropractic Care: A Team Approach to Healing in El Paso

Peptides are getting more attention in wellness, injury care, and functional medicine. But they should not be viewed as magic shots or cure-all treatments. In an integrated chiropractic clinic, peptides may work best when they are part of a bigger plan that includes chiropractic care, nutrition, rehabilitation, lifestyle change, and medical oversight.

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, focuses on a whole-body model of care. His clinic materials describe a multidisciplinary practice that blends chiropractic care, functional medicine, physical therapy, rehabilitation, personal injury care, and nutrition-focused support. In this model, Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, serves as Medical Director and Collaborative Physician, with clinic materials listing her as NPI #1164426749 and Texas MD License #J2933.

The goal is simple: help the body work better from the inside out.

What Are Peptides?

Peptides are short chains of amino acids. Amino acids are the building blocks of protein. A peptide is usually smaller than a full protein and can act like a message that tells cells what to do. StatPearls defines a peptide as a short string of 2 to 50 amino acids, and notes that peptides play important roles in normal body processes (Forbes Kaprive & Krishnamurthy, 2023).

In simple terms, peptides are like text messages inside the body. They may help guide processes such as:

Tissue repair
Inflammation control
Metabolism
Immune response
Hormone signaling
Cellular communication

Several wellness and chiropractic resources describe peptides as amino-acid messengers that can support tissue repair, metabolism, immune function, and cellular health when used as part of an individualized care plan.

Peptides Are Catalysts, Not Cure-Alls

A catalyst helps a process proceed more efficiently, but it does not do all the work by itself. That is a useful way to understand peptide therapy in an integrative clinic.

For example, a tissue-repair peptide may signal the body to support healing in muscles, tendons, ligaments, or connective tissue. But the body still needs the right raw materials to complete the repair. If a person has poor protein intake, low nutrients, high inflammation, poor sleep, or ongoing joint stress, the peptide signal may not be enough.

This is why peptide therapy should not be treated as a stand-alone solution. ProCredits explains that, in chiropractic settings, peptides may fit best alongside manual therapy, graded loading, sleep, protein intake, and progressive rehabilitation. Back to Wellness Chiropractic also describes peptide therapy as a support tool that may complement chiropractic care, exercise, nutrition, and lifestyle habits.

Nutrition Gives Peptides the Building Blocks

Peptides may send the message, but nutrition supplies the materials.

Think about building a house. The blueprint tells the workers what to build. But without wood, nails, concrete, and tools, the house cannot be finished. Peptides may act like the blueprint. Food supplies the building materials.

Your body needs:

Protein for amino acids
Vitamin C for collagen support
Zinc for tissue repair and immune support
Magnesium for muscle and nerve function
Omega-3 fats to support a healthy inflammatory response
Hydration for circulation and cellular function
Fiber and whole foods for gut and metabolic health

Med Matrix explains that peptides do not work in a vacuum. The body needs protein, vitamins, minerals, gut health, and lab-guided nutrition to respond well to peptide signals. Clean Eatz makes a similar point: tissue-repair peptides cannot build new tissue without raw materials, and adequate protein helps provide the amino acids needed for repair.

Why Protein Matters So Much

Protein is one of the most important parts of a peptide-supportive nutrition plan. Peptides themselves are made of amino acids, and the body uses amino acids to build and repair tissue.

For injury recovery, protein helps support:

Muscle repair
Ligament and tendon remodeling
Collagen production
Immune defense
Blood sugar balance
Lean muscle preservation

This matters in both injury care and weight management. For example, GLP-1 medications and related metabolic therapies may reduce appetite. That can help with weight loss, but if the patient does not eat enough protein, the body may lose muscle along with fat. Clean Eatz notes that high-protein nutrition is important during peptide or GLP-1-based plans because every calorie needs to support lean tissue and metabolic health.

Chiropractic Care and the Nervous System

The nervous system controls and coordinates many body functions. It helps guide movement, pain signals, digestion, muscle tone, balance, and recovery. When the spine or joints are not moving well, the body may guard, tighten, compensate, or move in unhealthy ways.

Chiropractic care focuses on improving spinal and joint function. In an injury or wellness clinic, chiropractic adjustments may help reduce mechanical stress, improve movement, and support better nervous system communication. This does not mean chiropractic care “cures” every condition. It means that better structure and better movement may create a healthier environment for recovery.

Spectrum Pain Management describes the combination of chiropractic care and peptides as a multidisciplinary approach where chiropractic care works on spine and joint function while peptides support cellular-level healing, inflammation control, and pain modulation.

How Peptides, Nutrition, and Chiropractic Work Together

In an integrated clinic, each part of the plan has a job.

Chiropractic care may help improve alignment, movement, joint function, and nervous system balance.

Nutrition may provide the amino acids, vitamins, minerals, and healthy fats needed for repair.

Peptides may send targeted signals that support repair, metabolism, inflammation balance, or recovery.

Rehabilitation may retrain the body so the patient can move safely and build strength.

Medical oversight helps ensure the care plan is appropriate, safe, and aligned with the patient’s medical history.

This is the value of a team-based model. Meeting Point Health describes peptide therapy as a nonsurgical support tool that may help promote tissue repair, reduce inflammation, and support recovery when used with regenerative orthopedic care. The same principle applies in integrative chiropractic care: peptides may work better when the patient also receives structural care, nutrition support, and rehab.

The El Paso Multidisciplinary Model

At Injury Medical Clinic PA in El Paso, Dr. Alex Jimenez brings a dual-scope perspective as both a Doctor of Chiropractic and a board-certified family nurse practitioner. His website lists him as Dr. Alex Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, and describes services that include chiropractic care, functional medicine, personal injury care, sports injury care, rehabilitation, wellness, and nutrition.

Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, adds medical direction and collaborative oversight. This type of setup is common in integrative and injury-focused clinics because many patients need more than one type of care. A person recovering from a car accident, work injury, sports injury, or chronic pain issue may need spinal care, medical screening, lab review, nutrition guidance, rehabilitation, and careful documentation.

Dr. Jimenez’s clinical content also emphasizes functional medicine, musculoskeletal rehabilitation, injury recovery, weight management, body composition, thyroid health, gut health, inflammation, and collaborative care.

What a Patient Plan May Include

A peptide-supported integrative plan may include several steps:

A detailed health history
Injury or pain evaluation
Lab testing when needed
Nutrition review
Protein and hydration goals
Chiropractic adjustments
Rehabilitation exercises
Lifestyle coaching
Medical review by qualified providers
Follow-up tracking

The plan should always be personalized. A patient with a ligament injury may need a different approach than a patient focused on metabolic health. A patient with chronic inflammation may need a different plan than someone recovering from a sports injury.

The key is not to chase trends. The key is to match the treatment to the patient.

Safety and Medical Oversight Matter

Peptide therapy should be handled carefully. Some peptides are FDA-approved for specific medical uses, such as certain GLP-1 medications for diabetes or obesity. Other peptides discussed in wellness spaces are not FDA-approved and may have limited human safety data.

The FDA has warned that certain compounded bulk drug substances, including some peptides, may present safety risks, may have limited safety information, or may raise concerns about impurities, immunogenicity, and route of administration. This is why patients should avoid ordering “research peptides” online or using products without qualified medical guidance.

Responsible care should include:

A licensed provider
Proper screening
Clear goals
Legal sourcing
Pharmacy quality review
Patient education
Follow-up monitoring
A plan that includes nutrition and lifestyle support

Peptides should be used with care, not hype.

Why the “Inside-Out” Approach Makes Sense

Healing is not just about one shot, one adjustment, or one diet. The body repairs itself through many systems working together.

Your nervous system guides communication.
Your muscles and joints help you move.
Your blood flow carries oxygen and nutrients.
Your gut absorbs the food your cells need.
Your immune system manages inflammation.
Your hormones and metabolism affect energy, weight, sleep, and recovery.

Peptides may help send specific signals, but the body still needs a strong foundation. That foundation includes healthy food, enough protein, restorative sleep, hydration, movement, stress control, and proper spinal and joint function.

This is why integrated care can be powerful. It does not rely on one therapy to do everything. It uses the right tools together.

Final Thoughts

Peptides are biological messengers made from amino acids. They may support repair, inflammation balance, metabolism, and cellular communication. But they are not cure-alls. In an integrated chiropractic clinic, peptides are best understood as catalysts that may support a larger plan.

Nutrition gives the body the building blocks. Chiropractic care supports movement and nervous system function. Rehabilitation builds strength and stability. Functional medicine looks for deeper health patterns. Medical oversight helps keep the plan safe and appropriate.

At Injury Medical Clinic PA in El Paso, Texas, the multidisciplinary model led by Dr. Alex Jimenez, DC, APRN, FNP-BC, with medical direction from Dr. Maria Guadalupe Cardenas, MD, reflects this team-based approach. The goal is to help patients recover, function better, and support healing from the inside out.

An Introduction to *FUNCTIONAL MEDICINE* (2021) | El Paso, Tx

References

Back to Wellness Chiropractic. (2026). Peptide therapy in Parker, Colorado.

Clean Eatz. (n.d.). This is peptide nutrition 101.

Forbes Kaprive, J., & Krishnamurthy, K. (2023). Biochemistry, peptide. StatPearls Publishing.

Holistiq. (2026). What are peptides? A practical guide for modern wellness.

Jimenez, A. (2026). El Paso, TX chiropractor Dr. Alex Jimenez, DC | Personal injury specialist.

Jimenez, A. (2026). Dr. Maria Cardenas, MD: Board-certified internal medicine specialist.

Med Matrix. (2026). Nutrition and peptide therapy: How they work together for better results.

Meeting Point Health. (2024). Peptide therapy for injury repair: Faster healing with regenerative orthopedic support.

Parker Chiropractic and Acupuncture. (n.d.). Peptide therapy.

ProCredits. (2025). Peptide therapy for chiropractors: Tissue repair and metabolic health.

Spectrum Pain Management. (2024). Unlocking the power of peptides in pain management: A chiropractic perspective.

U.S. Food and Drug Administration. (2026). Certain bulk drug substances for use in compounding that may present significant safety risks.

Integrative Care and Treatment for Cardiorenal Syndrome

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Uncover the benefits of integrative care for cardiorenal syndrome in achieving optimal patient outcomes and well-being.

Abstract

Welcome to our educational post where we delve into the intricate relationship between the heart and the kidneys, a condition known as Cardiorenal Syndrome (CRS). I am Dr. Alex Jimenez, and today, we will embark on a journey to understand the modern, evidence-based understanding of this dynamic crosstalk in acute and chronic heart failure. We will explore the latest findings from leading researchers, examining the physiological mechanisms—neurohormonal activation, inflammation, renal tubular injury, and splanchnic congestion—that drive worsening cardiac and renal function. This post will detail how we assess and evaluate patients, distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD), and cover a comprehensive diagnostic and treatment plan. Furthermore, we will explain how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, integrates medical oversight by Dr. Maria Guadalupe Cardenas, MD, with my integrative chiropractic care, functional medicine protocols, personal injury management, and rehabilitation to provide comprehensive, evidence-based treatment for our patients. You will learn why we tailor diuretic strategies, optimize guideline-directed medical therapy (GDMT), and leverage lifestyle, biomechanical, and autonomic-regulating approaches to improve outcomes.

Our Integrative Team: A Collaborative Model of Care

At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, we pride ourselves on a unique, multidisciplinary approach to patient care. I, Dr. Alex Jimenez, bring my expertise as a Doctor of Chiropractic (DC), an Advanced Practice Registered Nurse (APRN) with board certification as a Family Nurse Practitioner (FNP-BC), and certifications in Functional Medicine (CFMP, IFMCP). My focus is on understanding the body as an interconnected system and utilizing non-invasive, evidence-based therapies to restore function and well-being.

Our practice is fortified by the invaluable expertise of our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933). With over 40 years of profound experience as an internist, Dr. Cardenas provides the crucial medical direction and oversight typical of multidisciplinary, integrative, and injury-care clinics where an MD collaborates with a chiropractor. This collaborative model allows us to blend the best of chiropractic, functional medicine, and conventional medicine. Together, we coordinate a spectrum of services, including medical management, integrative chiropractic care, functional medicine, rehabilitation, and personal injury services to address complex cardiometabolic, musculoskeletal, and personal injury needs, ensuring our patients receive holistic and personalized treatment plans.

Cardiorenal Syndrome: The Heart–Kidney Crosstalk

When I care for patients with heart failure, the heart–kidney axis is central. The heart is not just a pump; it is an endocrine organ producing atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP/NT-proBNP), and C-type natriuretic peptide (CNP). The kidneys—and the adrenal system—produce renin, angiotensin I/II, and aldosterone (via the RAAS pathway). In health, these systems maintain balance: natriuretic peptides promote vasodilation and natriuresis (salt and water excretion), while RAAS promotes vasoconstriction and sodium/water retention.

In heart failure, decreased cardiac output and elevated filling pressures trigger chronic RAAS and sympathetic nervous system (SNS) activation. Initially compensatory, these mechanisms become maladaptive, driving fluid retention, venous congestion, and renal injury. Over time, the kidney’s endocrine power predominates. A persistently elevated NT-proBNP is not just a sign of “heart stretch”—it reflects an endocrine attempt to counter RAAS, much like a rising TSH in hypothyroidism tries to stimulate the thyroid. Clinically, I watch this tug-of-war: the kidneys tend to win unless we intervene decisively.

The Evolution of Thought: From Forward Flow to Backward Flow

To fully grasp the current approach to managing Cardiorenal Syndrome, it is helpful to look at how our understanding has evolved. A little over forty years ago, with the rise of cardiac transplantation, we gained unprecedented access to hemodynamic data through right heart catheterizations. Initially, the prevailing belief was that contractility—the heart’s pumping strength—was the most critical factor. The focus was on improving “forward flow.” High filling pressures and the resulting congestion were seen as a necessary “cost of doing business” to maintain cardiac output.

As we gathered more hemodynamic data, our focus shifted. We began to appreciate the role of systemic vascular resistance (SVR), the resistance the heart must overcome. This led to increased use of vasodilators to lower SVR, thereby reducing afterload on the heart.

The Underappreciated Hero: The Right Ventricle

For many years, the right ventricle (RV) was overlooked, often seen as a passive conduit. All attention was on the left ventricle (LV), the “beast” that pumps blood to the body. However, we now recognize the profound importance of the right ventricle. The RV is our priming pump, managing venous return and determining how much blood gets to the LV. When the RV struggles, it leads to a pressure backup throughout the venous system. This is where the concept of “backward flow” failure becomes critical. The rising venous pressure within the abdominal organs—the portal vein, the splenic vein, and crucially, the renal vein—is the real culprit behind much of the organ dysfunction in advanced heart failure.

Abdominal and Splanchnic Congestion: The Hidden Reservoir

My clinical observations have shown that fluid does not just accumulate in the legs or lungs; it begins to pack itself into the abdominal cavity, a process known as visceral or splanchnic congestion. This is the vascular bed of the liver, spleen, omentum, and intestines.

The liver and spleen become enlarged (splenomegaly).
Fluid builds up around the intestines and within the abdominal wall muscles, causing abdominal wall edema.
This is not the same as ascites (free fluid in the peritoneal cavity) but a deep, organ-level congestion.

When we perform echocardiograms, we often see the inferior vena cava (IVC) is “plump” and does not collapse properly during inspiration—a clear sign of high venous pressure. This abdominal congestion elevates intra-abdominal pressure, impairs renal venous outflow, reduces effective renal perfusion, and worsens diuretic responsiveness. When patients report bloating, early satiety, or right upper quadrant discomfort, I suspect splanchnic pooling. This aligns with current research recognizing the critical role of venous congestion—not just low perfusion—in cardiorenal deterioration (Damman et al., 2014; Mullens et al., 2020).

The Kidney Under Pressure: Understanding Veno-Renal Dynamics

The kidneys operate on a pressure gradient. Think of the glomerulus as a filter where arterial blood enters under high pressure and exits into the low-pressure venous system. This wide pressure gradient is essential for efficient filtration. When venous pressure rises due to systemic congestion, this gradient narrows, filtration becomes less effective, and the kidneys become “congested.” This has led to a paradigm shift from a “pre-renal” view (blaming low blood flow to the kidneys) to a more nuanced “veno-renal” understanding. We now know that it is equally important, if not more so, to decongest the kidneys by lowering venous pressure.

Initial Diagnostic Workup: Uncovering the Root Cause

When a patient presents with shortness of breath (dyspnea), a comprehensive diagnostic panel is essential.

Assessing Kidney Function: Baseline is Key

One of the first and most critical steps is to determine the patient’s baseline renal function. A patient may arrive at the hospital with a creatinine of 1.9 mg/dL, suggesting an Acute Kidney Injury (AKI). However, their history might reveal their creatinine has been stable at that level for months. This distinction helps us differentiate between true AKI, AKI on Chronic Kidney Disease (CKD), and their stable, chronic state, and helps set realistic treatment goals.

While creatinine is common, I increasingly rely on the Glomerular Filtration Rate (GFR), which provides a more accurate measure of kidney function and is crucial for medication dosing. Modern therapies like SGLT2 inhibitors have specific GFR thresholds for safe initiation. The GFR also helps us stage CKD from Stage 1 (GFR > 90) to Stage 5 (GFR < 15), at which point dialysis discussions begin.

Essential Laboratory Tests

Complete Blood Count (CBC): This helps rule out other causes of dyspnea, such as anemia, which can mimic heart failure symptoms. I have seen cases where severe dyspnea was not from worsening heart failure but from a critically low hemoglobin of 5 g/dL. Correcting the anemia can lead to dramatic improvement (Anker et al., 2018).
Comprehensive Metabolic Panel (CMP): I prefer a CMP because it includes liver function tests. The liver and kidneys are “ide or die friends”; when one struggles, the other often follows. Liver congestion from heart failure can elevate liver enzymes, which can provide crucial context.
BNP or Pro-BNP: These key biomarkers indicate heart stress and strain.
Lactate: Elevated lactate is a marker of poor perfusion. In heart failure, it helps me risk-stratify patients and suggests malperfusion, meaning I need to be more aggressive with treatment.
Troponin: This is used to assess for acute myocardial injury, such as a heart attack.
Urinalysis and Urine Microalbumin: I look for proteinuria (protein in the urine). Gross proteinuria might suggest a disease like nephrotic syndrome, which can cause severe swelling (anasarca) mistaken for heart failure.

Imaging and Other Diagnostic Tools

Echocardiogram: This ultrasound of the heart is vital for assessing its structure and ejection fraction. My general rule is to order a new echo if the patient has not had one in the last six months.
Renal Ultrasound: This is crucial to rule out a post-obstructive process, such as hydronephrosis (swelling of the kidneys due to urine backup).
12-Lead EKG: An electrocardiogram helps me look for signs of ischemia or arrhythmias, such as atrial fibrillation (A-Fib).

The Pertinent Physical Assessment

I rely on the New York Heart Association (NYHA) functional classification to quantify the impact of heart failure on a patient’s daily life, from Class I (no limitation) to Class IV (symptoms at rest). Key signs of congestion include:

Orthopnea: Shortness of breath when lying flat. I often ask, “How many pillows do you sleep on?”
Paroxysmal Nocturnal Dyspnea (PND): Waking up suddenly at night feeling breathless, often described as a “feeling of panic.”
Bendopnea: A specific sign where a patient becomes short of breath from bending over to tie their shoes.
Dyspnea on Exertion (DOE): I ask about specific functional activities, such as “Can you push a vacuum cleaner?”
Other Signs: Weight gain, early satiety, abdominal bloating, and peripheral edema.

Phenotypes of Cardiorenal Syndrome

To tailor treatment, we identify the CRS phenotype:

Type 1 (Acute Cardiorenal): Acute heart failure leads to AKI.
Type 2 (Chronic Cardiorenal): Chronic heart failure causes progressive CKD.
Type 3 (Acute Renocardiac): AKI causes acute heart failure.
Type 4 (Chronic Renocardiac): CKD leads to cardiac dysfunction.
Type 5 (Secondary): A systemic condition (e.g., lupus, sepsis) causes simultaneous heart and kidney dysfunction.

Optimizing Diuretic Therapy for Decongestion

When a patient is volume overloaded, diuretic therapy is a cornerstone. To optimize outcomes, I tailor the choice and dose to the site of action in the nephron.

Loop Diuretics: Choosing the Right Agent and Dose

The three agents I preferentially use are furosemide, torsemide, and bumetanide.

Potency and Equivalence (oral): 40 mg furosemide ≈ 20 mg torsemide ≈ 1 mg bumetanide.
Bioavailability: Oral furosemide has highly variable bioavailability (10-100%), making it unpredictable. Torsemide and bumetanide offer 80-100% bioavailability and more consistent effects. Because of this, I rarely use oral furosemide and favor torsemide or bumetanide for outpatient control.
Dosing Rhythm: To minimize nocturia and fall risk, I time doses early morning and mid-afternoon.

A mild rise in creatinine after starting loop diuretics is often RAAS-mediated rather than AKI. I do not reflexively stop them unless there are signs of true hypoperfusion. When the diuretic ceiling is reached, I add a thiazide-type diuretic (e.g., metolazone) to achieve sequential nephron blockade rather than escalating loop diuretic doses.

Guideline-Directed Medical Therapy and Advanced Support

Improving cardiac performance unloads the venous system and benefits renal perfusion.

Key Therapies: ARNI (sacubitril/valsartan), ACE inhibitors/ARBs, MRAs (mineralocorticoid receptor antagonists), and SGLT2 inhibitors are foundational. Dr. Cardenas oversees selection and safety, ensuring we balance benefits with renal function and hyperkalemia risks.
SGLT2 inhibitors such as dapagliflozin and empagliflozin are game-changers. They can be initiated at an eGFR ≥ 20 mL/min/1.73 m² and confer cardio-renal protection even without diabetes (McMurray et al., 2019; Heerspink et al., 2020). They promote modest natriuresis and improve tubuloglomerular feedback.
Inotrope Support: For patients with refractory low urine output, temporary inotropes like dobutamine or milrinone can improve cardiac output and renal perfusion.
Ultrafiltration and Mechanical Support: For extreme fluid overload, we collaborate with nephrology for ultrafiltration. In severe cases, temporary mechanical circulatory support (Impella, Protek Duo, ECMO) can be lifesaving.

Beating the Odds: “Conquering Congestive Heart Failure”- Video

Beating the Odds: "Conquering Congestive Heart Failure" | El Paso, Tx (2023)

Integrative Chiropractic Care in Cardiorenal Management

Patients often ask how chiropractic integrates with heart and kidney care. Our approach is evidence-guided and coordinated with medical oversight. The nervous system, housed within the spine, is the master controller of every organ. Spinal misalignments, or subluxations, can interfere with the autonomic nervous system, disrupting signals that regulate heart rate, blood pressure, and kidney function.

Autonomic Regulation: Gentle, low-force chiropractic techniques and targeted myofascial work reduce sympathetic overdrive and improve parasympathetic tone. Because SNS overactivation fuels inflammation and RAAS, calming the autonomic nervous system supports hemodynamic stability.
Thoracic Mobility and Respiratory Mechanics: Improving rib cage and thoracic spine motion enhances ventilatory efficiency, reduces dyspnea, and promotes venous return through better diaphragmatic excursion. This “respiratory pump” is a major driver of venous and lymphatic return.
Postural and Biomechanical Optimization: Correcting kyphosis and forward head posture can lower intra-abdominal pressure, potentially diminishing venous stasis in the splanchnic bed.
Pain Reduction and Mobility: Reduced pain decreases catecholamine release and afterload, supporting cardiovascular efficiency. Improved mobility encourages graded activity, enhancing skeletal muscle pump function.

I have observed in clinical practice that patients who adopt optimized thoracic and diaphragmatic mechanics, alongside medical decongestion, often report faster relief of abdominal bloating and orthopnea. You can explore additional clinical observations at my sciatica resource and professional page:

Functional Medicine and Rehabilitation: Addressing Root Drivers

We combine functional medicine with rehabilitation to support cardio-renal physiology:

Nutrition: Personalized sodium targets, adequate protein, and cautious potassium and magnesium
Glycemic Control: Addressing insulin resistance, which worsens RAAS signaling.
Sleep and Breathing: Treating sleep apnea to reduce nocturnal SNS surges.
Graded Activity: Cardiorespiratory-friendly rehabilitation boosts the skeletal muscle pump and lowers venous congestion.

Putting It All Together: A Patient-Centered Plan

This synergy of medical direction from Dr. Cardenas, integrative chiropractic care from me, and functional medicine and rehabilitation targets the physiological drivers—congestion, RAAS/SNS overactivation, inflammation, and mechanical inefficiencies—to achieve more durable improvement. Patients can expect a clear plan to relieve congestion, close monitoring of kidney function, hands-on care to improve breathing mechanics, and practical coaching aligned with their medical therapy. By combining precise pharmacology with guideline-supported therapies and an integrative framework, we can restore hemodynamic balance and protect renal function to improve quality of life.

References

SEO Tags: cardiorenal syndrome, heart failure, kidney disease, RAAS, venous congestion, diuretic therapy, SGLT2 inhibitors, ARNI, integrative chiropractic care, functional medicine, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas MD, El Paso Injury Medical Clinic, El Paso Chiropractor, splanchnic congestion, autonomic nervous system, rehabilitation, personal injury care, NYHA Classification, GFR, creatinine, AKI, CKD, diuretic resistance, torsemide vs furosemide, mechanical circulatory support Impella

Arm and Shoulder Injuries After Auto Accidents: Treatment

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Arm and Shoulder Injuries After Auto Accidents: Integrated Care for Pain, Healing, and Function

Arm and shoulder pain after a car accident can feel confusing. Some people feel pain right away. Others feel okay at first, then notice stiffness, weakness, numbness, or sharp pain hours or days later. This can happen because the body releases adrenaline during a crash, which may hide symptoms for a short time.

Motor vehicle accidents can injure the shoulder, collarbone, upper arm, elbow, wrist, and hand. These injuries often happen from direct impact, seatbelt force, airbag deployment, or bracing for impact by gripping the steering wheel or pushing against the dashboard. Complete Care notes that bracing, gripping the wheel, whiplash trauma, body position, and seatbelt use can affect the type and severity of shoulder and arm injuries after a crash (Complete Care, 2025).

Why Auto Accidents Hurt the Shoulder and Arm

The shoulder is one of the most mobile joints in the body. It lets the arm lift, reach, rotate, push, pull, and stabilize the upper body. Because it moves so much, it also depends on the coordinated work of muscles, tendons, ligaments, cartilage, and nerves.

During an auto crash, the shoulder may be injured by:

A seatbelt pulling hard across the chest and shoulder
The arm hitting the door, steering wheel, dashboard, or airbag
The driver or passenger bracing for impact
The head and neck snapping forward and backward in whiplash
The shoulder being forced outside its normal range of motion
Compression through the collarbone, ribs, or upper arm

Even a low-speed crash can cause shoulder pain because the body is thrown forward, twisted, or restrained in a split second. Shoulder trauma can affect bones, tendons, soft tissue, and nerves. The Dominguez Firm notes that shoulder injuries after car accidents may involve nerves, tendons, soft tissue, bones, the rotator cuff, neck pain, and arm injuries (Dominguez Firm, n.d.).

Common Arm and Shoulder Injuries After a Crash

Auto accident trauma can cause several types of injuries. Some injuries are mild and heal with conservative care. Others may need imaging, specialist evaluation, injections, rehabilitation, or surgery.

Common injuries include:

Rotator cuff tears
Shoulder sprains and strains
Collarbone fractures
Upper arm fractures
Shoulder dislocations
Labral tears
Deep bruising and soft-tissue trauma
Nerve irritation or nerve compression
Whiplash-related shoulder and arm pain
Wrist, hand, or elbow injuries from bracing

Alexander Orthopaedics lists rotator cuff tears, fractures, dislocations, whiplash-related shoulder pain, bruising, sprains, and strains as common shoulder injuries after car accidents (Alexander Orthopaedics, 2023).

Rotator Cuff Tears

The rotator cuff is a group of muscles and tendons that helps keep the upper arm bone stable in the shoulder socket. It also helps the arm lift and rotate. A crash can tear the rotator cuff when the shoulder is pulled, twisted, hit, or suddenly overloaded.

A rotator cuff injury may cause:

Pain at the top or side of the shoulder
Pain that travels toward the elbow
Weakness when lifting the arm
Pain when reaching overhead
Clicking, grinding, or catching
Trouble sleeping on the injured side
Loss of shoulder motion

Bupa explains that rotator cuff tears can occur suddenly after an accident and may cause pain, weakness, limited range of motion, and clicking or grating with movement (Bupa, n.d.).

Fractures of the Collarbone, Shoulder, or Upper Arm

A fracture is a broken bone. In an auto accident, fractures can happen when the shoulder hits the door, dashboard, steering wheel, or pavement after a motorcycle crash. The collarbone can also break from seatbelt pressure or a direct blow.

Common fracture sites include:

Clavicle, or collarbone
Humerus, or upper arm bone
Scapula, or shoulder blade
Bones near the shoulder socket

Fractures may cause severe pain, swelling, bruising, deformity, and trouble moving the arm. Hull & Zimmerman note that shoulder injuries after car accidents may affect the upper arm, collarbone, shoulder blade, muscles, soft tissues, and ligaments (Hull & Zimmerman, 2025).

Shoulder Dislocations

A shoulder dislocation happens when the upper arm bone comes out of the shoulder socket. This can happen during a crash when the arm is forced backward, outward, or upward. The American Academy of Orthopaedic Surgeons explains that shoulder dislocations can occur after trauma, including a motor vehicle collision (AAOS, n.d.).

A dislocated shoulder may cause:

Sudden severe pain
A visible change in shoulder shape
Weakness
Numbness or tingling
Trouble moving the arm
A feeling that the shoulder is unstable

A dislocation should be treated by a trained healthcare provider. A person should not try to force the shoulder back into place at home.

Sprains, Strains, and Soft-Tissue Injuries

Not every painful shoulder injury shows up as a broken bone. Many accident injuries affect soft tissues, including muscles, tendons, ligaments, and fascia. A sprain happens when ligaments are stretched or torn. A strain happens when muscles or tendons are overstretched or injured.

Soft-tissue injuries may cause:

Aching pain
Swelling
Bruising
Muscle spasms
Stiffness
Reduced range of motion
Pain that gets worse with movement

Cleveland Clinic explains that soft-tissue injuries include sprains, strains, contusions, and tendon injuries, and that injuries that do not heal well may lead to instability, chronic inflammation, or long-term tissue problems (Cleveland Clinic, 2025).

Nerve Pain After Shoulder Trauma

Some patients feel pain that travels from the neck or shoulder into the arm, wrist, or hand. This may happen when muscles swell, joints lose normal motion, or nerves are irritated after whiplash or shoulder trauma.

Nerve-related symptoms can include:

Burning pain
Numbness
Tingling
Weak grip
Arm heaviness
Pain that travels below the elbow

These symptoms should be evaluated. They may come from the shoulder, neck, brachial plexus, or spinal nerve roots.

Why Early Evaluation Matters

After a crash, pain alone does not always show how serious the injury is. A small ache may turn into a bigger problem if the shoulder joint becomes stiff, unstable, or inflamed. Alexander Orthopedics notes that shoulder injuries after car accidents can be difficult to assess based on pain alone and may require examination, range-of-motion testing, X-rays, MRI, CT arthrogram, or other imaging, depending on the suspected injury (Alexander Orthopedics, 2023).

A thorough evaluation may include:

Health history
Crash-mechanism review
Orthopedic tests
Neurologic screening
Range-of-motion testing
Strength testing
X-rays for possible fracture
MRI or ultrasound for soft-tissue injury
Referral when advanced care is needed

A Multidisciplinary Path to Recovery

Arm and shoulder injuries after auto accidents often need more than one type of care. Pain control alone may not restore motion. Exercise alone may not correct joint irritation. Chiropractic care alone may not heal a torn tendon. A coordinated plan can help each part of recovery work together.

An integrative clinic may combine:

Chiropractic adjustments
Rehabilitation exercises
Functional medicine support
Personal injury documentation
Physical therapy-style movement care
PRP, PFP, or MFAT when clinically appropriate
Epidural spinal injections for spine-related nerve pain
IV infusion therapies for hydration and nutrient support
Shockwave therapy
MLS laser therapy
Spinal decompression
Graston technique
Cupping
Home exercise and posture training

This type of model looks at structure, inflammation, tissue repair, nerve irritation, and function.

Chiropractic Care and Rehabilitation

Chiropractic care focuses on joint motion, spinal alignment, muscle balance, and nervous system function. After a crash, the neck, upper back, ribs, and shoulder girdle may all become stiff or irritated. Gentle chiropractic adjustments may help restore normal movement and reduce mechanical stress.

Rehabilitation then builds strength and control. This matters because the shoulder needs stable muscles to move safely. Bupa explains that physiotherapy can help improve shoulder strength and mobility after a rotator cuff injury, while treatment depends on the type and severity of the injury, age, and activity level (Bupa, n.d.).

Rehabilitation may include:

Range-of-motion work
Rotator cuff strengthening
Scapular stabilization
Neck and upper-back mobility
Posture correction
Grip and arm strengthening
Progressive return-to-work or return-to-sport drills

Regenerative Therapies: PRP, PFP, and MFAT

Regenerative therapies are used to support the body’s repair process. They are not magic fixes, and they are not right for every patient. However, they may be considered when soft tissue, ligaments, tendons, or joints need added healing support.

PRP, or platelet-rich plasma, uses a patient’s own blood. The blood is processed to concentrate platelets, which contain growth factors involved in tissue repair. Johns Hopkins Medicine describes PRP as a treatment that uses concentrated platelets to support the body’s healing process and to help with muscles, tendons, ligaments, pain, mobility, and inflammation when clinically appropriate (Johns Hopkins Medicine, n.d.).

Research on PRP for rotator cuff tendinopathy shows promise, but results can vary by preparation method, injection technique, injury type, and patient factors. A systematic review and meta-analysis published in PLOS ONE found PRP to be safe and more effective for long-term shoulder pain symptoms and function associated with rotator cuff injury, while also calling for more standardized research (A. Hamid & Sazlina, 2021).

PFP, or platelet-free/platelet-poor plasma depending on clinic protocol, may be used as part of a broader biologic plan. MFAT, or microfragmented adipose tissue, uses processed fat tissue to support damaged joints and soft tissues. These therapies should be performed only after proper evaluation and medical oversight.

Shockwave Therapy and MLS Laser Therapy

Shockwave therapy uses acoustic energy to stimulate tissue response, improve circulation, and support tendon healing. A 2024 systematic review and meta-analysis found that extracorporeal shockwave therapy may improve function in rotator cuff tendonitis and may help pain in upper-limb tendonitis, with a low rate of adverse effects (Xiong et al., 2024).

MLS laser therapy and other photobiomodulation tools use light energy to support pain control and tissue recovery. Evidence on laser therapy varies by condition, dose, and treatment plan, but reviews suggest it may help pain and healing in some musculoskeletal conditions when used properly (Cotler et al., 2015).

Epidural Spinal Injections and IV Infusion Support

Some shoulder and arm pain starts in the neck. If a cervical nerve root is inflamed, pain may travel into the shoulder, arm, wrist, or hand. In those cases, an epidural spinal injection may be considered as part of a medical plan. Cleveland Clinic explains that epidural steroid injections place anti-inflammatory medicine around spinal nerves to treat pain caused by irritated or inflamed nerve roots (Cleveland Clinic, 2021).

IV infusion therapy may support hydration, electrolyte balance, and nutrient delivery. It should not replace orthopedic care, chiropractic care, rehabilitation, or emergency care. But in medically appropriate cases, IV therapy may support recovery by providing hydration and supplementing vitamins, minerals, and overall wellness needs.

Medical Oversight With Dr. Maria Guadalupe Cardenas, MD, and Dr. Alex Jimenez, DC

At Injury Medical Clinic PA in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, integrates chiropractic care, functional medicine, personal injury care, rehabilitation, and related services. His clinical observations, shared through DrAlexJimenez.com and LinkedIn, emphasize a whole-person approach that considers injury mechanics, inflammation, mobility, nutrition, diagnostics, and long-term function (Jimenez, n.d.-a; Jimenez, n.d.-b).

The practice also uses a medical-director model. Clinic materials list Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, as Medical Director and Collaborative Physician, with NPI #1164426749 and Texas MD License #J2933. Dr. Jimenez’s practice materials describe Dr. Cardenas as part of the medical oversight structure for multidisciplinary injury care (Jimenez, n.d.-c).

This setup is common in integrative and injury care clinics. The MD provides medical direction, safety oversight, and internal medicine perspective. The chiropractor and rehabilitation team focus on musculoskeletal function, movement restoration, and conservative injury recovery. Together, the team can better coordinate care for patients with shoulder pain, arm injuries, spine pain, nerve symptoms, and complex auto accident trauma.

A Clear Recovery Journey

A strong care plan often follows a simple path:

Find the injury. The team evaluates pain, motion, strength, nerve signs, and crash mechanics.
Control pain and inflammation. Care may include chiropractic support, soft-tissue work, laser, shockwave, or medical options.
Restore motion. The shoulder, neck, ribs, and upper back must move well together.
Support tissue healing. PRP, PFP, MFAT, or other options may be considered when appropriate.
Rebuild strength. Rehab helps the shoulder become stable again.
Return to daily life. The goal is safer lifting, driving, sleeping, working, and exercising.

When to Seek Care Right Away

A person should seek medical care quickly after a crash if they have:

Severe shoulder or arm pain
A visible deformity
Numbness or tingling
Weakness in the arm or hand
Chest pain or trouble breathing
Headache, dizziness, or confusion
Loss of shoulder motion
Pain that gets worse over time
Pain that wakes them at night
Bruising, swelling, or suspected fracture

Early care can help prevent stiffness, weakness, chronic pain, and delayed recovery.

Conclusion

Arm and shoulder injuries after auto accidents can involve the rotator cuff, collarbone, upper arm, shoulder joint, soft tissues, and nerves. These injuries may come from direct collision, seatbelt force, airbag impact, whiplash, or bracing against the steering wheel or dashboard.

Because the shoulder is complex, recovery often works best when care is coordinated. Chiropractic care can help restore motion. Rehabilitation can rebuild strength. Regenerative options like PRP, PFP, and MFAT may support tissue repair when appropriate. Shockwave, MLS laser therapy, spinal decompression, Graston, cupping, IV infusion support, and epidural spinal injections may also play a role depending on the injury.

At Injury Medical Clinic PA in El Paso, the collaboration between Dr. Alex Jimenez, DC, and Dr. Maria Guadalupe Cardenas, MD, reflects a multidisciplinary care model that combines chiropractic treatment, medical oversight, functional medicine, personal injury care, and rehabilitation. For people recovering after a crash, that kind of integrated plan can help connect the dots between pain relief, healing, documentation, and a safer return to normal life.

The road to Recovery "Chiropractic Care" | El Paso, Tx (2023)

References

A. Hamid, M. S., & Sazlina, S. G. (2021). Platelet-rich plasma for rotator cuff tendinopathy: A systematic review and meta-analysis. PLOS ONE, 16(5), e0251111.

Alexander Orthopaedics. (2023, April 21). 5 common shoulder injuries from a car accident.

American Academy of Orthopaedic Surgeons. (n.d.). Shoulder dislocation.

Bupa. (n.d.). Rotator cuff injuries and tears: Treatments and symptoms.

Cleveland Clinic. (2021, December 29). Epidural steroid injection (ESI): What it is, benefits, risks & results.

Cleveland Clinic. (2025, February 21). Soft tissue injury: What it is, types, causes & treatment.

Complete Care. (2025, March 17). Hand, wrist, and shoulder pain after a car accident.

Cotler, H. B., Chow, R. T., Hamblin, M. R., & Carroll, J. (2015). The use of low-level laser therapy (LLLT) for musculoskeletal pain. MOJ Orthopedics & Rheumatology, 2(5), 00068.

Dominguez Firm. (n.d.). Shoulder injuries caused by car accidents.

Hull & Zimmerman, P.C. (2025, September 25). Shoulder injuries after a car accident.

Jimenez, A. (n.d.-a). El Paso, TX chiropractor Dr. Alex Jimenez, DC.

Jimenez, A. (n.d.-b). Dr. Alexander Jimenez, DC, APRN, FNP-BC, IFMCP, CFMP, ATN.

Jimenez, A. (n.d.-c). Car accident specialist in El Paso, TX.

Johns Hopkins Medicine. (n.d.). Platelet-rich plasma (PRP) injections.

Xiong, Y., Peng, L., Huang, F., & others. (2024). Efficacy and safety of extracorporeal shock wave therapy for upper limb tendonitis: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine, 11, 1394268.

Integrated Posture Care Combining Multiple Therapies

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Building the Future of Doctor-Integrated Medicine Today

Integrated Posture Care: How Chiropractic, Spinal Decompression, PRP, PFP, mFAT, Shockwave, and MLS Laser Therapy Work Together

Poor posture is more than a bad habit. Over time, it can place stress on the muscles, ligaments, discs, joints, and nerves that help hold the spine upright. When the head moves forward, the shoulders round, or the lower back loses support, the body must work harder to stay balanced. This extra work can cause muscles to weaken, tighten, shorten, or develop tiny microtears. Ligaments can also become overstretched or irritated, making it harder for the spine to stay stable.

This is why posture problems often need more than one type of care. Chiropractic adjustments and spinal decompression may help improve movement and reduce pressure on spinal structures. Regenerative therapies such as platelet-rich plasma (PRP), platelet-free plasma (PFP), and micro-fragmented adipose tissue (mFAT) may help support the tissues that hold the spine together. MLS laser therapy and shockwave therapy may also help reduce inflammation, improve blood flow, and support tissue repair (Ospina Medical, 2025; Wiederholz, 2025).

These therapies do not “correct posture” by themselves. Instead, they help create the mechanical and biological conditions the body needs to heal, move better, and hold healthier alignment.

Why Poor Posture Can Cause Pain

Good posture keeps the head, shoulders, spine, hips, knees, and feet working together. Poor posture changes that balance. When one part of the body shifts out of place, other areas must compensate.

Common posture problems include:

Forward head posture
Rounded shoulders
Tight chest muscles
Weak upper back muscles
Flattened or overarched lower back
Tight hip flexors from long sitting
Uneven shoulders or hips
Neck, back, or sciatic pain

Research on postural kyphosis found that chiropractic spinal manipulation combined with stretching and strengthening exercises produced the greatest improvement in posture compared with either approach alone (Branco & Moodley, 2016). This supports a key idea: posture care works best when paired with active rehabilitation.

The Real Goal: Better Support for the Spine

The spine is not held in place by bones alone. It depends on muscles, ligaments, discs, fascia, tendons, and the nervous system. When these tissues become irritated or damaged, a person may find it difficult to “stand up straight” even when they try.

That is why posture treatment should not only focus on appearance. The deeper goal is to improve:

Joint motion
Spinal stability
Muscle balance
Nerve function
Tissue healing
Pain control
Movement confidence

A multidisciplinary approach may be beneficial when pain, inflammation, ligament laxity, disc pressure, or tissue damage makes postural correction more difficult.

Chiropractic Adjustments: Restoring Joint Motion

Chiropractic care focuses on the spine, joints, muscles, and nervous system. When spinal joints are stiff or not moving well, nearby muscles may tighten to protect the area. This can lead to pain, poor mobility, and more postural stress.

Chiropractic adjustments are designed to restore joint motion and improve mechanical function. In posture care, adjustments may help reduce restricted movement, allowing the body to respond better to stretching, strengthening, decompression, and rehabilitation.

Posture-focused chiropractic care may include:

Spinal adjustments
Soft tissue work
Corrective exercises
Posture education
Ergonomic coaching
Movement retraining

Chiropractic care may also complement regenerative care by helping reduce mechanical strain on healing tissues (The Center for Integrative and Functional Health and Wellness, n.d.).

Spinal Decompression: Reducing Pressure on Sensitive Structures

Spinal decompression uses gentle stretching forces to reduce pressure on spinal discs, joints, and irritated nerves. It is often used for patients with disc-related back pain, bulging discs, or sciatica symptoms.

When the spine is compressed from poor posture, prolonged sitting, injury, or muscle imbalance, discs and nerves can become irritated. Decompression may help create more space and reduce mechanical pressure. This can make it easier for patients to move, exercise, and participate in postural rehabilitation.

Spinal decompression is not a stand-alone cure. It works best when paired with movement correction, strengthening, chiropractic care, and lifestyle changes.

PRP, PFP, and mFAT: Biological Support for Damaged Tissue

Regenerative medicine focuses on helping the body’s natural repair systems work better. In posture-related spinal problems, the target may include irritated ligaments, tendons, joints, discs, or soft tissues.

PRP uses a patient’s own platelets, which contain growth factors that may support tissue repair. PFP is a platelet-based plasma preparation that may be used as part of a biologic treatment plan. mFAT uses micro-fragmented adipose tissue, which may provide a natural tissue scaffold and signaling support for damaged structures.

These therapies may be considered when chronic poor posture has contributed to:

Ligament strain
Tendon irritation
Joint degeneration
Disc-related pain
Chronic spinal instability
Soft tissue overload

Regenerative therapies do not replace chiropractic care. They may enhance it by supporting tissues that structural care alone cannot fully rebuild (APEX Biologix, 2026).

Epidural Spinal Injections: Calming Severe Nerve Irritation

Epidural spinal injections are often used when nerve inflammation is a major part of the problem. This may include radiating pain, sciatica, numbness, tingling, or severe nerve irritation.

When nerve pain is severe, patients may avoid movement. This can further weaken muscles and worsen posture. By reducing nerve-related pain and inflammation, epidural injections may help a patient become more active in rehabilitation.

These injections are usually part of a larger plan. They may help calm pain enough for the patient to begin strengthening, walking, stretching, and correcting movement habits.

Shockwave Therapy: Priming the Tissue

Shockwave therapy uses acoustic waves to stimulate tissues. It may help improve blood flow, break down scar-like restrictions, support collagen activity, and activate local healing pathways. Some clinical sources describe shockwave as a way to “prime” tissue before or after PRP or similar regenerative injections (Carolina Non-Surgical Orthopedics, n.d.; Ospina Medical, 2025).

For posture-related pain, shockwave therapy may be used around tight, irritated, or chronically overloaded tissues. It may be helpful when tissues have poor circulation or have become stiff from long-term stress.

In a combined plan, shockwave therapy may help prepare the tissue environment, so regenerative care can work more effectively.

MLS Laser Therapy: Reducing Inflammation and Supporting Repair

MLS laser therapy is a form of photobiomodulation. It uses light energy to support cellular activity, reduce inflammation, and improve tissue repair. In regenerative spine care, MLS laser therapy may be used after procedures to reduce swelling, soreness, and discomfort (Wiederholz, 2025).

Laser therapy may also support oxygen delivery and cellular energy production, which are important for healing. In a posture plan, MLS laser therapy may help calm irritated tissues, allowing patients to move better and participate in rehab.

Why the Combination Matters

Each therapy has a different job.

Chiropractic care helps improve movement and alignment. Spinal decompression helps reduce pressure. PRP, PFP, and mFAT help support tissue repair. Epidural injections help calm severe nerve irritation. Shockwave therapy may improve circulation and tissue response. MLS laser therapy may reduce inflammation and support healing.

Together, these therapies may help create a better healing environment by addressing both sides of the problem:

The mechanical side: joint movement, spinal pressure, posture, and alignment
The biological side: inflammation, tissue quality, ligament support, and healing capacity

This is important because posture problems often involve both. A person may know how to stand correctly but may not be able to hold that position because pain, weakness, inflammation, or tissue damage gets in the way.

The El Paso Multidisciplinary Model

At Injury Medical Clinic PA in El Paso, Texas, this type of care can be understood through a multidisciplinary model. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, integrates chiropractic care, functional medicine, personal injury care, rehabilitation, and related services. His clinical materials describe a practice focus that includes chiropractic, personal injury, auto accident care, spine care, sports injuries, functional medicine, rehabilitation, and integrative health support (Jimenez, n.d.).

Dr. Maria Guadalupe Cardenas, MD, is listed in clinic materials as Board Certified in Internal Medicine, Medical Director, and Collaborative Physician, with NPI #1164426749 and Texas MD License #J2933. Public physician profile information also describes Dr. Cardenas as an internal medicine physician in El Paso with over 40 years of experience (Healthgrades, n.d.; Jimenez, 2026).

This kind of setup is common in integrative and injury care clinics. The chiropractor focuses on spinal mechanics, movement, posture, rehabilitation, and neuromusculoskeletal care. The medical director provides medical oversight, an internal medicine perspective, and collaborative support for services requiring medical supervision.

What a Patient-Centered Posture Plan May Include

A well-rounded posture plan may include:

A detailed history and physical exam
Posture and movement assessment
Neurological screening when needed
Imaging or diagnostic review when appropriate
Chiropractic adjustments
Spinal decompression
Corrective exercises
Core and hip strengthening
MLS laser therapy
Shockwave therapy
Regenerative medicine consultation
Functional medicine support
Ergonomic coaching
Personal injury documentation when needed

The goal is not to force the body into a perfect position. The goal is to help the body move better, heal better, and hold alignment with less pain.

The Role of Functional Medicine

Functional medicine may also support posture recovery. Chronic inflammation, poor sleep, stress, low activity, nutrient gaps, and metabolic problems can affect healing. If the body lacks adequate internal support, muscles and ligaments may recover more slowly.

Functional medicine may look at:

Nutrition
Hydration
Inflammation
Sleep
Stress load
Hormone balance
Blood sugar control
Recovery capacity

This matters because posture is not only a spine issue. It is a whole-body issue.

What Patients Should Understand

Patients should understand that posture correction takes time. Passive care may reduce pain, but long-term improvement usually requires active participation.

Helpful habits include:

Taking movement breaks during the day
Strengthening the upper back and core
Stretching the chest, hips, and neck
Setting screens at eye level
Avoiding long periods of sitting
Walking daily when safe
Following the care plan consistently

Regenerative therapies, chiropractic care, decompression, shockwave, and laser therapy can help create better healing conditions. However, posture improves most when patients also build strength and mobility and adopt better daily habits.

Final Thoughts

Poor posture can weaken muscles, strain ligaments, irritate nerves, and place uneven stress on the spine. When pain or tissue damage makes it difficult to maintain healthy alignment, a combined approach may provide stronger support than a single therapy.

Chiropractic care and spinal decompression address the mechanical side of posture. PRP, PFP, and mFAT may support the biological side by helping damaged tissues heal. Epidural injections may calm severe nerve irritation. Shockwave and MLS laser therapy may help improve the healing environment.

At Injury Medical Clinic PA in El Paso, Dr. Alex Jimenez and the multidisciplinary team, under the medical oversight of Dr. Maria Guadalupe Cardenas, MD, represent an integrative model that brings together chiropractic care, internal medicine oversight, functional medicine, personal injury care, and rehabilitation. This kind of coordinated care helps patients move from pain control toward better function, stronger posture, and long-term recovery.

Chiropractic: The Secret to Unlocking Mobility | El Paso, Tx (2023)

References

APEX Biologix. (2026, February 13). Why regenerative therapies belong in chiropractic practices.

Branco, K. C., & Moodley, M. (2016). Chiropractic manipulative therapy of the thoracic spine in combination with stretch and strengthening exercises, in improving postural kyphosis in women. Health SA Gesondheid, 21, 303-308.

Carolina Non-Surgical Orthopedics. (n.d.). PRP combined with shockwave therapy (ESWT + EPAT).

Healthgrades. (n.d.). Dr. Maria Cardenas, MD – Internist in El Paso, TX.

Jimenez, A. (n.d.). El Paso, TX family practice nurse practitioner and chiropractor: Dr. Alex Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN.

Jimenez, A. (2026). Dr. Maria Cardenas, MD (Board Certified Internal Medicine Specialist).

Jimenez, A. (n.d.). Regenerative therapies and shockwave treatment benefits.

Ospina Medical. (2025, August 29). Boosting PRP & stem cell results with laser and shockwave therapy.

Stem Cell Medical Center. (n.d.). Workplace ergonomics: Regenerative solutions for office-related spine issues.

The Center for Integrative and Functional Health and Wellness. (n.d.). Enhancing recovery with chiropractic care after stem cell treatment.

Wiederholz, M. (2025, October 1). The role of MLS laser therapy in regenerative spine care: A Q&A with Matthias Wiederholz, MD.

Inpatient Management Techniques for Gastrointestinal & Liver Care

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Delve into the complexities of inpatient management and its impact on improving health outcomes in liver and gastrointestinal function.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I walk you through practical, modern, evidence-based strategies for inpatient management of complex gastroenterology and hepatology problems. I present a clear, stepwise approach to triaging and treating upper and lower GI bleeding, optimizing anticoagulation decisions, and distinguishing cholangitis from choledocholithiasis. I also cover oropharyngeal versus esophageal dysphagia, severe ulcerative colitis and Crohn’s disease flares, acute pancreatitis care, and small bowel obstruction and fecal impaction strategies. On the hepatology side, I explain restrictive transfusion thresholds in cirrhosis; acute liver failure criteria and early N-acetylcysteine use; precipitating factors and treatments for hepatic encephalopathy; hepatorenal syndrome management; portal vein thrombosis; ascites management; and the difference between liver injury enzymes and liver function markers. Throughout, I show how our multidisciplinary team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas integrates chiropractic care, functional medicine, rehabilitation, and internal medicine oversight to support whole-person recovery and reduce readmissions, highlighting clinical observations and the latest findings from leading researchers.

Our Multidisciplinary Model: Medical Oversight and Integrative Care

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, my practice operates in a collaborative, integrative model common to injury and functional care clinics. Dr. Maria Guadalupe Cardenas, MD — Board Certified in Internal Medicine (NPI #1164426749, Texas MD License #J2933) — serves as our Medical Director and Collaborative Physician. With over 40 years of experience, Dr. Cardenas provides comprehensive medical direction, inpatient coordination, and evidence-based internal medicine guidance, while I direct integrative chiropractic and functional rehabilitation strategies. This structure allows an MD to provide medical oversight alongside a chiropractor, ensuring safety, coherence, and depth of care.

How We Integrate Care

Medical oversight (Internal Medicine, Dr. Cardenas): Diagnostic workup, hospital-to-ambulatory transitions, medication management, anticoagulation decisions, and procedural coordination.
Integrative chiropractic care (Dr. Jimenez): Mechanical assessment, regional interdependence modeling, spinal and extremity adjustments (as indicated), graded mobility, motor control retraining, and pain-modulating manual therapies.
Functional medicine: Nutrition optimization, microbiome balance, endocrine/metabolic drivers, inflammatory load reduction, validated testing, and targeted supplementation.
Rehabilitation: Dosage-specific exercise therapy for tissue capacity building; neuromuscular retraining; fascia and myofascial interventions; ergonomics and graded load management.
Personal injury care: Documentation, causation analysis, functional restoration, coordinated imaging, and safe recovery pathways.

This integrated approach reduces modifiable risks (e.g., NSAID exposure), improves physiologic resilience (nutrition, activity), and aligns endoscopic, pharmacologic, and rehabilitative care so patients recover faster and more safely.

Upper GI Bleeding: Triage, Physiology, and Endoscopic Strategy

I begin by distinguishing urgent upper GI bleeding from cases that are safe for expedited outpatient evaluation. Melena often suggests a proximal source, yet slow colonic transit in older adults can present right-sided colonic bleeding as melena. Melena can persist up to five days after bleeding stops. I correlate stool appearance with hemodynamics, symptoms, and serial hemoglobin.

Red Flags for Urgent Upper Source

Hemodynamic instability: presyncope/syncope, tachycardia, hypotension
Ongoing hematemesis or maroon/bright red hematochezia suggesting brisk upper source
Cirrhosis/portal hypertension, variceal risk
Rising BUN/Cr ratio from digested blood nitrogen load (Laine & Jensen, 2012)

Common Etiologies

Peptic ulcer disease, varices, portal hypertensive gastropathy
Malignancy, marginal ulcers post-Roux-en-Y
Mallory-Weiss tears
Pill esophagitis (e.g., doxycycline)

Why This Matters Physiologically

Blood digestion in the upper GI tract elevates BUN
Portal hypertension increases variceal rupture risk; vasoconstrictors reduce portal inflow.
NSAIDs inhibit COX, reducing mucosal prostaglandins and bicarbonate/mucus protection.

Immediate Management Priorities

Resuscitation: IV fluids, crossmatch; airway protection if ongoing hematemesis.
Pharmacologic hemostasis:

High-dose IV PPI to stabilize clots on exposed vessels (Laine & Jensen, 2012).
If varices suspected: octreotide infusion plus antibiotics to lower infection and rebleeding (Chavez-Tapia et al., 2013).

Medication reconciliation: I explicitly name OTC NSAIDs and combinations: ibuprofen, naproxen, meloxicam, aspirin, BC powder, Alka-Seltzer. Patients often omit these unless specifically asked.

Endoscopy Timing and Risk Stratification

Target EGD within 12–24 hours after stabilization for most admitted patients (Barkun et al., 2019).
Use Glasgow-Blatchford Score to guide admission vs. outpatient pathways. Low-risk profiles with normal hemoglobin and stable vitals may be suitable for outpatient evaluation.

When melena persists, but vitals and hemoglobin are stable, I consider residual blood transit; with dizziness or presyncope, I assume ongoing bleeding and non-diagnostic GD; if anemia is severe, I expand to colonoscopy or CT angiography. For obscure bleeding, I consider CT angiography and push enteroscopy to reach distal duodenum and proximal jejunum.

Lower GI Bleeding: Timing, Pain Clues, and Strategy

In lower GI bleeding, I ask early: has this happened before, can the patient prep for colonoscopy, and could hematochezia reflect brisk upper bleeding? Evidence supports measured timing: urgent (<24h) vs. elective (24–96h) colonoscopy often shows no significant difference in key outcomes when prep is optimized; rushing a poorly prepared exam is non-diagnostic (Laine et al., 2019; Strate et al., 2019).

Pain Guides Differential

Painless bleeding: diverticulosis, angiodysplasia, internal hemorrhoids
Painful bleeding: ischemic colitis, IBD, infectious colitis, malignancy

I match findings to physiology: a tiny, non-bleeding gastric erosion does not explain a hemoglobin level of 4 g/dL; I escalate imaging and colonoscopy as appropriate.

Anticoagulation During GI Bleeding: Balancing Risks

I weigh the thrombotic risk of holding anticoagulation versus the rebleeding risk of continuing it. Decisions hinge on indication (e.g., mechanical valve, high-risk AF), severity, timing of last dose, renal function, and concomitant NSAIDs/aspirin.

Reversal and Resumption

Warfarin: Vitamin K and 4-factor PCC for life-threatening bleeding (Tomaselli et al., 2017).
DOACs: idarucizumab (dabigatran); andexanet alfa or PCC for factor Xa inhibitors, guided by onset and renal status.
Restarting: For high-thrombotic-risk patients, I resume within 7 days after hemostasis, which reduces thromboembolic events and mortality while maintaining an acceptable rebleed risk (Qureshi et al., 2014).

In hospital, I sometimes use a heparin infusion bridge (short half-life) to test tolerance, enabling rapid reversal if rebleeding occurs.

Considering Alternatives

For AF patients with recurrent bleeding, I advocate discussing Watchman left atrial appendage closure as a pathway to reduce long-term anticoagulant dependence when appropriate.

Dysphagia: Oropharyngeal vs. Esophageal Pathways

I differentiate oropharyngeal dysphagia (difficulty initiating swallow, nasal regurgitation, coughing/choking) from esophageal dysphagia (food sticking sensation seconds after swallowing). Solids,s then liquids suggest mechanical stricture; liquids ± solids suggest motility disorder.

Oropharyngeal evaluation: bedside swallow, modified barium swallow for aspiration risk.
Esophageal workup: EGD for structural lesions, then manometry if needed (ASGE Standards of Practice Committee, 2014).

Mechanism guides care: oropharyngeal dysfunction demands swallow safety; esophageal pathology benefits from dilation, anti-reflux therapy, or motility-directed interventions.

IBD Flares: Steroids, Biologics, and Thromboprophylaxis

For severe ulcerative colitis, I start IV corticosteroids (e.g., methylprednisolone 60 mg/day). Non-response within 3–5 days triggers rescue therapy (infliximab or cyclosporine) (Rubin et al., 2019). For severe Crohn’s disease, I use systemic steroids for induction and consider early anti-TNF or other biologics based on phenotype.

Physiology: Corticosteroids suppress NF-κB and cytokine cascades; biologics target specific mediators to achieve mucosal healing and reduce complications.
Rule out infection (especially difficile) before escalating immunosuppression.
Monitor CRP daily and consider fecal calprotectin; use CT/MR enterography for complications.
Thromboprophylaxis: IBD carries high VTE risk; I prefer short-half-life heparin and rarely see worsening rectal bleeding.

A hospital flare is a turning point for optimizing maintenance biologic therapy, checking antibodies against current agents, and adjusting dosing frequency.

Acute Pancreatitis: Fluids, Nutrition, and Pain Control

I favor aggressive early IV fluids—Lactated Ringer’s — to reduce systemic inflammation compared with saline (de-Madaria et al., 2022). Under-dosing fluids is common; I titrate to perfusion goals. I apply multimodal pain control:

Scheduled NSAID (e.g., ketorolac if no contraindication, short duration)
Scheduled acetaminophen
Neuropathic agents (gabapentin/pregabalin) for sharp, stabbing pain
Opioids for breakthrough only

I start early enteral nutrition — even clear high-protein drinks — to maintain gut integrity and reduce bacterial translocation; I avoid prophylactic antibiotics unless infection is confirmed. I differentiate early fluid collections (rarely drained) from mature pseudocysts (>4 weeks old with a thick wall) w, for which endoscopic drainage is considered if symptomatic.

Cholangitis vs. Choledocholithiasis: Infection vs. Obstruction

Choledocholithiasis: CBD stone, cholestatic labs (alkaline phosphatase, GGT, bilirubin), dilated ducts on imaging.
Acute cholangitis: Infection superimposed on obstruction; Charcot’s triad (fever, RUQ pain, jaundice) and Reynolds’ pentad (hypotension, AMS) suggest sepsis (Kiriyama et al., 2018).

Cholangitis requires urgent antibiotics and ERCP within 24 hours to decompress the biliary tree (Buxbaum et al., 2021). Obstruction alone may need ERCP but is less time-sensitive; I use MRCP/EUS if diagnosis is uncertain (ASGE Standards of Practice Committee, 2019).

Root Causes of GUT DYSFUNCTION- Video

Root Causes of *GUT DYSFUNCTION* | El Paso, Tx (2021)

Mesenteric Ischemia and Ischemic Colitis: Watershed Physiology

In systemic hypotension (e.g., during dialysis) with vascular disease, the colon’s watershed regions (splenic flexure and rectosigmoid) are vulnerable. CT may show bowel wall thickening in these zones; colonoscopy reveals dusky, friable mucosa or deep ulcers.

Management:

Restore perfusion and blood pressure
Consider anticoagulation and vascular evaluation if occlusion suspected
Surgery for necrosis
Gentle laxatives (e.g., polyethylene glycol) to maintain soft stool and minimize intraluminal pressure.

Fecal Impaction: Imaging-Guided, Hands-On Care

I pull up imaging to localize impaction:

Right colon impaction: Oral laxatives to move stool; enemas are ineffective.
Rectal impaction: Digital disimpaction first; otherwise, enemas and suppositories fail. I use lubricants and may pre-soften with glycerin suppositories.

Post-clearance, I start a new bowel regimen; overflow diarrhea is common and should not lead to withholding laxatives.

Restrictive Transfusion Strategy: Cirrhosis-Specific Adjustments

I transfuse at hemoglobin <7 g/dL in most GI bleed and at 7–8 g/dL in cardiovascular disease or symptomatic anemia (Villanueva et al., 2013). In cirrhosis with variceal bleeding, I target 7–8 g/dL, avoid excessive volume, and correct coagulopathy judiciously (Tripathi et al., 2015). Over-transfusion increases portal pressure and rebleeding.

Acute Liver Failure: Early Definition and NAC

I apply the following criteria: evidence of liver injury (elevated aminotransferases), INR ≥1.5, any encephalopathy, and onset within 26 weeks without preexisting cirrhosis (Lee, 2012). I act early: identify the etiology (e.g., acetaminophen toxicity), start N-acetylcysteine (NAC), manage the risk of cerebral edema and hypoglycemia, and refer early to transplant centers. NAC replenishes glutathione, limiting oxidative damage; I monitor for rare hypersensitivity.

Hepatic Encephalopathy: Precipitants and Treatment

Common precipitants:

Infection (SBP, UTI, pneumonia)
GI bleeding (nitrogen load)
Electrolyte disturbances (hypokalemia, metabolic alkalosis)
Constipation, sedatives, dehydration, renal dysfunction

Treatment:

Lactulose titrated to 2–3 soft stools/day; I set hold parameters to avoid dehydration and electrolyte loss.
Rifaximin to reduce ammonia-producing flora; prevents recurrence when added to lactulose (Bass et al., 2010).
Nutrition: Adequate protein — I avoid overrestriction; plant and dairy proteins may produce less ammonia.

I counsel on driving safety due to cognitive effects; a local DMV assessment may be warranted.

Hepatorenal Syndrome (HRS): Pathophysiology and Therapy

Splanchnic vasodilation reduces effective arterial blood volume, triggering renal vasoconstriction and a decrease in GFR without structural damage. I use albumin to expand plasma volume and vasoconstrictors:

Terlipressin (first-line where available); alternatives include norepinephrine in ICU or midodrine/octreotide combinations (Angeli et al., 2015).
Address infections, hold nephrotoxins; consider TIPS and transplant

Ascites and Portal Hypertension Complications

I confirm portal hypertensive ascites with SAAG; I avoid fluid restriction unless sodium <120 mEq/L. I start morning diuretics (e.g., furosemide 40 mg plus spironolactone 100 mg) and titrate to minimize nocturia. For recurrent variceal bleeding, I perform serial banding and initiate non-selective beta-blockers; I favor carvedilol for its dual beta- and alpha-1-adrenergic effects, which reduce portal pressure and improve outcomes. For refractory cases, I consider early TI, PS ideally when MELD <18.

Portal Vein Thrombosis (PVT): When to Anticoagulate

I evaluate sudden decompensation (new ascites/encephalopathy) with Doppler ultrasound and CT/MRI to define extent and exclude malignant thrombus. Elevated INR does not protect against clotting. I generally avoid hypercoagulable workups in cirrhosis due to poor interpretability.

Chronic occlusive PVT with cavernous transformation: focus on portal hypertension management and variceal screening; anticoagulation often not recommended.
Acute PVT with ischemic symptoms: consider anticoagulation (DOACs selected on a case-by-case basis), sometimes without induction dosing to limit bleeding risk; follow with repeat imaging at 3–6 months (Northup et al., 2021).

Liver Enzymes vs. Liver Function: The Right Lens

Liver injury markers, ALT and AST, reflect hepatocellular injury.
Cholestatic markers: Alkaline phosphatase, GGT reflect bile duct involvement.
Function indicators: Bilirubin, albumin, INR reflect excretory and synthetic function. True function is better captured by bilirubin and INR than aminotransferases.

I use the R-factor to classify injury patterns:

R = (ALT / ALT ULN) / (Alk Phos / Alk Phos ULN)

R > 5: hepatocellular
R < 2: cholestatic
R 2–5: mixed

Aminotransferases in the thousands point to ischemic hepatitis, acute viral hepatitis, or severe DILI (e.g., acetaminophen). I reserve liver biopsy for diagnostic uncertainty or suspected autoimmune hepatitis with high-titer serologies.

I take meticulous histories, calling the pharmacist and explicitly asking about nonprescription supplements. I frequently see “liver cleanse” products cause DILI in patients told they have fatty liver.

Peptic Ulcer Disease: Root-Cause Strategy and Lifelong PPI in Select Patients

I ask: what truly caused the ulcer? NSAIDs, H. pylori, and pill esophagitis are common drivers.

For NSAID-related ulcers, I switch to COX-2 selective agents and add PPI gastroprotection when high-risk. I emphasize non-NSAID pain plans — triptans when appropriate, magnesium, neuromodulators — and for osteoarthritis, structured exercise, weight management, topical NSAIDs, duloxetine, and targeted manual therapy.
I test and treat pylori per ACG guidance and confirm eradication (Chey et al., 2017).
For pill esophagitis, I counsel on upright dosing with water and avoiding recumbency for 30–60 minutes; I consider alternatives for high-risk patients.

In large hiatal hernias with CCameron’sulcers, I strongly advocate lifelong PPI when surgery is not feasible, especially if the patient requires long-term anticoagulation.

Integrative Chiropractic Care: Supporting GI and Liver Recovery

My integrative chiropractic and rehab methods complement medical therapy:

Pain modulation without systemic NSAIDs: By improving joint mechanics, segmental mobility, and neuromuscular control, I reduce reliance on ulcerogenic medications — crucial post-bleed or in portal hypertension.
Autonomic balance: Gentle, evidence-informed spinal manipulation and soft-tissue techniques can modulate sympathetic overactivity, influencing visceral pain and motility through visceral-somatic reflexes. Not a replacement for medical care, but a potent adjunct.
Respiratory and rib mechanics: Optimized thoracic mobility supports diaphragmatic function, venous/lymphatic return, and reduces intra-abdominal pressure spikes that exacerbate reflux or portal pressures during strain.
Graded exercise prescription: Enhances endothelial function, insulin sensitivity, and muscle mass, mitigating sarcopenia in cirrhosis and aiding NAFLD/MASLD
Functional medicine support: Targeted nutrition, protein adequacy, fiber modulation, and microbiome-informed strategies complement lactulose/rifaximin regimens and support mucosal healing in IBD.

Under Dr. Cardenas’ oversight, we align manual therapy timing with anticoagulation and bleeding risks, monitor anemia and fluid-electrolyte status, and coordinate progression after ERCP or endoscopic therapy.

Clinical Observations and Practical Pathways

From complex radiculopathy to sciatica, patients often self-medicate with OTC NSAIDs they do not disclose unless specifically named. I emphasize explicit medication reconciliation and non-NSAID pain plans to reduce GI risk while preserving function (clinical notes at sciatica. clinic; LinkedIn: Dr. Alex Jimenez). In older adults, slow transit can mislead clinicians to an upper source when right-sided angiodysplasia is the culprit; early non-diagnostic after nondiagnostic EGD reduces length of stay and anesthesia exposure. For hepatic encephalopathy, caregiver engagement and lactulose titration education consistently lower readmissions; we integrate nutrition coaching to sustain outcomes.

Putting It All Together: A Practical Inpatient Pathway

Initial assessment

- Stabilize airway, breathing, circulation; check orthostatics.
- Identify red flags for brisk upper GI bleeding.
- Order CBC, CMP, INR, type and screen/crossmatch; consider BUN/Cr ratio.
- Start high-dose IV PPI; add octreotide and antibiotics if varices suspected.

Risk stratify and plan endoscopy

- Use validated bleeding scores to guide level of care and timing.
- Target EGD within 12–24 hours; consider early colonoscopy prep when colonic source suspected or EGD unlikely to explain severity.

Medication and cause analysis

- Conduct granular OTC and supplement review; test for pylori.
- Adjust or reverse anticoagulation per agent and severity; plan resumption based on thrombotic risk and hemostasis.

Hepatology-specific steps

- Restrictive transfusion strategy (Hb 7–8 g/dL); avoid overcorrection in variceal bleeds.
- Screen and treat precipitating factors for hepatic encephalopathy; lactulose plus rifaximin when indicated.
- Evaluate for HRS if renal function declines in advanced liver disease; initiate albumin and appropriate vasoconstrictors.
- Consider acute liver failure criteria; start NAC when indicated and refer early to transplant-capable centers.

Integrative overlay

- Implement non-NSAID pain strategies, targeted manual therapy, and graded exercise.
- Provide nutrition support for mucosal healing and protein adequacy.
- Coordinate close outpatient follow-up under Cardenas’oversight to align medical and chiropractic care.

This comprehensive, integrative model shortens recovery timelines, reduces avoidable readmissions, and delivers practical strategies that fit real-world needs.

References

Author and Clinical Insights

Clinical insights and patient education: https://sciatica.clinic/
Professional profile: https://www.linkedin.com/in/dralexjimenez/

SEO tags: upper GI bleeding, melena vs hematochezia, proton pump inhibitor therapy, octreotide variceal bleeding, choledocholithiasis vs cholangitis, urgent ERCP timing, dysphagia workup, oropharyngeal vs esophageal dysphagia, ulcerative colitis severe flare, CCrohn’sdisease inpatient steroids, anticoagulation reversal GI bleed, restrictive transfusion strategy, cirrhosis transfusion threshold, acute liver failure criteria, hepatic encephalopathy lactulose rifaximin, hepatorenal syndrome albumin vasoconstrictors, liver enzymes vs liver function, integrative chiropractic care GI, functional medicine gastroenterology, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, Cameron’s ulcers, Watchman procedure, mesenteric ischemia watershed, fecal impaction disimpaction, acute pancreatitis lactated Ringer’s, carvedilol portal hypertension, TIPS procedure, portal vein thrombosis

Sciatica Pain Relief in El Paso with Regenerative Methods

Dr Alexander D Jimenez DC, APRN, FNP-BC, CFMP, IFMCP

Sciatica Pain Relief in El Paso: How PRP, mFAT, PFP, and Regenerative Epidurals Work with Chiropractic Care

Sciatica can make everyday life hard. The sharp pain, tingling, or numbness that shoots from the lower back down one leg often comes from pressure on the sciatic nerve. This nerve starts in the lower spine, travels through the buttocks, and runs down each leg. Common causes include bulging or herniated discs, tight ligaments, or spinal stenosis that pinch or irritate the nerve.

Many people want options beyond strong pain pills or surgery. Regenerative and biologic treatments offer a different path. These approaches calm nerve swelling and support the body’s own repair of damaged spinal discs and ligaments. When combined with chiropractic care, they create a layered plan that addresses both the inflammation and the mechanical problems causing the pain.

At clinics like Injury Medical Clinic PA in El Paso, Texas, doctors use these methods under careful medical oversight. The goal is real healing, not just temporary relief.

How These Treatments Fight Sciatica

Spinal discs and ligaments have very little natural blood flow. This makes it tough for the body to send healing cells and nutrients to injured areas on its own. Injections deliver concentrated repair signals directly to the problem spots. Chiropractic adjustments and supportive therapies then improve blood flow and joint mobility, allowing healing signals to work more effectively.

The result is a complete approach: calming the irritated nerve, supporting tissue repair, and restoring proper spinal mechanics.

PRP (Platelet-Rich Plasma) Injections

PRP uses a high concentration of platelets taken from your blood. Platelets contain growth factors that tell the body to reduce swelling around nerves and help repair torn or degenerated discs and ligaments.

Key points about PRP:

Doctors draw a small amount of your blood and spin it in a centrifuge to separate and concentrate the platelets.
The PRP is then injected, often with imaging guidance, near the irritated nerve or into damaged disc or ligament tissue.
Growth factors released by platelets help calm nerve inflammation and, in some cases, encourage disc material to heal or resorb more quickly.
Many patients experience longer-lasting pain relief compared to traditional steroid shots because the treatment supports actual tissue repair instead of only masking symptoms.

A 2023 systematic review and meta-analysis of randomized trials found that PRP injections significantly reduced chronic low back pain at 1, 3, and 6 months after treatment compared with control groups. The treatment was well tolerated, with no major differences in side effects.

PRP offers a natural option that uses your body’s own healing tools.

PFP (Platelet-Fibrin Products)

PFP, sometimes called platelet-rich fibrin or similar fibrin-based products, builds on the concept of PRP by adding a natural scaffold. This fibrin matrix acts like a supportive framework that stays in place and slowly releases growth factors over time.

Key points about PFP:

It creates a stable structure that holds healing signals in the treated area longer than standard PRP alone.
The sustained release helps repair damaged ligaments and discs that may be pressing on the sciatic nerve.
Doctors often use PFP when longer-term structural support is needed alongside control of inflammation.
Because it comes from your own blood, it carries a very low risk of allergic reaction or rejection.

This scaffold approach allows the body more time to rebuild supportive tissues around the spine.

mFAT (Microfragmented Adipose Tissue)

mFAT uses a small amount of your own fat tissue, usually taken from the abdomen or thigh area through a gentle lipoaspiration procedure. The fat is processed into tiny fragments that contain mesenchymal stem cells, immune cells, and other regenerative factors.

Key points about mFAT:

The processed fat acts as both a cushion and a source of active cells that help rebuild degenerated discs and joints.
It helps stop ongoing inflammation while supporting tissue repair in areas with poor blood supply.
Injections are guided by ultrasound or X-ray for precise placement.
Many patients notice gradual improvement over weeks to months as the cells work to restore function and reduce pain.

mFAT provides the body with extra building blocks and protective cells exactly where the sciatic nerve is irritated by damaged spinal structures.

Traditional and Regenerative Epidural Injections

Epidural injections deliver medication into the space around the spinal nerves. They are a common tool for quick relief when sciatica pain becomes severe.

Traditional epidural injections usually contain a corticosteroid (steroid) and a numbing medicine. The steroid quickly reduces swelling around the nerve root, which can ease pain, tingling, and weakness within days. This option works well for quick relief, so patients can resume physical therapy or daily activities. However, steroids primarily reduce inflammation temporarily. They do not repair the underlying disc or ligament damage, and repeated use can cause side effects such as changes in blood sugar or bone thinning.

Regenerative epidurals replace or combine steroids with orthobiologics like platelet lysate (a processed form of PRP). Platelet lysate releases growth factors that calm nerve inflammation and promote tissue healing. This version avoids many steroid side effects and supports longer-term recovery of the spinal structures pressing on the sciatic nerve.

Both types are done with imaging guidance for safety and accuracy.

Combining Regenerative Treatments with Chiropractic Care

Injections alone can calm the nerve and start healing. Chiropractic care adds the mechanical piece. Gentle spinal adjustments restore proper joint movement and reduce pressure on the sciatic nerve caused by misalignment or tight muscles. Therapies like shockwave treatment further boost local blood flow, helping the healing factors from injections reach deep spinal tissues more effectively.

This integrative method solves a key problem: discs and ligaments heal slowly because of limited blood supply. Injections deliver concentrated repair signals. Chiropractic care and related therapies improve circulation and alignment so those signals can do their job. Patients often report better mobility, less pain, and improved daily functioning when both approaches are used together.

Rather than choosing one treatment, many people benefit from a personalized plan that layers these options based on their specific imaging, symptoms, and goals.

Expert Multidisciplinary Care in El Paso

At Injury Medical Clinic PA in El Paso, Texas, patients receive coordinated care from a team experienced in spine and nerve conditions. Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, brings more than 35 years of chiropractic experience plus advanced nurse practitioner training. His clinical observations emphasize whole-person care that addresses root causes such as disc damage, ligament strain, inflammation, and mechanical stress on the sciatic nerve. He has helped thousands of patients, including those with personal injuries and chronic spinal issues, using evidence-based, multimodal approaches that combine regenerative therapies with chiropractic and functional medicine.

Working alongside him is Dr. Maria Guadalupe Cardenas, MD, a board-certified internist with over 40 years of experience (NPI #1164426749, Texas MD License #J2933). She serves as Medical Director and Collaborative Physician, providing medical oversight, safety review, and guidance for procedures such as injections. This MD-chiropractor collaboration is common in integrative and injury-focused clinics. It allows advanced regenerative treatments to be performed safely while chiropractic care restores movement and function.

The team also incorporates functional medicine principles, rehabilitation, and personalized plans. This setup supports patients who want to avoid or delay surgery and reduce reliance on long-term medications.

A Clear Path Forward

Sciatica does not have to control your life. PRP, PFP, mFAT, and regenerative epidural options target both the inflammation that irritates the sciatic nerve and the damaged discs or ligaments that cause the pressure. When paired with chiropractic care that improves alignment and blood flow, these treatments offer a comprehensive, non-surgical strategy focused on healing and lasting relief.

If you are dealing with ongoing sciatica pain in the El Paso area, learning more about these integrative options can help you make informed decisions. A thorough evaluation, including imaging and clinical assessment, allows the care team to recommend the right combination for your situation.

Sciatic Nerve Pain Treatment El Paso, TX Chiropractor

References

El Paso Chiropractor Blog. (2026, June). Integrative chiropractic and regenerative medicine in El Paso: A modern path for spine, joint, and injury recovery. https://www.elpasochiropractorblog.com/2026/06/integrative-chiropractic-and.html

Injury Medical Clinic PA. (n.d.). Regenerative medicine options for spinal health. https://healthcoach.clinic/regenerative-medicine-options-for-spinal-health/

Integrative Rehab Medicine. (n.d.). Treating the spine and nerves with PRP (platelet lysate) epidural injections. https://irehabmed.com/treating-the-spine-and-nerves-with-prp-platelet-lysate-epidural-injections/

Naples Regenerative Institute. (n.d.). How PRP can treat your sciatica. https://www.naplesregenerativeinstitute.com/blog/how-prp-can-treat-your-sciatica

Orthopedic & Sports Injury Specialists. (n.d.). Understanding the role of epidural injections in spine pain management. https://www.osistl.com/blog/understanding-the-role-of-epidural-injections-in-spine-pain-management

Singjie, L. C., Kusuma, S. A., Saleh, I., & Kholinne, E. (2023). The potency of platelet-rich plasma for chronic low back pain: A systematic review and meta-analysis of randomized controlled trial. Asian Spine Journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC10460651/

Spine Center Atlanta. (n.d.). What is microfragmented adipose tissue or mFAT treatment? https://spinecenteratlanta.com/what-is-microfragmented-adipose-tissue-or-mfat-treatment/

University of Iowa Hospitals & Clinics. (n.d.). Microfragmented adipose tissue (MFAT). https://uihc.org/services/microfragmented-adipose-tissue-mfat

1...345...162 Page 4 of 162